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U S T T R O D U C T I I : СИМ 
1. GENERAL ASPECTS OF LIPOPROTEINS 
The plasma lipoproteins represent spherical macromolecular 
complexes consisting of lipids and specific proteins termed 
apolipoproteins. Their major function is the transport of 
hydrophobic lipids of dietary or endogenous origin within the 
hydrophilic environment of the plasma to the tissues which 
utilize the constituent fatty acids or cholesterol for 
oxidative metabolism (heart and skeletal muscle), 
triglyceride synthesis .for storage of energy (adipose 
tissue), or maintenance of cellular function and membrane 
integrity (1). 
By ultracentrifugation the lipoproteins can be separated 
into different classes. The largest and least dense particles 
are the chylomicrons which originate in the intestine and 
carry dietary lipids and consist mainly of triglycerides. 
They are normally not present in fasting serum. The very low 
density lipoproteins (VLDL) are secreted by the liver and are 
also triglyceride-rich (1). VLDL are sequentially lipolyzed 
by the action of lipoprotein lipase to form VLDL-remnants or 
intermediate density lipoproteins (IDL). These particles are 
then partly rapidly removed from the circulation by the liver 
and partly converted to low density lipoproteins (LDL), which 
are then cleared from the circulation (2, 3, 4) (Fig. 1). 
The high density lipoproteins (HDL) originate from both the 
intestine and the liver (5). The exact function of HDL is not 
yet completely understood. They are probably involved in the 
so called reverse cholesterol transport. They may accept 
cholesterol from extrahepatic tissues and transfer it to the 
liver or to other lipoproteins (VLDL and LDL) which are 
subsequently taken up by the liver (6). 
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Recently, a "new" lipoprotein, lipoprotein(a) (Lp(a)) or 
sinking pre-ß, has gained much interest, especially by the 
discovery of different "phenotypes" by Utermann et al. (7) 
and the elucidation of the structure of its protein component 
(8). Lp(a) closely resembles LDL in lipid composition and in 
the presence of apolipoprotein B-100. The distinguishing 
feature of Lp(a) is the presence of apolipoprotein(a) bound 
to apo B-100 by a disulphide linkage (9, 10). 
B-100 
Production 
of VLDL 
Removal of 
VLDL remnants 
Lipolysls 
of VLDL 
e> 
Conversion of 
VLDL remnants 
to LDL 
Other Sites 
Fig. 1. Major steps in the metabolism of lipoproteins containing 
apolipoprotein B-100. Production of VLDL apo B-100 is by the liver. 
Lipolysis of VLDL-triglycerides occurs via lipoprotein lipase. The 
resultant VLDL remnants, or IDL, can have two fates. They can be cleared 
by the liver via apo B-100, E receptors or be converted to LDL. LDL 
likewise can be removed by the same receptors, either in the liver or 
extrahepatic tissues. Reprinted with permission of the J. Lipid Res. 
from: S.M. Grundy, J. Lipid Res. 1984; 25: 1611-1618, Fig. 1. 
4 
1.1. Structure and function of LDL 
LDL are isolated by ultracentri fugation in the density 
range of 1.019-1.063 g/ml. In general, lipids comprise 75 % 
of the mass of the LDL particle and protein makes up 25 % 
(11). About 60 % of the mass of LDL lipid consists of 
cholesterol (approximately 80 % in the form of cholesteryl 
ester and the remaining 20 % as free cholesterol). 
Apolipoprotein В is the principal protein component of LDL as 
reviewed by Kane (12). In electrophoresis on agarose gel or 
other supporting media the majority of LDL comigrate with ß-
globulines. Thus, LDL is commonly referred to as ß-
lipoprotein. Under electron microscopy LDL appear as globular 
particles 20-25 nm in diameter. A variety of structural 
models have been proposed for LDL. In general, it is assumed 
that the cholesteryl esters and triglycerides form the 
hydrophobic core, which is surrounded by a surface coat of 
apolipoprotein B-~100, a protein with a molecular mass of 
approximately 514,000 (13), and phospholipids with the polar 
head oriented towards the aqueous medium (14). Physico-
chemical investigations employing small-angle X-ray 
scattering and "C-Nuclear Magnetic Resonance (NMR) have 
shown that the configuration of the cholesteryl esters in the 
core of the LDL is temperature dependent and may alternate 
between concentric layering at 10 °C and a random 
configuration at 45 "С (15, 16). The main function of LDL is 
to deliver cholesterol to the liver and peripheral cells by 
means of receptor-mediated endocytosis as reviewed by 
Goldstein and Brown (17). 
1.2. Catabolism of LDL by liver cells, peripheral cells and 
macrophages 
A specific cell surface receptor for LDL was initially 
described for cultured human fibroblasts by Goldstein and 
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Brown (18). The existence of these LDL receptors has later 
been demonstrated for smooth muscle cells of the arterial 
wall (19), endothelial cells (20), lymphocytes (21) and 
hepatocytes (22). The LDL receptors, also called apo B,E 
receptors because they recognize LDL apolipoprotein B-100 as 
well as apolipoprotein E, play an important role in the 
clearance of LDL particles from the circulation (Fig. 2). 
The liver may be responsible for about 75 % of the total 
plasma LDL clearance by LDL receptors (23). This is best 
illustrated by the improved clearance of LDL from the plasma 
and near normalization of the plasma LDL-cholesterol 
concentration after liver transplantation in patients with 
homozygous familial hypercholesterolemia (defect in the 
expression of the LDL receptors) (24, 25). Furthermore, the 
LDL receptors perform a key function in precisely regulating 
cholesterol metabolism in the tissues and prevent an 
overaccumulation of cholesterol in the cells. (17, 26). After 
interaction with the receptor, a LDL particle becomes 
internalized and after dissociation of the receptor from the 
endosomes, LDL is delivered to the lysosomes. The protein 
component of LDL is then nearly completely degraded to its 
constituent amino acids whereas the cholesteryl esters are 
hydrolyzed to free cholesterol. The cells are able to control 
their levels of free cholesterol by means of three regulatory 
mechanisms which counteract the increase of the cholesterol 
concentration, thereby assuring an adequate supply of the 
sterol while at the same time preventing its 
overaccumulation: 1. The activity of the key enzyme in de 
novo synthesis of cholesterol 3-hydroxy~3~methylglutaryl-
coenzyme A reductase (HMG-CoA reductase) is suppressed (27). 
2. The activity of acyl-coenzyme A: cholesterol-
acyltransferase (ACAT) is augmented, so that excess 
cholesterol can be stored in the form of cholesteryl esters 
(28). 3. The synthesis of LDL receptors is inhibited, thereby 
avoiding further influx of cholesterol (Fig. 2) (29). 
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Fig. 2. Sequential steps in the LDL· pathway in cultured manmalian cells. 
Reprinted with permission of Dr. M.S. Brown from: M.S. Brown and J.L. 
Goldstein, Proc. Natl. Acad. Sci, USA 1979; 76: 3330-3337, Fig. 3. 
In human macrophages the uptake of LDL-cholesterol occurs 
also through a process of receptor-mediated endocytosis . 
However, the mechanism differs from that in the cell types 
mentioned above. Macrophages express few receptors for native 
LDL, whereas they exhibit an abundant amount of receptors for 
chemically or biologically modified LDL: the acetyl- or 
"scavenger" receptors. When incubated with native LDL, even 
in high concentrations, cultured macrophages usually do not 
accumulate substantial amounts of cholesterol. In contrast, 
modified LDL is an effective cholesterol donor for 
macrophages through the acetyl-receptor. Apparently, the 
synthesis of the acetyl-receptor is not regulated by the 
cellular cholesterol content (as described for the LDL apo 
B,E receptor). Since there is no negative feedback on the 
uptake of cholesterol, incubation of macrophages with 
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modified LDL can more readily lead to lipid-laden foam cells 
(30, 31, 32). These foam cells characterize fatty streaks 
which are believed to represent early atherosclerostic 
lesions (33). 
Modification of LDL can either occur chemically by 
acetylation (31), acetoacetylation (34), carbamylation (35), 
or treatment with malondialdehyde (32) or biologically by the 
incubation of LDL with cultured endothelial or smooth muscle 
cells (36, 37, 38, 39). A common characteristic of these 
chemical and biological modifications is the increase of the 
net negative charge of LDL by derivatization of the epsilon 
amino groups of lysine residues of apo В (40, 41, 42, 43). 
Several lines of evidence show that the cell-mediated 
modification of LDL involves free-radical peroxidation of LDL 
lipids. In vitro exposure of LDL to cultured endothelial 
cells and smooth muscle cells results in peroxidation of LDL 
(containing increased levels of thiobarbituric acid-reactive 
substances) (36, 44, 45). These cell-mediated effects can be 
mimicked by incubation of LDL solely in a cell-free medium 
under oxidative conditions (46). Addition of antioxidants or 
chelators for transition metal ions prevented the 
modification of LDL by cells or in a cell-free medium (36, 
44, 45). The polyunsaturated fatty acids, which are largely 
present in all lipoprotein classes including LDL as glyceryl 
esters in phospholipids or triglycerides, are highly 
sensitive towards oxidative degradation by means of free 
radical chain reactions (47). 
1.3. LDL and atherosclerosis 
The LDL have long been implicated in the development of 
atherosclerosis (48, 49). Perhaps the most convincing 
evidence that these lipoproteins are causative factors in the 
disease is the genetic disorder, familial hyper­
cholesterolemia, in which homozygous patients develop 
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massive LDL serum concentrations, as a consequence of the 
absence of the LDL receptor, and frequently die within the 
second decade of life from complications of coronary artery 
atherosclerosis (50). The reasons for the atherogenicity of 
LDL are incompletely understood. The concentration of LDL-
cholesterol in plasma has been shown to be highly correlated 
to the incidence of coronary artery disease (49) but there 
are still many patients who develop coronary heart disease 
with LDL-cholesterol levels that are within the normal 
range. 
The last decade evidence is accumulating that human plasma 
LDL are comprised of discrete subfractions, varying in size, 
density, lipid content and, possibly, in atherogenic 
behavior. Subjects with similar LDL-cholesterol 
concentrations may differ in the distribution of these LDL 
subfractions. Thus, a more complete understanding of LDL 
heterogeneity could help us to obtain a better insight in the 
atherogenic potential of LDL. 
2. HETEROGENEITY OF LDL 
2.1. Detection and isolation of LDL subfractions 
Early evidence for the existence of LDL heterogeneity was 
provided by equilibrium banding in a high-salt density 
gradient, during analytical ultracentrifugation (51, 52, 53, 
54). Later Krauss et al. (55) demonstrated the presence of 
distinct LDL bands by gradient gel electrophoresis, a 
technique which separates particles by size. Recently, their 
results were confirmed by McNamara et al. (56), who also 
separated LDL subfractions by gradient gel electrophoresis 
from whole serum. 
Until now the preparative methods for isolation of LDL 
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subfractions have made use of sequential isolation (57, 52), 
sequential isolation of LDL followed by density gradient 
ultracentri fugation (57, 58, 59, 60), and the large-scale 
density gradient subfractionation method (61). 
The number of LDL subfractions reported for the density 
range of 1.019-1.063 g/ml depends on the method used and 
whether arbitrary or non-arbitrary density cuts are taken and 
varies from three (62, 61, 63) to twelve (64). 
By analytical ultracentrifugation Fisher distinguished 
subjects with mono- and polydisperse LDL (62). For subjects 
with monodisperse LDL, most of the lipoprotein mass is 
localized within a narrow region of the LDL density range and 
most LDL particles are of similar molecular size. When 
examined by density gradient equilibrium ultracentrifugation, 
monodisperse LDL bands form a discrete peak with a broad 
base. In contrast, subjects with polydisperse LDL have a 
heterogeneous LDL pattern with respect to density and 
particle size; density gradient ultracentrifugation yields an 
asymmetric banding pattern which may contain several compo-
nents. In general, polydisperse LDL consisted of two major 
LDL subpopulations with peak flotation rates (Sf values) of 
Sf 10 (density approximately 1.025 g/ml) and Sf 4 (density 
approximately 1.050 g/ml), respectively, of which the latter 
(with the lowest molecular mass) predominated (62). 
2.2. Physicochemical characteristics of LDL subfractions 
The peak flotation rate, as measured by analytical 
ultracentrifugation, declines progressively (Sf 12 to Sf 0) 
with increasing density of the LDL subfractions (17, 55, 58). 
The same is true for the particle size as determined by 
electron microscopy (21-28 nm) and gradient gel 
electrophoresis (22-27 nm) (52, 55, 58). Also, the molecular 
mass of the LDL subfractions, calculated from hydrodynamic 
data obtained by analytical ultracentrifugation, decreases 
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from 3.2 to 1.9 xlO β g/mol with increasing density of the 
LDL subclasses (51, 52, 58, 65). 
Ion-exchange chromatography showed that LDL form also a 
heterogeneous collection of particles with respect to 
electric charge (66, 67). 
The LDL subfractions share certain compositional features: 
cholesteryl ester are the principal lipids (36-43 % of total 
LDL mass), triglycerides are a minor component, representing 
only 2 to 6 % of LDL mass. The relative contents of free 
cholesterol (accounting for 7-11 %) and of cholesteryl esters 
diminish with increasing density of the LDL subclasses. The 
relative phospholipid content (19 to 22 % of LDL mass) also 
decreases with increasing density of the LDL subfractions. 
The relative amount of protein approximates 20 % for the most 
buoyant to 30 % for the least buoyant subfraction (58, 60, 
61, 63). However, whatever the density or size of the LDL 
subfractions may be, each LDL particle contains only one 
single molecule of apo В (68). Measurement of LDL apo В can 
thus provide a more accurate assessment of the number of LDL 
particles tham measurement of LDL-cholesterol. The protein in 
LDL subfractions consists of predominantly apo B-100 (> 95 
% ) , but small amounts (< 5 %) of apo E, apo A-I and apo C-III 
could also be detected (60, 63, 69, 70). In addition, several 
studies indicate the presence of Lp(a) in the heavy (> 1.040 
g/ml) LDL subfractions (55, 60, 61, 71). 
Experiments were performed by Fisher et al. to establish 
intra-individual variations of LDL molecular mass during the 
year (65). The molecular mass of LDL of 69 individuals with 
monodisperse LDL (see section 2.1) was determined on two 
different occasions after an overnight fast. While the 
molecular mass for the different individuals varied from 2.4 
to 3.9 xlO6 g/mol, the mean intra-individual difference 
appeared to be 0.07 xl0e g/ml with a standard deviation of 
0.08x10s g/ml, indicating that LDL differing in molecular 
mass more than 0.2x10e g/ml may be considered to be different 
macromolecules (62, 65). 
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Studies on the influence of meals and the diurnal rhythm on 
LDL heterogeneity and molecular mass were performed in 
several laboratories (56, 62, 72). By analytical 
ultracentrifugation it appeared that LDL molecular mass 
varies only slightly with the time of the day or in 
relationship to meals (62). Furthermore, the consumption of a 
fatty meal did not affect the LDL subfraction distribution or 
band intensity as detected by Polyacrylamide gradient (2-16%) 
gel electrophoresis (56). Dietary manipulation during a 
longer period alters only minimally size and composition of 
LDL (62, 73). In conclusion, although not consistently 
studied, the intra-individual variation in LDL heterogeneity 
appears to be minimal. 
2.3. Genetic control of LDL subfractions 
several lines of evidence indicate some genetic control 
for the LDL subfraction distribution. A study of individuals 
in five families performed by Fisher et al. (65) yields 
molecular mass data for LDL consistent with a single gene 
locus genetic mode of inheritance without dominance. 
Recently, individuals were classified according to the 
presence of either LDL subclass pattern A or pattern В 
(Fig. 3). The patterns were detected by gradient gel 
electrophoresis and characterized by a predominance of large, 
buoyant LDL particles and small, dense LDL particles, 
respectively (74, 75, 76), Segregation analysis of family 
studies suggested a dominant mode of inheritance with a 
frequency of 25 % for LDL subclass pattern В and a reduced 
penetrance for men under age 20 and for premenopausal women. 
The predominance of dense LDL particles with a decreased 
cholesterol to apo В ratio was also described among patients 
with hyperapobetalipoproteinemia (see section 2.7b). A 
dominant trait of inheritance has been suggested for this 
disorder (77). However, the existence of a common recessive 
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allei at a very high frequency has not been excluded. A high 
frequency of small dense LDL has also been observed among 
patients with familial combined hyperlipoproteinemia (FCH) 
(see section 2.7b). A dominant model of inheritance was 
initially proposed for this disorder (78). 
Pattern A Pattern В 
282 Part.cleMze (x10"%i) 249 286 pär».cie sue (хіб"' 246 
Fig. 3. LDL subclass patterns Ά and В determined by gradient gel 
electrophoresis. Solid lines=densitometric tracings of gradient gel 
bands. Dotted lines determined by mathematical modeling. Reprinted with 
permission of Dr. M.A. Austin and the Lancet, ref. 74, Fig. 1. 
I t might be p o s s i b l e t h a t t h e gene c o n t r o l l i n g LDL 
molecular mass and LDL subc las s p a t t e r n s i s a l s o involved in 
the development of i iyperapobetal ipoproteinemia and FCH. A 
p o s s i b l e b a s i s for t h i s idea i s t h a t v a r i a t i o n in the gene 
for apo В could r e s u l t in d i f f e r e n t LDL subc las s p a t t e r n s . 
The apo В gene has been cloned (13) and t h e c lones have been 
used t o i d e n t i f y a number of common r e s t r i c t i o n fragment 
length DNA polymorphisms (RFLP's) (79, 80, 81, 82, 83, 84, 
85, 86) . These RFLP's may r e f l e c t s t r u c t u r a l d i f fe rences in 
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the functional domains of the apolipoprotein В molecule and 
thereby affect: a) the lipid binding properties of apo B, b) 
the LDL affinity for the apo B,E receptor (see section 1.2), 
c) the uptake of LDL by the macrophage scavenger receptor 
(see section 1.2), d) the binding of LDL to proteoglycans of 
the arterial wall (87) and e) the rate of synthesis of apo B. 
Indeed, population studies have provided some evidence that 
alleles for apo в may be associated with altered serum lipid 
levels (88, 89, 90), atherosclerosis (91, 92), differences in 
fractional catabolic rate and degradation of LDL by 
mononuclear cells (93, 94). Furthermore, it seems quite 
possible that the discrete subfractions described for LDL are 
determined by differences in the lipid binding domain of the 
apo В gene. 
2.4. Lipoprotein precursors of LDL subfractions 
Heterogeneity of human VLDL with respect to physico-
chemical characteristics has been demonstrated by a variety 
of different techniques (95, 96, 97, 98). Recently the 
presence of two major IDL subspecies was shown in normal (and 
hypertriglyceridemic) plasma by gradient gel electrophoresis 
(98). The existence of these heterogeneities raises the 
question whether subfractions of VLDL and IDL differ in their 
capacity to form LDL and whether they give rise to the same 
or different LDL forms. 
Small and large VLDL differ in the extent to which they 
give rise to LDL in normal and hypertriglyceridemic human 
subjects (3, 4). Moreover, Marzetta et al. (99) found 
preferential precursor-product relationships between VLDL and 
certain LDL subfractions by injecting autologous radiolabeled 
VLDL and -LDL into normolipidemic subjects and patients with 
FCH with known LDL structural heterogeneity. These 
experiments suggest that specific LDL density subfractions 
were derived from VLDL precursors while others were derived 
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from VLDL-independent sources (99). These findings are in 
agreement with those of Musliner et al., who injected 
subfractions of radioiodinated lipoproteins with d<1.0l9 g/ml 
from normal and dysbetalipoproteinemic human plasma into rats 
(100). Since the rat does not possess transfer protein 
activity, lipid remodeling of LDL by cholesteryl 
ester/triglyceride transfer was circumvented (101; see 
section 2.5). This allowed them to investigate the direct 
conversion of subfractions of triglyceride-rich precursor 
lipoproteins to LDL subclasses in an in vivo setting. Their 
studies led to the identification of multiple precursor-
product relationships involving individual VLDL, IDL and LDL 
subpopulations. Small VLDL were suggested to give rise to 
IDL-1 (particle diameter 28.0-30.0 ran, d=l.008-1.022 g/ml), 
which in turn yielded a LDL product with the characteristics 
of human LDL-II (particle diameter 25.5-26.5 run, d=1.030-
1.040 g/ml). Furthermore, cholesteryl-ester enriched 
subspecies within the smaller, denser portion of the IDL 
spectrum were suggested to form a LDL subspecies 
corresponding in size and density to the LDL-I subclass 
(particle diameter 26.0 to 27.5 nm, d=l.025-1.030 g/ml). 
Similar precursor-product relationships were found in 
studies of the in vitro lipolysis of the VLDL and IDL 
subfractions using bovine milk lipoprotein lipase (102). 
These experiments suggest that the formation of LDL-I and 
LDL-II from VLDL and IDL precursors in vivo in the rat may 
occur by direct lipolysis. 
Smaller and denser LDL subfractions than formed in these 
in vivo- (in the rat) and in vitro studies have been 
described in human plasma (55, 58). This may be explained by 
the presence in human plasma of lipid transfer activity that 
is required for further processing of the larger primary 
products (LDL-I and LDL-II) by additional cycles of 
cholestérol/triglycéride exchange and the subsequent 
lipolysis (see section 2.5). 
In conclusion, the existence of heterogeneous LDL may be 
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explained by a combination of the lipolysis of specific 
triglyceride-rich precursor subspecies into large LDL 
subfraction products and the subsequent "remodeling" of these 
LDL products by lipid transfer and lipolysis as occurs in 
human plasma. 
Incorporating both these precursor-product relationships 
and the "remodeling theory", Krauss constructed a 
hypothetical metabolic model, consisting of dual pathways 
(103). In one pathway the processing of small VLDL and IDL-1 
gives rise to the subsequent LDL subfractions II, HIB 
(particle diameter 24.2-24.6 nm, d=l.038-1.050 g/ml) and IVB 
(particle diameter 21.8-23.2 ran, d=l.048-1.065 g/ml). In 
another pathway, particles in the IDL-2/LDL-I spectrum, after 
triglyceride enrichment, may give rise to LDL-IIIA (particle 
diameter 24.7-25.2 nm, d=l.038-1.050 g/ml) and LDL-IVA 
(particle diameter 23.3-24.2 nm, d=l.048-1.065 g/ml). This 
latter pathway is suggested to be involved in the apo В 
overproduction in FCH, hyperapobetalipoproteinemia (see 
section 2.7b) and the dense LDL subfraction pattern. 
2.5. Modulation of LDL by transfer and exchange reactions 
The composition of LDL is reportedly related to the 
concentration of HDL-cholesterol and serum triglycerides. 
Buoyant LDL is linked with enhanced HDL-cholesterol and 
decreased VLDL levels and dense LDL with decreased HDL 
concentrations and increased VLDL levels (104, 105, 106, 107, 
108, 109). A mechanism that may explain this relationship is 
the activity of plasma core lipid transfer proteins (110). 
These proteins are known to initiate the transfer of 
cholesteryl ester from LDL to VLDL and of triglycerides in 
the opposite direction (105, 107, 111). The presence of 
triglycerides in LDL, then allows continued particle size 
reduction through the action of lipase, yielding LDL 
populations that gradually become smaller and denser (112, 
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113). These exchange reactions are related to the mass ratio 
between VLDL and LDL. This processing of LDL along a 
continuous cascade from large to small LDL species does, 
however, not explain the occurrence of a limited number of 
discrete LDL subfractions. 
2.6. Metabolic aspects of LDL subfractions 
Teng et al. (59) isolated two major LDL subfractions: 
light LDL-l (relatively buoyant, large and enriched in 
cholesterol and poor in protein) and heavy LDL-2 (relatively 
dense, small and enriched in protein and poor in 
cholesterol), by discontinuous density gradient 
ultracentrifugation of human serum for 40 h. Autologous LDL-l 
and LDL~2 were differentially labeled and injected (and 
reisolated) in normal subjects (114). The fractional 
catabolic rate for light was higher than for heavy LDL. This 
might indicate that light LDL has a higher affinity for the 
LDL receptor than heavy LDL. These results are in agreement 
with the finding that antibodies to antigenic sites close to 
the binding region react more strongly with light than with 
heavy LDL (115). 
Using human LDL-l and LDL-2 isolated by the same method as 
described above (59), Knight et al. did not observe 
differential binding and degradation of the LDL subfractions 
by cultured fibroblasts and macrophages (116). 
2.7. LDL and hyperlipoproteinemia 
a) Hypertriglyceridemia 
By analytical and density gradient ultracentrifugation, 
the LDL fraction in hypertriglyceridemia was found to be 
polydisperse (62, 117). Furthermore, LDL particles are 
described to be small with a relative increase in 
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triglyceride and protein content at the expense of free and 
esteri fied cholesterol and phospholipids (108, 118, 119). 
In vitro studies with human cultured fibroblasts showed 
that LDL from hypertriglyceridemic patients exhibited a lower 
affinity for the LDL receptor. Furthermore, 
hypertriglyceridemic LDL was less effective in both the down-
regulation of the LDL-receptor activity and the inhibition of 
cellular cholesterol synthesis (120, 121). These results may 
be relevant to lipoprotein and cholesterol metabolism in the 
hypertriglyceridemic state; LDL apo В turnover studies in 
hypertriglyceridemic subjects showed an accelerated removal 
from plasma of the apo В part of the LDL (122, 123). 
b) Familial combined hyperlipoproteinemia and hyperapobeta-
lipoproteinemia 
These two metabolic disorders share specific LDL 
subfraction profiles. Familial combined hyperlipidemia (FCH) 
is an autosomal dominant disorder that is variably expressed 
as hypercholesterolemia alone (phenotype IIA), hyper­
triglyceridemia alone (phenotype IV), or both 
hypercholesterolemia and hypertriglyceridemia (phenotype IIB) 
(78). The LDL subfraction distribution is characterized by 
the presence of a large proportion of LDL particles that are 
very small and dense and have a low cholesterol to apo В 
ratio (124, 125). Another disorder, which appears to share 
some characteristics with FCH (126), is hyperapobeta-
lipoproteinemia, a lipoprotein phenotype defined by the 
combination of enhanced levels of apo В with normal or near-
normal concentrations of LDL-cholesterol. A similar LDL 
profile as described above for FCH has also been observed for 
hyperapobetalipoproteinemia: increased numbers of small, 
dense, protein (apo B) enriched LDL particles (127). 
The metabolic and genetic basis of a dense LDL subfraction 
pattern, hyperapobetalipoproteinemia and FCH and their 
relation remains to be elucidated. The increased number of 
dense LDL in these disorders may be explained by enhanced LDL 
synthesis by the liver (114, 128, review: 129). 
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с) Familial hypercholesterolemia 
By analytical and density gradient ultracentrifligation, 
LDL in normolipidemia and hypercholesterolemia was found to 
be monodisperse (62, 117). In addition, patients with 
familial hypercholesterolemia show an altered LDL in terms of 
an enhanced size and molecular mass, cholesterol enrichment 
and triglyceride and protein depletion (53, 59, 130, 131, 
132, 133). 
2.8. LDL heterogeneity and risk for atherosclerosis 
Possible differences between LDL subfractions in their 
capacity to induce atherosclerosis were studied using 
different approaches: 
1. In association with the predominance of dense, small, 
protein-enriched LDL particles increased serum triglycerides 
and decreased HDL-cholesterol levels were found (see section 
2.5). The fact that low HDL-cholesterol levels are 
associated with increased risk for cardiovascular disease may 
provide indirect evidence for the atherogenicity of dense 
LDL. 
2. FCH ала hyperapobetalipoproteinemia are both 
characterized by the relative abundance of the small and 
dense LDL particles with a decreased cholesterol to apo в 
ratio (see section 2.7b), and associated with increased risk 
of coronary artery disease. 
3. Until now three studies have directly assessed LDL 
heterogeneity in relationship to atherosclerosis. Fisher 
(62) evaluated LDL molecular mass and heterogeneity 
(dispersity) in subjects with and without clinically assessed 
atherosclerosis using analytical ultracentrifugation. He 
found that the molecular mass of monodisperse LDL of patients 
with coronary artery disease (CAD) (n=20) was the same as 
that of controls (n=34). Polydisperse LDL (see section 2.1) 
was associated with hypertriglyceridemia and impaired glucose 
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intolerance but not with atherosclerosis. However, the data 
suggest an increased association of polydisperse LDL with 
atherosclerosis in hypertriglyceridemic diabetic patients. In 
these subjects who are prone to premature atherosclerosis, 
LDL polydispersity was found to be associated with high 
plasma VLDL and low HDL concentrations. Grouse et al. (109) 
demonstrated a significantly lower LDL molecular mass (more 
dense) for angiographically ascertained CAD patients (n=46) 
than for controls (n=47). However, LDL molecular mass 
decreased as plasma triglycerides increased and 
concentrations of triglycerides were greater in CAD patients 
than in controls. After covariance adjustment for 
triglycerides, there was no LDL molecular mass difference 
between CAD patients and controls. Recently Austin et al. 
(75) investigated the association of LDL subclass patterns 
with CAD in a case-control study of nonfatal myocardial 
infarction (n=109 and 121, respectively). It was found that 
LDL subclass pattern B, characterized by a preponderance of 
small, dense LDL particles was associated with a threefold 
increased risk of myocardial infarction, independent of age, 
sex, and relative weight. Furthermore, the small, dense LDL 
subfraction pattern was associated with relatively enhanced 
levels of plasma triglycerides, VLDL, and IDL and a reduction 
in HDL-cholesterol levels. It appeared that the relative risk 
associated with the small, dense LDL subfraction pattern was 
reduced when controlled for HDL-cholesterol level, and was 
reduced to insignificance when controlled for plasma 
concentration of triglycerides. 
4. The metabolic behavior of the LDL subfractions has been 
studied by in vitro and in vivo studies (see section 2.6). 
Until now, however, it is not clear whether the metabolic 
differences between LDL subfractions found in vivo can 
account for differences in their atherogenicity. 
5. There is evidence that the surface charge of LDL may 
play a role in the atherogenicity of LDL (30). By agarose gel 
electrophoresis. Chapman et al. (60) documented differences 
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in the net electric charge of individual LDL subspecies, 
isolated by density gradient ultracentrifugation. 
Furthermore, by ion-exchange chromatography Avogaro et al. 
(66) were able to isolate a LDL subfraction with a relatively 
more negative electric charge. The incubation of this LDL 
subfraction with cultured macrophages led to a higher 
increase in cellular cholesterol in spite of a lower rate of 
uptake as compared to total LDL (see section 1.2). Thus, LDL 
subfractions with a net negative electric charge may be 
considered as potentially more atherogenic in comparison with 
neutral LDL subfractions. 
6. The binding of LDL to the arterial proteoglycans may 
also play a role in the process of atherosclerosis (134). 
Data suggest that LDL particles that are less dense, more 
positively charged, enriched in cholesteryl esters, and that 
have liquid crystalline cholesterol cores at body 
temperature, preferentially bind to the arterial 
proteoglycans (87, 135, 136, 137). 
3. ANIMAL MODELS FOR THE STUDY OF THE HETEROGENEITY OF LOW 
DENSITY LIPOPROTEINS 
The origin of LDL heterogeneity and the possible 
differences of the various LDL subfractions in their capacity 
to induce atherosclerosis remain to be established. A greater 
understanding may be obtained by means of a suitable animal 
model. 
Studies in non-human primates may be relevant to the 
question of LDL heterogeneity and atherosclerosis. Various 
reports have established that monkey LDL is also 
heterogeneous in size and density (138, 139). There are 
differences in the characteristics of the LDL subfractions 
between man and monkeys in their association with 
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atherosclerosis. For human beings many investigators found an 
association between small LDL and increased incidence of CAD 
(see section 2.8). As reviewed by Rudel (140), a contrasting 
situation occurs in nonhuman primates. Many cholesterol-fed 
monkeys have large, cholesteryl ester enriched apo B-100-
containing LDL in plasma, the size of which is positively 
correlated to the severity of coronary atherosclerosis (141, 
142). In these hypercholesterolemic animals hepatic VLDL 
cholesteryl ester secretion is higher (143) and LDL clearance 
is delayed. However, lipolysis is high and low plasma 
triglyceride concentrations are maintained, resulting in a 
minimal exchange of cholesteryl esters for triglycerides (see 
section 2.5). Large, cholesteryl ester-rich LDL result. In 
human beings, however, the relatively high plasma 
triglyceride levels, compared to monkeys, prevent 
accumulation of the large cholesteryl ester enriched LDL 
particles. Thus, in monkeys the enhanced hepatic cholesteryl 
ester secretion together with the decreased cholesteryl 
ester-triglyceride exchange leads to formation of enlarged, 
relatively atherogenic LDL. 
The pig may also be a suitable model in the study of LDL 
heterogeneity for two main reasons. As in man, LDL is the 
major cholesterol carrying lipoprotein (64). The plasma 
cholesteryl ester transfer activity is only 19 % of that in 
man (101). This reduces the modulation and the change in 
number or composition of LDL subfractions by exchange 
reactions. 
4. OUTLINE OF THE STUDY 
Increased levels of total plasma cholesterol and LDL-
cholesterol are associated with an increased risk for 
developing coronary artery disease. However, many patients 
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who develop this disease have normal LDL-cholesterol levels. 
It is now well recognized that human plasma LDL are comprised 
of discrete subfractions, varying in size, density and lipid 
content and that subjects with similar LDL-cholesterol 
concentrations may have differences in their LDL subfraction 
distribution. Thus, a more complete understanding of LDL 
heterogeneity could help us to obtain a better insight in the 
atherogenic potential of LDL and may provide us an additional 
tool for the diagnosis of subjects with a high risk profile 
for atherosclerosis. 
For this purpose, a simple and accurate method for both the 
detection and isolation of LDL subfractions was needed. In 
Chapter 2 we describe such a method that consists of a single 
19.5 h run of density gradient ultracentrifugation of serum 
prestained with Coomassie Brilliant Blue. 
The last decade the mechanism by which cells normally 
regulate their cholesterol content has intensively been 
studied and elucidated. However, the current understanding of 
the cellular metabolism of LDL subfractions is limited and 
the literature regarding the interaction of LDL subfractions 
with peripheral cells is minimal. Furthermore, although the 
liver is the principal organ for the catabolism of LDL, the 
interaction of LDL subfractions with the LDL receptor of 
human hepatocytes has not been studied. We considered the 
possibility that the different physicochemical 
characteristics of the LDL subfractions may result in a 
different interaction with human fibroblasts and hepatocytes. 
To test this idea, we studied the receptor-mediated 
association (specific binding to the receptor plus receptor-
mediated internalization) and the degradation of the protein 
component of the light and heavy LDL subfractions to its 
constituent amino acids (Chapter 3). In addition, kinetic 
studies with light and heavy human LDL subfractions were 
performed in the guinea pig (Chapter 3). In Chapter 4 we 
extended the in vitro experiments with Hep G2 cells, as a 
model for human hepatocytes, and determined cell association, 
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Stimulation of cholesterol esterification and inhibition of 
sterol synthesis after incubation of the cells with three 
different LDL subfractions. 
In the search for a suitable animal model in the study of 
LDL heterogeneity we performed comparative studies on the LDL 
subfractions of pig and man (Chapter 5). The pig showed in 
previous studies heterogeneous LDL and a plasma cholesteryl 
ester transfer activity of only 19 % relative to man. This is 
expected to reduce the modulation and the change in number 
or composition of the distinct LDL bands by exchange 
reactions. 
In Chapter 6 we applied the density gradient 
ultracentri fugation method to study the pattern of LDL 
subfractions in normolipidemies and in subjects with the 
various forms of hyperlipoproteinemia phenotypes I to V. The 
physicochemical characteristics of these subfractions were 
compared in order to gain more insight into the metabolic 
basis of LDL heterogeneity. 
From previous studies it appeared that the combination of a 
normal LDL-cholesterol concentration and an increased LDL-
protein (LDL apo B) content must be considered as a risk 
factor for coronary artery disease (CAD). In Chapter 7 we 
investigated whether the composition of LDL, expressed as the 
ratio LDL-cholesterol to LDL-protein, is an independent risk 
factor for CAD and whether it has any predictive power to 
detect subjects with CAD in comparison with other known lipid 
and lipoprotein risk factors. 
In Chapter 8 the prevalence of the LDL subfraction 
distribution among 131 healthy individuals was studied. 
Furthermore, the interdependency of LDL subfraction patterns 
and other known risk factors for CAD, especially HDL-
cholesterol and serum triglycerides were investigated. 
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a single run of 19 5 h r without a preceding sequential 
isolation of LDL Identification and isolation of the sub-
fractions is facilitated by staining -the serum with 
Coomassie Brilliant Blue R prior to ultracentnfugation 
T h e physicochemical characteristics of the L D L subfrac 
tions isolated from pooled h u m a n sera were also deter­
mined 
M A T E R I A L S A N D M E T H O D S 
Summary A single spin density gradient ultrac«ntrifug<ition 
method in a swinging bucket rotor has been applied for the de­
tection and isolation of low density lipoprotein (LDL) sublrac 
tions The visualization of the LDL heterogencity was facilitated 
by prestaimng the serum with Coomassie Brilliant Blue R prior 
to density gradient ultracentnhigation for 19 5 hr A total of 13 
human serum pools was analyzed In each pool, two LDL ьиЬ-
fractions, a lighter LDLi subfraction, occasionally showing a 
subdivision into two bands, L D L I A and L D L I B , and a heavier 
LDL2 could be dearly distinguished by the banding pattern in 
the density gradient Physicochenucal characteristics of the 
isolated LDL subfractions were determined The simple method 
for detection and isolation of these subfractions presented here 
may facilitate future studies on LDL heterogeneity — Swinkels, 
D. W., H L M. Hak-Lemmers, and P. N M. Demacker Sin 
gle spin density gradient ultracentnfugation method for the dp 
tection and isolation of light and heavy low dcnsit> lipoprotein 
subfrattions J Lipid Res 1487 28, 1233 -1249 
Supplementary key wonU LDL heterogeneity ' poolt d serum 
• apoproteins · chemiral composition 
L D L has usually been regarded as a homogeneous enti­
ty despite long standing evidence to the contrary (1-3) 
The existence of different fractions of L D L was suggested 
m earlier studies (1-3) and recently confirmed in normal 
subjects (4-7) 
To determine the physicochenucal characteristics and 
metabolic behavior of these L D L subclasses m healthy or 
hyperhpidemic individuals, there is a need for a simple 
and accurate isolation method for these subfractions U n 
til now the preparative methods for isolation of L D L sub-
fractions have made use of sequential flotation (2), zonal 
ultracentnfugation (8), sequential isolation of L D L fol­
lowed by density gradient ultracentnfugation (3, 5, 9), 
and the large-scale density gradient subfractionation 
method as described by Lee and Downs (6) These 
methods are all time-consuming and based on arbitrary 
cuts m the density region of LDL, except for the latter 
which is sensitive enough to detect minor subfractions but 
requires a large volume of serum and is less suitable for 
hypertnglycendemic serum due to wall-adherence effects 
of the tnglycende-nch particles 
In this report we desenbe a density gradient method for 
the isolation of LDL subfractions from 3 4 ml of serum, 
which is also suitable for hypertnglycendemic serum, in 
Sera 
Blood was sampled from subjects (18-81 yr old) visiting 
the outpatient clmic of our hospital, after fasting over­
night and within 2 hr after a light breakfast Under these 
conditions chylomicrons may be expected to be absent 
because serum tnglycendes are similar to the fasting 
values (10) Sera with triglycerides higher than 2 5 mmol/1 
were excluded, as well as sera from patients who used 
drugs known to affect lipoprotein metabolism or from 
subjects with diseases causing secondary hyperlipidemia 
Sera were isolated within 2 hr Serum pools were made by 
pooling the individual sera ot 10 to 18 persons Concen 
tratmns of triglycerides, total cholesterol, and H D L -
cholesterol m the 13 pools studied ranged from 1 08 to 
2 00 mmol/1, from 4 38 to 7 16 гшпоУ!, and from 1 00 to 
117 mmol/1, respectively 
Density gradient ultracentnfugation 
The method we used for isolation of L D L subfractions 
was based on the density gradient ultracentnfugation pro­
cedure described by Kuchinskiene and Carlson (11) for the 
isolation of V L D L subfractions and L D L T h e method 
was modified as follows Fresh pooled serum (3 4 ml) was 
pipetted into siliconized polycarbonate centrifuge tubes, 
capacity 14 ml (MSE, cat no 34411 125), then, unless 
otherwise stated, 20 /d of a freshly prepared 15 g/I 
aqueous solution of Coomassie Brilliant Blue R (Sigma, 
no B-0630) was added Finally, 0 48 g of K B R was added 
and dissolved, by stirring with a spatula, m order to bring 
the density to 110 g/ml The prestained serum was over-
layered successively with 2 5 ml of d 1 065 g/ml solution 
(mixture of appropriate volumes of solutions of d 1 006 
and d 110 g'ml), 2 5 ml of d 1 020 g/ml solution (mixture 
of appropriate volumes of d 1 006 and d 1 225 g/ml solu 
Abbreviations VLDI very low density lipoproteins, d < 1 006 g/ml 
or pre β lipoproteins LDL, low density hpoprotems, d 1019-1 063 g/ml 
or β lipoprolems L D L I t relatively light LDL consisting of L D L I A and 
LDLig (d 1023-1029 and 1030-1034 g/ml, respectively), LDL,, 
relatively heavy I DL of d 1 036-1 041 g/ml Lp (a) sinking pre β lipo 
proteins, HDL, high density lipoproteins, d 1 063-1 0Л g/ml or a lipo 
proteins, apo apoproteins 
' l b whom correspondence should be addressed at Department of 
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tion) and hnally with 2 Ч ml of d 1 № 6 g/ml solution 
Densitv solutions d 1 006, d 1 10, and d 1 225 g/ml were 
prepared as described (12, 13) for optimal staining, the 
density solutions were adjusted to p H 4 5-5 0 with 1 N 
HCl І Ъ е tubes were ullracentnfuged for 19 5 hr mdudmg 
15 mm of acceleration, deceleration of 45 mm not included) 
at 37,000 rpm (ξ*. 160,000) in the І Ь С SW 41 rotor (no 
488, 6 χ 14 ml) at 2 0 o C , in an 1EC-B60 ultracentrifuge 
(Damon/IEC, Needham H e c h t s , MA 02194) or an M S i 
Prespin 75 ultracentrifuge with an M S E T i 40 rotor (cat 
no 43127-111) 
Aftei ultracentnfugation, photographs of the tubes 
were taken under optimal illumination Subsequently, 
L D L bands wcie aspirated slowly bv means of a rubber 
bulb pipette held against the inner side of the tube, just 
below the meniscus When the pipette was held in the 
same position, л critical point was reached at which a t on-
tinuous flow of fluid was aspirated into the pipette, 
regularly separated by air segments This How was main­
tained by lowering the pipette opening at the same rate 
that the fluid was aspirated In this way coloied subfrat 
tions could be recovered quantitatively without disturbing 
the gradient With some experience, only 10 mm is needed 
for aspirating two L D L subfrartions from six tubes 
When the serum contained visible amounts of sinking 
pre β lipoproteins (LP a), care was tak<n not to remove 
these lipoproteins together with the heavy L D L fraction 
Volumes of the isolated fractions were calculated by 
weighing, after correction for the average densities 
T h e use of suitable ultracentnfuge tubes appeared to be 
of utmost importance for obtaining a clear banding pat­
tern, especially m hyperlipidemii sera Results with IEC 
polycarbonate Autoclear tubes were unsatisfactory In 
contrast to findings of Holmquist (14), surface modifica­
tion with polyvinyl alcohol did not improve the results 
Rather, the polyvinvl alcohol interfered with the staining 
procedure resulting in a faint green color instead of a 
strong blue color 
Rebanding of 1 D L subfractions during a second ultra 
ccntnfugation was studied as follows From an individual 
known to have three distinct L D L subfractions, L D L ^ , 
L D L , в and LDLj were isolated by aspiration after the 
first run Subsequently, these fractions were dialyzed over 
night against 5 1 of saline containing 0 1 g of ethyl 
enedlammetetraacetatc per liter, p H 7 4, followed by 
recentnfugation T h e volume of the LDL subfractions 
was adjusted by the addition of albumin, 40 g/1, to com­
pensate for the sei u m proteins present in the original 
serum 
Analytical methods 
For gradient gel electrophoresis, commercially 
available 2-16% Polyacrylamide gels were used as m ref 
4 (Pharmacia, Uppsala, Sweden, cat no 19 1264-01) 
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Agarose gel elet trophoresis was. performed m 0 8% 
agarose in barbital buffer, p H 8 6, as previously described 
(15) 
The apoprotein composition of the L D I subfractions 
including apoB-100 and other high molecular weight pro­
teins was studied with SDS gel electrophoresis using 
3%/4% discontinuous Polyacrylamide disc gels (16) 
Lipoproteins mixed with SDS phosphate buffer and 
dithiothrcitol as a reducing reagent were boiled and im­
mediately loaded onto the gels This resulted in complete 
delipidation of the apoproteins Albumin, apoA-I, and 
a p o b were determined by rocket Immunoelectrophoresis 
ApoA-I and apoE were purified by Sephacryl S 200 col­
umn chromatography (Pharmacia, Uppsala, Sweden) 
ApoE was further purified by preparative flat-bed isoelec 
trie focusing (17) Monospecific antisera were raised in 
rabbits and the rocket Immunoelectrophoresis was per­
formed as described (17) LDL subfractions were ana­
lyzed without further dilution (Lowry protein range 800 
to 1000 mg/1) against a serum pool of known apoprotein 
com enti ations in suitable dilutions 
Total cholesterol, unestenfied cholesterol, phospholi­
pids, and triglycerides were determined by enzymatic, 
eommemally available reagtnts (Boehrmger-Mannheim, 
FRG, cat η α 237574, 310328 and Sera Park, Мііеь, Italy, 
cat no 6639, respectively) ' I h e protein content of the 
LDL was determined by the method of Lowry et al (18) 
A digital density meter (Anton Paar К G , Grar, Aus­
tria) or a pytnometer was used for measurement of 
relative densities and for calibration of the density sohl 
tiens at 2 0 o C 
Wilcoxon's paired test was used to test differences for 
significance All results are expressed as mean ± SD 
RESULTS 
Profile of densi ty gradient a n d the d i s t r ibut ion of 
cholesterol along the gradient 
The profile of the density gradient was determined after 
ultracentnfugation of a d 1 006 g/ml solution, instead of 
serum, on two different days (Fig. 1) From fractionation 
mark б downwards, the gradient appears to be rather 
linear The layering procedure was reproducible as judged 
by the small standard deviation ol the measured densities 
along the gradient The distribution of cholesterol along 
the gradient in the tube after ultracentnfugation of pre-
stained and nonstained sera on two different days revealed 
three peaks, representing VLDL, LDL, and H D L (Fig 
1) No subdivision of L D L and H D L into clear subfrac 
tions could be observed because of the relatively large 
pooled fractions (0 5 ml) in which cholesterol determina­
tion was performed Boundaries and density distribution 
of stained and nonstained cholesterol-containing lipopro­
teins were similar (Fig 1) 
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Fig. 1. Profile of the density gradient and distribution of cholesterol along the gradient after density gradient 
ultracentrifugation The numbers on the horizontal axis indicate fractionation marks The relative density was de­
termined in pooled fractions after ultracentrifugation of a solution with a density of 1.006 g/ml instead of pooled 
serum (Δ), Cholesterol in the various fractions was determined after density gradient ultracentrifugation of pre-
stained (O) or nonstained serum (#} The data shown are the means of the duplicate results on two different days 
The arrows indicate the middle position of the LDL subfractions: L D L ^ (a), LDL,g (b), and L D L Ï (С) 
Banding pattern of LDL subfractions 
In all pooled sera two heavily stained bands could be 
seen separated in the L D L region by a clear interface of 
approximately 1.5 mm (between d 1.033 ±0.003 and d 
1.038 ±0.002 g/ml) (Fig. 2). Even without staining, this 
subdivision of L D L into two subfractions was usually visi­
ble. When stained, the light LDLi fraction occasionally 
showed a subdivision into two bands called L D L J A and 
LDLiB- However, the separation between LDLiA and 
L D L Î B was not as clear as between LDLiB and LDLj 
(Fig. 2). The density of subfraction LDLiA was between 
1.025 ±0.003 and 1.028 ± 0.003 g/ml (n = 3); of L D L ^ 
between 1.030 ± 0.002 and 1.033 ±0.002 g/ml (n = 10), 
and of LDL2 between 1.036 ± 0.002 and 1.41 ± 0.002 g/ml 
(n = 10). In some pooled sera a faint band was present 
with density boundaries between 1.044 ± 0.03 and 
1.053 ± 0.03 g/ml, presumably representing sinking pre-j3 
lipoproteins. The method appeared to be suitable for the 
analysis of LDL heterogeneity in hypertriglyceridemic 
sera. Fig. 2 shows the results obtained in three sera with 
triglyceride concentratrions of 3.1, 7.5, and 52.2 mmol/1. 
Even in the last serum the triglyceride-rich lipoproteins 
did not adhere to the wall and could be recovered in the 
first l-ml portion after some experience in performing the 
aspiration technique. The sera of patients X and Ζ ap­
peared to contain one single LDL band of relatively 
decreased intensity; two L D L bands were present in the 
serum of patient Y. The density of the LDL was related 
to the triglyceride concentration: the density was lowest in 
the serum of the subject with the highest triglyceride con­
centration. 
*—a 
— b 
-13 
Л 8 1 І 
pool pat. χ pat. y p a t . 
Fig. 2. Banding pattern after density gradient ultracentrifugation of 
prestained human pooled serum and serum of three hypertriglyceri­
demic patients. For the pooled serum the arrows indicate the middle 
position of the visible bands. L D L | A (a), L D L ^ (b), and LDL 2 (c) The 
numbers indicate the fractionation marks as used in Fig. 1. A faint band, 
presumably sinking pre-)3 lipoproteins and occasionally observed at frac­
tionation mark no 14, is absent. Sera of the three hypertriglyceridemic 
patients were obtained after overnight fasting and were ultracentnfuged 
as described for pooled serum Plasma triglyceride for patients x, y, and 
ζ were 3 I, 7 5, and 52 2 mmol/1, respectively 
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Duration of ultracentrifugation 
Prolonging the time of ultracentrifugation from 19 5 to 
39 hr had no effect on the location of the LDL bands nor 
on the number of LDL bands (data not shown) In the 
light of the results of Kuchinskiene and Carlson (11), 
studies on the effect of shortening the ultracentrifugation 
time seemed redundant In addition, considerably shorter 
ultracentniugation runs are not attractive because of the 
increasing nsk for contamination with VLDL remnants, 
HDL, or serum proteins The length of ultracentrifuga­
tion allows one run each day and provides enough time 
for unloading and loading the rotor 
Recovery, reproducibility, and rebanding pattern 
Recovery of cholesterol in the various lipoprotein frac­
tions VLDL, LDL,, LDLj, and HDL, together with the 
serum proteins, amounted to 91 4 ± 8 1% of that in total 
serum (n - 6) The amount ot cholesterol recovered in 
LDL1 and LDLj was 86 4 ± 2 0% of that in the total LDL 
fraction isolated sequentially between d 1 019 and 1 063 
g/ml (n -= 6) 
Within dav precision expressed as the CV of the 
cholesterol content in the LDLj and LDLj fractions of a 
serum pool ultracemrifuged in sixfold m the same rotor 
was dependent on the absolute cholesterol concentration 
(Table 1). Between-day precision determined by ulti a 
centnfugation of a serum pool on 4 sue cessive days was 
also satisfactory These results shown in Table 1 were ob­
tained by an experienced technician 
In the rebanding experiment in which L D I ^ A , 
LDL]!!, and LDLj were recentrifuged in the presence of 
albumin, colored bands were detectable in the tubes with 
boundaries similar to the bands in the original serum 
From L D L , A to LDL[B and LDLj a clear stepwise 
decrease in the density of the colored bands could be seen 
without any overlap However, the bands were less sharp 
and the intermediate layer between the subfractrons, 
clearly present in the first ultracentrifugation, had faded 
TABLE 1 Within and twtween-day precision of the density 
gradient ultraccnmFugation method* 
TABLF 2 Chemita] composition of LDL ι and LDI i' 
Component LDLj 
Fraction 
LDL, 
LDL, 
Within Day Fiecision* 
Chdratero! 
rnroW 
t 69 i 0 05 
0 77 ± 0 06 
CV 
% 
3 0 
7 8 
Between Day Precision' 
Cbolesterol CV 
mmol/l % 
1 69 ± 0 03 1 8 
0 76 ± 0 Ot 2 3 
'fjtpressfd as the coefficient of variation (%) of the cholesterol con 
tent of the LDL, and LDL3 subfraettons 
Mean ± SD of sut sample» of pool A ultracentnfuged in the same 
rotor 
' Mean ± SD of four samples of pooî В analyzed on 4 successive days 
m two different rotors, the pool was stored at 4 0 C Isolated subfractmns 
were stored at 4 ο 0 and cholesterol was determined on the same da> 
Cholesterv] ester 
Free cholesterol 
Tnglvcendes 
Phospholipids 
Protein 
'Relative chemical 
η - 10} 
'Ρ < 0 0 1 
Ό 05 < F < 0 1 
41 1 ± 1 7 
107 ± 1 3 
3 4 i 2 0 
22 8 ± 0 5 
21 6 ± 17 
composuion (percent of dry ma1«, 
37 7 ± 4 0* 
106 ± 2 5 
2 2 ± 1 3 ' 
21 3 ± 0 9 ' 
28 2 ± 3 0* 
mean ± SD 
Physicochemical characteristics of the LDL subfrac­
tions 
LDLj contained significantly more cstenfied 
cholesterol and phospholipids, and less protein than 
LDL2 (P < 0 01) The percentage of triglycerides in 
LDL) tended to be higher than in LDL2 (Table 2) 
When three subfractions were found, the relative con 
tent of cholesteryl esters, free cholesterol, and phosphoh 
pids decreased and that of proteins increased from 
LDLiA to L D L ^ to LDL2 (Table 3) 
The mobilities of LDL, and LDLj on agarose gel were 
similar (Fig, 3) With SDS-polyacrylamide gel elec­
trophoresis, no differences were detectable in the apopro­
tein composition By densitometric scanning, less than 
5% of the absorbance was due to staining outside the 
apoB-100 band (Fig. 4) 
On the gradient gel electrophoresis, LDL2 moved faster 
than LDLi and L D L ^ moved faster than LDLiA (Fig. 
5) Since smaller particles move the fastest, this indicates 
that the size is inverse to the hydrated density of the par­
ticles within the respective LDL subfractions 
Rocket Immunoelectrophoresis of LDLjA, L D I ^ B , and 
LDLj showed that residual albumin, apoE, and apoA-1 
contributed less than 5% to the total protein mass of 
L D L I A , L D L I B , and LDL2 ApoA-1 was the major con 
taminating protein followed by apoE and albumin 
(Table 4) 
DISCUSSION 
By means of a relatively simple method we could con­
firm heterogeneity of LDL described in previous studies 
(1-7) The prestaimng procedure with Coomassie Bril­
liant Blue R facilitated the identification of these LDL 
subfractions as well as of minor fractions present within 
the density range of LDL, such as sinking pre-/î lipopro-
teins The staining effect is maximal and the protein-dye 
complex is most stable at a low pH (19) Staining at a pH 
between 4 5-5 0, slightly below the isoelectric point of 
LDL (20), proved to be satisfactory The LDL bands were 
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TABLE 3. Chemical composition of LDL 1 A , LDLtg, and L D L / 
Component 
Cholesteryl ester 
Free cholesterol 
Triglycerides 
Phospholipids 
Protein 
LDL.A 
43.3 ± 2.2 
10.3 ± 0 8 
5.6 ± 1.4 
20.9 ± 0.3 
19.8 ± 0.6 
LDL.B 
42.2 ± 1.1 
9.7 ± 0.8 
3.8 ± 0.6 
19.9 ± 0.6 
24.1 ± 0 8 
LDL, 
39.0 ± 3.2 
9.4 ± 2.2 
4 1 ± 0.5 
19.4 ± 0.5 
28.0 ± 0.6 
'Relative chemical composition (percent of dry mass, mean ± SD, 
η - 3). 
clearly visible and the density ranges of each LDL band 
could easily be determined by comparing the boundaries 
of the colored bands in the tubes with the density gradient 
profile. By comparing the boundaries and the profile of 
the cholesterol content along the gradient, it could be 
proved that the staining procedure did not result in a 
change of the density of the LDL, in agreement with 
earlier findings for the H D L subfractions (21). 
Although the staining procedure is useful for identifica­
tion, binding of Coomassie Brilliant Blue to the lipopro­
teins and the change in p H may alter the metabolic 
behavior. Therefore, for the purpose of in vivo or in vitro 
experiments it is advisable to use nonstained subfractions, 
which can be isolated on the basis of the colored bands in 
a reference tube in which the same serum is ultracentri-
fuged in the presence of Coomassie Brilliant Blue at pH 
4.5-5.0. 
Compared to other methods for isolation of LDL sub-
fractions (2, 3, 5, 9) our method is less laborious and very 
precise. LDL subfractions can be identified as distinct 
bands in just a single run. In other methods, usually two 
preceeding ultracentrifuge steps, requiring in total ap­
proximately 35 hr, are necessary to isolate pure LDL 
before LDL subfractions can be isolated in a density gra­
dient (3, 5, 9). The subfractions in these methods are 
generally isolated at rather arbitrarily defined density 
limits, whereas the distinct bands we isolated may repre­
sent physiological entities. 
The sensitivity of our method is at least as good as in 
the only other single-step ultracentrifuge method per­
formed in a fixed-angle rotor for 26 hr (6). In the latter 
method a large volume of serum is needed for identifica­
tion of minor bands. In addition, the method suffers from 
adherence effects caused by the triglyceride-rich particles 
present in sera of patients with hypertriglyceridemia, 
_c 
— pre-o 
— 9 
Fig. 3. 
LDL,; 
* - Ú 
Agarose gel electrophoresis of LDL! and LDLj; О, origin; 
2, LDL,. 
Fig. 4. SDS-polyacrylamide gel electrophoresis of LDL, and LDL,, 
From top to bottom are shown apoB-lOÒ band (a), and the potential 
migration distances of apoB-48 (b), albumin (c), apoE (d), and apoC (e). 
The numbers indicate LDL, (1) and LDL, (2), respectively 
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whereas our method appears suitable for the analysis oi 
L D L subfractions of sera Irom patients with various types 
of hyperlipoproteinemia t o r the isolation of L D L of type 
I, IV, and V, complete removal of the floating particles is 
important to prevent contamination of the L D L subfrac­
tions In the individual sera of health} donors, 1 to 3 sub 
fractions could be identified This excludes the possibility 
that the number of L D L bands we find in pooled serum 
is the result of the pooling procedure O n the contrary, the 
appearance of 2 or 3 L D L subfractions m pooled serum 
points to the presence m the individual sera of distinct low 
density lipoproteins with sharp density boundaries 
Otherwise, in the case of variation of the density of the 
LDL bands in the individual sera, pooling would result in 
a diffuse smear without distinct bands 
The differences m density of the main L D L subfrac 
tions, LDLi and L D L j , were related to differences m phy 
sicochemical characteristics The heavy L D L j were 
smaller and contained relatively more protein and less 
cholestervl esters and phospholipids than the lighter 
LDLi Chemical composition data of our L D L 1 and 
LDLi subfractions resemble those of fraction 1 or 2 and 
fraction 4, respectively, obtained by sequential isolation of 
L D L followed by density gradient ultracentnfugatton (5), 
of layers 2 and i obtained by the large scale density gra 
dient in a fixed-angle rotor (6), and also of L D L m and 
LDLiv obtained by sequential flotation, respectively (2) 
TMiLE + Contammatmn of LDL зиЫ аснопч by various proteins' 
£riut>im Albumin (n - 5) ApoK (n - 3) ApoA I (η - *) 
LDL, A 
LDL,» 
LDL, 
0 2 ± 0 1 
0 2 ± 0 1 
0 6 ± 0 1 
0 2 ± 0 1 
0 5 i 0 2 
I 2 i 0 1 
1 1 ± О 2 
1 4 ± 0 2 
2 + ± 0 2 
'Comamination of undiluted I DL subfractions by apoproteins A I 
E and by albumin was determined b) rocket immunoclectrophoresH and 
was expressed as percent of LDL protein ± SD 
Differences in the chemical composition may be explained 
by the differences m the sera studied or in methods ap­
plied We used shorter ultracentrifugation runs which 
may minimize loss ol apoproteins during ultracentrifuga 
tion (22, 23) T h e smaller size of the heavy L D L particles 
we found with gradient gel electrophoresis confirms 
earlier reports in which size determination of LDL sub 
fractions was performed by means of a similar procedure 
or by electron microscopy (4, 5, 6) LDLi and L D L j 
could not be distinguished on the basis of their elee 
trophoretic mobility, which may be accounted for by the 
comparable apoprotein composition More than 9b% of 
the protein consisted of apoB-100, traces of albumin, 
apoE, and apoA-I were less than 5% of total protein 
Similar results of contamination have been reported by 
Zechner, Moser, and Kostner (24) for isolation of total 
LDL by sequential ultracentrifugation 
In conclusion, this report presents a simple and quick 
method for identification and isolation of L D L subfrac­
tions from small amounts of serum T h e L D L subfrac­
tions isolated in this way can be used for physicochemical 
tharacteroations and for m vitro or m vivo metabolic 
studies Ш 
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Two low-density lipoprotein subfractions LDL-1 and LDL-2, with density ranges of respectively 1.023-1.034 
and 1.036-1.041 g/ml, were isolated by aspiration after density gradient ultracentrifugation of human 
pooled serum. In vitro interactions of both LDL subfractions with the LDL receptor of human cultured 
fibroblasts, human hepatoma cell line Hep G2 and human hepatocytes were compared. No difference in 
association (binding and internalization) nor in degradation between LDL-1 and LDL-2 by these cells was 
found. However, kinetic studies in guinea pigs showed that LDL-2 disappeared faster from the circulation 
and accumulated to a greater extent in the liver, compared to LDL·!. Thus, we were unable to show a 
difference in the LDL receptor-mediated uptake of both LDL subfractions by various cells in vitro. The 
results obtained in vivo suggest that LDL-1 is more atherogenic than LDL-2, because its longer half-life 
renders the particle more susceptible to uptake by the scavenger LDL receptor on macrophages. 
Introduction 
Human low-density lipoprotein appeared to be 
heterogeneous, and up to five LDL subfractions 
could be detected [1-7]. Recently, a method using 
density gradient ultracentrifugation was described 
for the rapid and quantitative isolation of two or 
three LDL subfractions from normal human 
Abbreviations- LDL, low-density lipoprotein, d - l 019-1.063 
g/ml; LDL-1, relatively light LDL, ¡/ = 1.023-1.034 g/ml; 
LDL-2 relaüvely heavy LDL, ¿=-1.036-1.041 g/ml. 
Correspondence: ,D Swinkels, Department of Medicine, Divi-
sion of General Internal Medicine, University Hospital 
Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Nether-
lands. 
pooled serum [8]. The most clearly separable sub-
fractions LDL-1 and LDL-2 appeared to differ in 
their physicochemical charactenstics: LDL-2 con-
tained less lipid and more protein and was smaller 
than LDL-1. 
To reveal the important role of LDL in the 
process of atherosclerosis, it is necessary to study 
the in vivo and in vitro behavior of LDL subfrac-
tions, Using cultured fibroblasts and macro-
phages, Knight et al. [9] showed no differential 
binding and degradation between LDL-1 and 
LDL-2 isolated from human serum by sequential 
ultracentrifugation followed by discontinuous 
density gradient ultracentrifugation for 40 h. 
However, after injection of the two radiolabeled 
LDL subclasses into human volunteers, LDL-1 
has a higher fractional catabolic rate than LDL-2 
[10]. 
0005-2760/88/S03.50 © 1988 Elsevier Science Publishers B.V (Biomedical Division) 
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Although the liver is the principal organ for the 
catabolism of LDL (for review, see Refs. 11 and 
12), the interaction of LDL subfractions with the 
LDL receptor of human hepatocytes has not been 
studied. This is of prime importance, because an 
alternative binding site besides the 'classic' LDL 
receptor has been described on isolated liver mem-
branes and on human hepatocytes in primary cul-
ture [13 16]. 
The purpose of our study was to compare the 
metabolic behavior of LDL-1 and LDL-2 isolated 
by a recently developed density gradient ultra-
centrifugation method from human pooled serum 
of normolipidemics. Studies were performed in 
vitro, using human fibroblasts, human hepatocytes 
and the human hepatoma cell line. Hep G2. The 
latter cell line was used also by others for lipopro-
tein studies [17-19]. In addition, fractional cata-
bolic rates of radioiodinated LDL-1 and LDL-2 
were determined in guinea pig, an animal model 
for the study of LDL metabolism [20]. 
Materials and Methods 
Cells 
Normal fibroblasts derived from the foreskin of 
two healthy newborns were grown in monolayer 
maintained in Ham F-10 medium supplemented 
with 10% (v/v) fetal calf serum, penicillin (100 
U/ml), streptomycin (100 /tg/ml), fungizone (2.5 
jug/ml) and L-glutamine (2 mmol/1). Cells of the 
human hepatoma cell line Hep G2 were grown in 
Eagle's modified basal medium, supplemented with 
the same additives in the same concentrations as 
described for fibroblasts. The human hepatoma 
cell line. Hep G2, was kindly supplied by Dr. 
Knowles (Science 209 (1980) 497 499). Both 
fibroblasts and Hep G2 cells were seeded on day 0 
of the experiment at a density of 1.1 -104 and 
1.4 · 104 cells per dish (cell culture cluster, 24 X 16 
mm, Costar, Badhoevedorp, The Netherlands), re-
spectively. Each dish contained 1 ml of culture 
medium supplemented with 10% (v/v) fetal calf 
serum. On day 3, the medium was renewed. On 
day 5. after washing the dishes with 1 ml of 
Hanks' balanced salts solution, the cells were in-
cubated with 1 ml of the fresh medium containing 
lipoprotein-deficient serum (isolated from the 
pooled serum of healthy subjects by uUracentrifu-
gation at 160000 X g for 46 h. final concentration, 
5 mg of protein/ml). Experiments with fibroblasts 
and Hep G2 cells were started on day 7 after the 
cells had been grown for 48 h in the presence of 
lipoprotein-deficient serum. Cells were then nearly 
confluent. Human hepatocytes were isolated and 
cultured as described previously [21], in Williams' 
E culture medium supplemented with 10% (v/v) 
fetal calf serum, L-glutamine (2 mmol/1), porcine 
insulin (20 mU/ml) , dexamethasone (50 nmol/i), 
fungizone (2.5 ¿ig/ml), gentamycin (50 /ig/ml), 
and vancomycin (100 (ig/ml). Hepatocytes were 
seeded at a density of 175 · IO3 cells per cm2 on 
Thermanox tissue culture cover slips (15 mm di-
ameter, Flow, Irvine, Scotland, No. 5414) which 
are attached to the bottom of dishes (Costar) with 
coagulated agarose. The medium was renewed 2-4 
h after cell seeding, and every 24 h thereafter. 
Experiments were started on day 4 after the cells 
had been grown for 24 h in the presence of 10% 
(v/v) lipoprotein-deficient Serum (5 mg of pro-
tein/ml). All cells were maintained at 37° С in a 
humidified atmosphere of 95% аіг/5% CO2. 
Sera 
Blood was sampled from subjects, aged 18-76 
years, visiting the outpatient clinic of our hospital, 
within 2 h after a light breakfast. Blood samples 
from patients using drugs known to affect lipopro­
tein metabolism or with diseases associated with 
hyperlipidemia were excluded. Sera of 10-18 indi­
viduals were isolated within 2 h, and pooled. 
Concentrations of triacylglycerols, total cholesterol 
and HDL cholesterol [22] in the pools studied 
ranged from 1.01-1.92 mmol/1, 4.44-6.98 mmol/l 
and 0.98-1.25 mmol/1, respectively. 
LDL subfractionation 
Isolation of LDL sub fractions was performed 
essentially as described previously [8]. For each 
experiment, 3.4 ml of the fresh pooled serum was 
pipetted into six polycarbonate centrifuge tubes. 
The density of the serum was raised to 1.10 g/ml 
by dissolution of 0.48 g of KBr. As reference for 
the position of LDL-1, 20 μ\ of a freshly prepared 
15 g/1 aqueous solution of Coomassie brilliant 
blue R was added to one of the tubes. The sera 
were then overlayered successively with 2.5 ml of 
d 1.065, 2.5 ml of d 1.020 and finally with 2.9 ml 
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of d 1 006 g/ml For optimal staimng, the density 
solutions used in the reference tube were adjusted 
to pH 4 5-5 0 with 1 M HCl The tubes were then 
ultracentnfuged for 19 5 h at 37000 rpm (160000 
X g) m the IEC SW 41 rotor (No 488, 6 X14 ml) 
at 20 " C , in an IEC B-60 ultracentnfuge 
(Damon/IEC, Needham Heights, MA) or an MSb 
Prespm 75 ultracentnfuge with an MSE Ti 40 
rotor (cat No 43127-111) With the use of the 
reference tube, LDL subfractions were then accu­
rately isolated by aspiration from tubes to which 
no Coomassie brilliant blue R had been added 
The non-stained LDL subfractions from 34 ml of 
serum were pooled and concentrated to a volume 
of approx 2 ml by a second run in a fixed-angle 
rotor (IEC No 468) m the IEC B-60 ultracentn­
fuge for 10 h at 168000 X g, dialyzed overnight 
against 5 1 of saline containing 5 mg/l gentamycin 
and 0 4 g/1 EDTA (pH 7 4), labeled and used for 
the metabolic studies Physicochemical character­
istics of LDL-1 and LDL-2 were determined be­
fore concentration, and have been published pre­
viously [8] 
Isolation of total LDL 
Total LDL ( d = 1 019-1 063), needed for com­
petition expenments, was isolated by sequential 
ultracentnfugation [23] followed by a single wash 
in the fixed angle rotor (IEC No 468) and dialyz-
ing overnight against 5 1 of saline containing 0 4 
g/1 EDTA and 5 mg/l gentamyem (pH 7 4) 
Labeling of LDL 
In the m vitro studies, total LDL and the LDL 
subfractions were labeled with 1 2 5 I [24,25J For the 
turnover experiments, the LDL subfractions were 
labeled differentially with n5\ and U 1 I The labeled 
LDL was dialyzed overnight against 5 1 of saline 
containing 5 mg/l gentamycin and 0 4 g of EDTA 
per 1 at pH 7 5 Specific activities of the lodmated 
LDL subfractions vaned from 80 to 150 cpm/ng 
of protein, and the tnchloroacetic acid and isopro-
panol precipitabihty of LDL radioactivity were, 
respectively, greater than 97 and 93% Less than 
1% of the radiolabel was found in lipid 
Association and degradation of LDL subfractiom 
Association and degradation studies using \ an-
ous cell types were performed as desenbed [26] 
Initially, for practical purposes, in vitro differenti­
ation between both LDL subfractions was per­
formed by competition experiments, in which both 
LDL subfractions competed with total radio­
labeled LDL for binding to the LDL receptor 
Later, direct studies were performed as well, which 
required the labeling of both LDL subfractions 
Cells were incubated for 4 h (fibroblasts) or 5 h 
(hepatocytes and Hep G2 cells) with, in the direct 
expenments, 0-200 jig protein/ml from each of 
the 12SI-labeled LDL subfractions and with, in the 
competition experiments, 15 /ig protein/ml 1 2 , I -
labeled total LDL in the presence of 0 200 μ g 
protem/ml of each of the unlabeled LDL subfrac­
tions EDTA in the LDL subfractions was cor­
rected for by the addition of a 1 1 (v/v) mixture 
of CaCl 2 (5 mmol/1) and MgCl2 (5 mmol/1) 
After incubation, the media were harvested and 
the cells were cooled to 4 °С and washed five 
times with 1 ml of buffer compnsing 50 mM 
Tns-HCl/150 mM NaCl/2 mg/ml bovine serum 
albumin (pH 7 4), followed by a 1 ml wash with a 
buffer compnsing 50 mM Tris-HCl/150 mM NaCl 
(pH 7 4) Subsequently, the cells were solubihzed 
m 0 2 M NaOH at room temperature The cell-as­
sociated radioactivity (i e , bound and internalized 
radioactivity) was quantitated, and the cellular 
protein was determined by the method of Lowry 
et al [27] The harvested medium was assayed for 
acid-soluble, non-iodide products of U5I-labeled 
LDL catabolism after precipitation with tnchloro­
acetic acid and subjection to potassium iodide/ 
hydrogen peroxide treatment followed by two 
chloroform extractions [26] Aspecifically associ­
ated and degraded 1 2 5 I-LDL was determined in 
the presence of a level ot unlabeled LDL that was 
at least 10-fold above saturation (500 μg LDL 
protein per ml) Differences between LDL-1 and 
LDL-2 in direct and indirect association and de­
gradation studies m fibroblasts and Hep G2 cells 
were tested by three-way analysis of vanance 
Independent vanables were LDL subfractions 
(levels of LDL-1 and LDL-2), LDL concentra­
tions (six levels) and the expenments (for indirect 
and direct studies, respectively, four and two 
levels) Dependent vanables were association and 
degradation 
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Turnover studies 
Under general anesthesia, both the jugular veins 
and the femoral arteries of male guinea pigs (body 
weights 400-800 g, purchased from TNO, Zeist, 
The Netherlands) were cannulated 3-6 days be­
fore the start of the experiment. The cannulas 
were kept patent by a 9 :1 (v/v) mixture of Dex-
tran (100 g/1) and citrate (3.8 g/1). The animals 
were then allowed to recover in the same cages as 
those used during the experiment. Food was given 
ad libitum. At / = 0, equal amounts (6 /iCi in 
40-80 μg LDL protein) of both 1 2 5 I - or 131I-labeled 
LDL subfractions were mixed and injected into 
the cannulated jugular veins of the non-fasted 
guinea pigs. For the kinetic studies, three pairs of 
LDL subfractions were used, and were injected 
into a total of 13 guinea pigs. To rule out the 
possibility of an isotope effect as the cause of any 
difference in fractional catabolic rate, the LDL-1 
was labeled with 1 2 5 I and LDL-2 with n i I in the 
first and third experiment, and in the second 
experiment, the isotope assignment was reversed. 
During the experiment, cannulas in the femoral 
arteries were extended to allow the animals to 
move freely while blood samples were taken. Inbe-
tween blood sampling, the cannulas were kept 
patent with citrate (3.8 g per 1 of saline). Blood 
samples (600 μΐ) were collected at different time 
intervals up to 48 h after administration of LDL. 
5 min before killing at 48 h, 200 IU of heparin 
(Tromboliquine, Organon, Oss, The Netherlands) 
was injected intravenously to prevent coagulation. 
The liver was perfused with Krebs-Ringer solution 
containing 5 IU of heparin per ml. Plasma was 
isolated within 1 h of blood sampling. Radioactiv­
ity of the plasma and the whole liver was counted 
in a Packard double-channel auto-gamma scintil­
lation spectrometer, model No. D.5220. The frac­
tional catabolic rate of both LDL subfractions 
was calculated from the plasma disappearance 
curve, by the method of Matthews [28], which 
assumes a simple two-compartment model, where 
plasma apoUpoprotein LDL equilibrates with an 
extravascular compartment, and where all irre­
versible loss of apoUpoprotein LDL occurs from 
the plasma compartment. In a representative 
experiment, more than 98 and 94% of radiolabel 
appeared precipitable with, respectively, trichloro­
acetic acid and isopropanol at all time intervals. 
The fractional catabolic rate, calculated from total 
plasma, trichloroacetic acid- and isopropanol-pre-
cipitable material, differed less than 1%. Dif­
ferences in fractional catabolic rate between the 
LDL subfractions were tested for significance by 
Student's paired i-test. 
Results 
Fractionation of LDL from pooled serum by density 
gradient ultracentrifugation 
In all pooled sera, two heavily stained bands 
could be seen, separated by a clear interface: 
LDL-1 and LDL-2 (Fig. 1). Even without staining, 
this subdivision of LDL into two subfractions was 
usually visible. When, occasionally, LDL-1 showed 
a subdivision into two bands (LDL-1 A and LDL-
1B), both were isolated together as one single light 
LDL subfraction: LDL-1. 
Fig. 1. LDL subfractions after density gradient ultracentrifuga­
tion of prestained human pooled serum. The arrows indicate 
the LDL subfractions used for the metabolic studies: LDL-1 
(1) and LDL-2 (2). 
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Association and degradation of LDL subfractions by 
human cultured fibroblasts, human hepatocytes and 
Hep G2 cells 
Competition expenments were performed with 
the fibroblasts (four expenments) and human 
hepatocytes m primary monolayer culture (one 
expenment) in tnplicate By vanance analysis, no 
significant differences were found m the competi-
20 ¿0 60 60 100 HO 
LDL Subfroclitm added ((ig / m l ) 
200 
20 40 60 80 100 140 200 
LDL Subfraction added (¿ ig /m l ) 
Ftg 2 Association (A) and degradation (B) of 125I-labeled 
control total LDL by human cultured fibroblaits in the pres-
ence of increasing amounts of LDL-1 and LDL-2 n,I-labeled 
control LDL (15 Mg/ml), isolated by sequential ultracentnfu-
gation of pooled serum, was incubated with the indicated 
concentrations of the unlabeled LDL subfractioos, LDL-1 (D) 
and LDL-2 (·), for 4 h at 37° С The medium was then 
removed, and its content of acid-soluble, non-iodme radioac­
tivity was measured (B) as well as the amount of 125I-labeled 
LDL associated (bound and internalized) with the cells (A) 
Results represent the means±SD of values from four sep­
arate expemnents, each with triplicate measurements 100% 
association = 1459 ±147 ng LDL/mg protem, 100% degrada­
tion -1265 ± 256 ng LDL/mg protem 
tion expenments between LDL-l and LDL-2 for 
fibroblasts (Fig. 2) In addition, in the expenment 
with hepatocytes, LDL subfractions competed 
equally well with total labeled LDL (Fig 3) Van­
ance analysis of the results of the direct binding 
studies performed with fibroblasts (two experi­
ments) and with Hep G2 cells (two expenments) 
in duphcate showed that both LDL subfractions 
were associated to a similar extent to these cells at 
the vanous concentrations of LDL protem studied 
ol—t—ι 
20 40 60 60 100 140 
LDL Subtraction added (мд/т і і ) 
0 20 40 60 ВО 100 140 200 
LDL Subtraction added (pg/mt ) 
Fig 3 Association (A) and degradation (B) of 125I-labeled 
control LDL by human hepatocytes m the presence of LDL-I 
and LDL-2 12iI-labeled control LDL (15 Mg/ml), isolated by 
sequential ultracentnfugation of pooled serum, was incubated 
with the indicated concentrations of the unlabeled LDL sub-
fractions, LDL-1 (Q) and LDL-2 (·), for 5 h at 17° С For 
details, see Fig 2 Values shown are the means±SD of 
tnplicate measurements 100% association —141 3± 16 5 ng 
LDL/mg protein, 100% degradation = 104 4 ± 3 50 ng 
LDL/mg protem 
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In addition, no differences were found in the 
amount of labeled LDL degraded (Figs. 4 and 5) 
In vivo experiments with light and heavy LDL 
subfractions 
The fractional catabohc rate of radioiodmated 
human LDL-1 ranged from 0.83 to 1.35 pools/day, 
and that of radioiodmated LDL-2 ranged from 
1.14 to 2.89 pools/day (Table I). Although the 
values vaned, and depended on the preparations 
injected, LDL-2 was always cleared 1 3-2,5-times 
20 «0 60 60 100 HO 
LOL Subtraction added (/iq/ml) 
20 iO 60 Θ0 100 U0 
LDL Sublraclton added (fig/ml) 
„ 5 
S г 
oi»*u 40 60 80 100 HO 
LDL Subtraction added (μς/ηηΙ) 
Fig. 4 Association (A) and degradation (B) of 125I-labeled 
LDL-1 and LDL-2 by human cultured fibroblasts Cells were 
incubated for 4 h at 37 ° С with the indicated concentrations of 
125I-labeled LDL-1 and LDL-2 For details, see Fig 2 Non­
specific association and degradation of LDL-1 (o) and LDL-2 
(·) was determined in the presence of an excess of the ap­
propriate unlabeled LDL subfraction Results of total associa­
tion or degradation of LDL-1 (Π) and of total association or 
degradation of LDL-2 ( +J represent the means of two separate 
experiments, each with duplicate measurements 
20 40 60 80 100 HO 200 
LDL Subtraction added C^g/ml) 
Fig 5 Association (A) and degradation (B) of i25I-labeled 
LDL-1 and LDL-2 by the human hepatoma cell line Hep G2 
Cells were incubated for 5 h at 37° С with the indicated 
concentrations of 125I-labeled LDL-1 and LDL-2 For details, 
see Figs 2 and 4 Results represent the averages of two 
separate experiments, each with duplicate measurements 
TABLE I 
FRACTIONAL CATABOLIC RATE OF HUMAN LDL-1 
AND LDL-2 IN GUINEA PIGS 
In Expts. 1 and 3, LDL-1 was labeled with ' " l and LDL-2 
with 1 3 l I , while m Expt 2, this isotope assignment was re­
versed In Expt 3, the fractional catabohc rate of 1,35 for 
LDL-1 is the mean of 1 42 and 1 29 pools per day, and the 
fractional catabohc rate of 2 04 for LDL-2 is the mean of 2 20 
and 1 88 pools per day 
Expt 
1 
2 
3 
л " 
6 
5 
2 
Fractional catabohc rate • 
LDL-1 
0 83±0 32 
1 18±022 
135 
LDL-2 
114±010 
289±041 
204 
* Pools/day, mean±S.D 
ь
 Number oí guinea pigs studied 
52 
IO 20 30 43 SO 
H o u r s a f t e r η e r t or4 
Fig 6 Isotope-decay curvei of human LDL-I and LDL-2 in a 
guinea pig of representative Fxpt 3 Both curves were biex 
ponential The fractional catabolic rates of LDL-1 and LDL 2 
were 1 42 and 2 20 pools/day respectively 
faster than LDL-1 ( P < 0 001) Fig 6 shows a 
typical dimumtion of LDL-1 and LDL-2 injected 
into a guinea pig from Exp 3 The fractional 
catabolic rate of LDL-2 appeared to correlate with 
the reciprocal change in the ratio of radioactivity 
in serum and liver 48 h after injection of 
equivalent amounts of human LDL-1 and LDL-2 
into guinea pigs, the ratio LDL-1/LDL-2 had 
decreased more than 2-fold m serum, and had 
increased from 1 23 to 1 47 m the liver (Table II) 
TABLE II 
LDL-2/LDL-1 RADIOACTIVITY IN GUINfcA PIG 
SERUM AND LIVER, 48 h AFTER INJECTION OF 
EQUIVALENT AMOUNTS OF RADIOIODINATFD HU­
MAN LDL-1 AND LDL-2 
In Expt 2, LDL-1 was labeled with n l I and LDL-2 with , 2 5 I , 
while in Expt 3, this isotope assignment was reversed For 
Expt 3, the ratio of 0 45 m serum is the mean of 0 48 and 0 42 
and the ratio of 1 23 in the liver is the mean of 1 19 and 1 27 
At ι ** 0, 6 μΟ of both isotopes were injected 
Expt 
2 
3 
/ I * 
5 
2 
LDL-2/LDL-2 radioactivity 
serum liver 
016±0 0 9 b ^ T i O l O 1 ' 
045 e 123 ' 
* Number of guinea pigs studied 
ь
 Ratio ' " I / 1 3 1 ! , mean±S D 
• Ratio , 3 1 I / 1 2 5 I 
However, the change in the ratio LDL-2/LDL-1 
in the liver was less than might be expected on the 
basis of the fractional catabolic rates of LDL-1 
and LDL-2 
Discussion 
The existence of subspecies of low-density lipo­
protein has been demonstrated by electrophoretic 
[4] and immunochemical [1,2] methods, and by 
ultracentnfugation [3,5,6,8] These subfractions 
have also been shown to differ m physical and 
chemical properties [3,8] The present studies were 
undertaken to determme whether these subfrac-
tions also differ in their metabolic behavior (in 
vitro and in vivo), which could have consequences 
for their ability to induce atherosclerosis 
To study association and degradation of LDL 
subfractions, we selected human fibroblasts, be­
cause m these cells the LDL receptor is well-char-
acterued However, the role of extrahepatic cells 
in the removal of LDL in vivo is restricted, espe­
cially due to the strong down-regulation of these 
cells when exposed to physiological concentrations 
of LDL [29] The hepatic LDL receptor appears to 
be critical for controling LDL cholesterol levels, 
as evidenced by the success of liver transplanta­
tion m a patient with homozygous familial hyper­
cholesterolemia [30] A high-affimty LDL receptor 
has recently been described on isolated hver mem­
branes and on human hepatocytes in primary 
culture [31,32] This hepatic LDL receptor was 
shown to be less sensitive to down-regulation by 
physiological concentrations of LDL [33] Besides 
tbs 'classic' LDL receptor, the existence of an 
alternative hepatic-binding site was recently sug­
gested [13-16] For the study of the role of LDL 
heterogeneity in the pathogenesis of atheroscleo-
sis, m vitro studies using human hepatocytes in 
primary culture are, therefore, essential However, 
human hepatocytes are difficult to obtain on a 
regular basis. Since the human hepatoma cell line, 
Hep G2, has been shown to provide a model for 
the study of binding, uptake and degradation of 
LDL by hepatocytes m vitro [17-19], we also 
mcluded this model system m our studies As 
shown in the Figs 2-5, no differences, withm 
expenmental error, m association and degradation 
between light and heavy LDL were found for all 
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three different cell types, in agreement with 
another report [9] These results are based partly 
on competition expenments in which LDL-1 or 
LOL'2 competed with total LDL no differences 
between both subfractions were found The results 
on the absence of differential binding and associa­
tion could be strengthened by direct binding ex­
periments, which are more suitable in this respect, 
and more interpretable In contrast to the m vitro 
findings, m vivo studies in guinea pigs show clearly 
differences in fractional catabolic rate of both 
subfractions This animal model was chosen be­
cause of its intermediate cholesteryl ester transfer 
capacity, which is similar to that m man [34] It 
was also used by others [20] to study the changes 
m LDL metabolism and composition by choles­
tyramine We found that radioiodmated LDL-2 
disappeared faster from the circulation than ra­
dioiodmated LDL-1 Also, the ratio LDL-2/LDL-
1 observed in the liver at the end of the expen­
ments favors the view that LDL-2 is more rapidly 
taken up by the liver than LDL-1 It should be 
noted, however, that after uptake, both LDL sub-
fractions are degraded, and the degradation prod­
ucts are subsequently excreted unless LDL is 
labeled with residualizing labels, such as tyramine 
cellobiose. or by sucrose [35,36] This may explain 
why the relative change of the LDL-2/LDL-1 
ratio in plasma is greater than that in the liver 
The m vivo results are consistent with the find­
ings of Vega and Grundy [37], who found a higher 
fractional catabohc rate for the tracer of the more 
dense LDL compared to the less dense LDL in 
moderate hypertnglycenderma in man Our results 
are, however, discordant with those of Teng et al 
[10], who injected and reisolated differentiaUy 
labeled autologous light and heavy LDL m normal 
subjects They reported a higher fractional cata­
bohc rate for light compared to heavy LDL The 
specific activity vs time curve for LDL-1 they 
constructed after analysis of the LDL from serum 
and reisolated LDL subfractions includes both the 
direct uptake of LDL-1 from the circulation plus 
its conversion to LDL-2 In our study, however, 
the fall-off curve for LDL-1 was based on the 
disappearance of the tracer of LDL-1 from whole 
plasma, and thus comprises the direct uptake of 
LDL-1 from the circulation plus, after being con­
verted to LDL-2, its uptake from the LDL-2 com­
partment Assuming that the direct removal of 
LDL-1 and LDL-2 from their respective compart­
ments is similar, which can be concluded from our 
results obtained from various cell types m vitro in 
the current study, the conversion of LDL-1 to 
LDL-2 before leaving the circulation signifies a 
longer circulation time for LDL-1 compared to 
LDL-2 Since a longer circulation time renders the 
LDL particle more susceptible to recognition by 
the scavenger LDL receptor on Macrophages 
[38,39], LDL-1 might be considered more athero­
genic than LDL-2 
Acknowledgements 
The cooperation and advice of Dr I Surya, Dr 
J Rijntjes and Dr H Mashage m the cell culture 
studies is gratefully acknowledged Mr G Grutters 
(Central Animal Laboratory) is thanked for tech­
nical assistance, Dr J Hendnks (Department of 
Statistical Consultation) for statistical advice and 
Prof Dr J Veerkamp for comments on the 
manuscript This study was supported by a grant 
(No G5/84) from the Research Fund of the 
University of Nijmegen 
References 
1 Lee, D M and Alaupovic Ρ (1970) Biochemistry 9 
2244-2252 
2 Hammond, M G and Fisher, W R (1971) J Biol Chem 
246 5454 5465 
3 Shen, M M S , Krauss, R M, Lmdgren F Τ and Forte, 
Τ M (1981) J Lipid Res 22,236-244 
4 Krauss. R M and Burke DJ (1982) J Lipid Res 23 
97-104 
5 Lee, D M and Downs, D (1982) J Lipid Res 23, 14-27 
6 Teng, В, Thompson G R , Smdertnan, A D , Forte Τ Μ , 
Krauss, R M and Kwiterovich, P O (1983) Proc Natl 
Acad. Sci USA 80, 6662-6666 
7 Fisher, W R (1983) Metabolism 32, 283-291 
8 Swinkels, D W , Hak-Lemmers, H L M and Demacker, 
Ρ Ν M (1987) J Lipid Res 28, 1233-1239 
9 Knight, В L, Thompson, G R and Soutar, A К (1986) 
Atherosclerosis 59, 301-306 
10 Teng, В , Smderman, A D , Soutar, A К and Thompson, 
G R (1986) J Chn Invest 77, 663 672 
11 Ame, A D , Pittman, R C and Sternberg, D (1982) 
Hepatology 2, 269-281 
12 Sternberg, D (1983) Arteriosclerosis 3, 283-301 
13 Hoeg, J M , Demosky, S i, }ι, Schaefer, E J, Stand, Τ E 
and Brewer. Η В, Jr (1984) J Clin Invest 73, 429-436 
54 
14 Hoeg, J M , Demosky, S J,, Jr, Lackner, К J, Osborne, 
J С, Jr, Oliver, С and Brewer, H В, Jr (1986) Biochim. 
Biophys Acta 876, 13-21 
15 Edge, S B , Hoeg, J M , Tnche, T , Scheider, P D and 
Brewer, H В (1986) J Biol Chem 261, 3800-3806 
16 Hœg, J M , Edge, S B , Demosky, S J , Jr, Starzl, T E , 
Tnche, T , Gregg, R E and Brewer, H B„ Jr (1986) Bio-
chim Biophys Acta 876, 646-657 
17 Havekes, L , Van Hinsbergh, V , Kempen, H J and Emeis, 
J (1983) Biochem J 214, 951-958 
18 Leichtner, A M Knegcr. M and Schwartz, AL (1984) 
Hepatology 4, 897-901 
19 Hlingworth D R . Lindsey, S and Hagemenas, F С (1984) 
Ьхр Cell Res 155,518-526 
20 Witsrum, J L, Young, S G fclam. R L , Carew, Τ E and 
Fisher M (1985) J Lipid Res 26, 92-103 
21 Rynljes, P J M , Mmhage, H J , Van Gemert P J L De 
Waal. R , Yap, S H (1986) Hepatology 3, 7-18 
22 Demacker, Ρ Ν M , Hijmans A G M , VovJanssen, H F , 
Van Ч Laar, A and Jansen, A P (1980) Clin Chem 26, 
1775-1779 
23 Havel, R J , bder, H A and Bragdon, J H (1955) J Clin 
Invest 34, 1345 1353 
24 MacFarlane, A S (1958) Nature 182 53 
25 Bilheimer, D W , Eisenberg, S and Levy, R I (1972) Bio-
chim Biophys Acta 260, 212-221 
26 Goldslem, J L, Basu, S К and Brown, M S (1983) Meth­
ods bnzvmd 98, 251-260 
27 Lowry, О H , Rosebrough, Ν J, Fan, A L and Randall, 
R.L (1951) J Biol Chem 193, 265-275 
28 Matthews, С Μ E (1957) Phys Med Biol 2, 36-53 
29 Goldstein, J L and Brown, M S (1977) Annu Rev Bio­
chem 46, 897-930 
30 Bilhermer, D W , Goldstern, J L, Gnmdy S M, Starzl, Τ E 
and Brown, M S (1984) N Eng J Med 311, 1658-1664 
31 Harders-Spengel, К , Wood, С В , Thompson, G R, Myant, 
N В and Soutar, А К (1982) Proc Natl Acad Sa USA 
79,6355-6359 
32 Kosykh, V A Preobrazhensky, S N . Ivanov, V О , Tsibul-
sky, V Ρ, Repin, V S and Srmmov V N (1985) FbBS Lett 
183, 17-20 
33 Havekes, L M, Verboom, H De Wit E . Yap, S H and 
Pnncen. H M G (1986) Hepatology 6, 1356-1360 
34 Ha, Y С and Barter, Ρ J (1982) Comp Biochem Physiol 
71В, 265 269 
35 Pittman, R С Green, S R , Attie, A П and Steinberg D 
(1979) J Biol Chem 254,6876 6879 
36 Pittman, R C Carew, T F , Glasj,, C K , Green, SR 
Taylor, C A and Attie, A D (1983) Biochem J 212, 
791-800 
37 Vega, G L and Grundy, S M (1986) Artenosderosis 6 
395-406 
38 Brown M S and Goldstein, JL (1981) Annu Rev Bio­
chem 52, 223-261 
39 Haberland, M E and Fogelman, A M (1987) Am Heart J 
113, 573-577 
55 

C m V P T E L R 4 
DIFFERENCES IN METABOLISM 
OF 
THREE NORMOLIPIDEMIC LOW DENSITY LIPOPROTEIN SUBFRACTIONS 
IN HEP G2 CELLS 
D.W. Swinkels, P.N.M. Demacker, J.C.M. Hendriks 
and A.F.H. Stalenhoef 
Submitted for publication 

ABSTRACT 
The metabolism of low density lipoprotein (LDL) 
subfractions was investigated in the human hepatoma cell line 
Hep G2. By means of a density gradient ultracentrifugation 
method three LDL subfractions were isolated from pooled serum 
of normolipidemic subjects: very light LDL-IA, light LDL-1B 
and heavy LDL-2, differing in size, relative lipid and 
protein content. Cell specific association, stimulation of 
cholesterol esterification and inhibition of sterol synthesis 
were determined in parallel after incubation of Hep G2 cells 
with increasing amounts of LDL-protein of the three LDL 
subfractions. These parallel experiments were repeated four 
times with freshly prepared LDL subfractions. Differences 
between LDL subfractions were tested by analysis of 
covariance. Cell specific association increased significantly 
more with increasing LDL-protein concentration for LDL-IA 
than for LDL-2. Results for LDL-1B were intermediate between 
those for LDL-IA and LDL-2. The corresponding cholesteryl 
ester formation increased significantly more with increasing 
LDL-protein concentration for LDL-IA than for LDL-1B, and for 
LDL-IB significantly more than for LDL-2. These differences 
between LDL subfractions in cholesteryl esterification were 
independent of the cholesterol content of the subfractions. 
Consistent with these findings, the '"'C-acetate 
incorporation to sterols decreased significantly more with 
increasing LDL-protein concentration for LDL-IA and LDL-1B 
than for LDL-2; when adjusted for differences in cholesterol 
content of the LDL subfractions these differences with regard 
to the "C-acetate incorporation were not significant. These 
metabolic differences between normolipidemic LDL subfractions 
in vitro may have implications for the metabolism and 
atherogenic potential of these distinct LDL subfractions in 
vivo. 
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INTRODUCTION 
By a variety of separation methods up to twelve low 
density lipoprotein (LDL) subfractions have been described 
(1-13). Recently, we developed a density gradient 
ultracentrifugation method by which it was possible to 
isolate two to three LDL subfractions from pooled serum (12). 
The LDL subfractions could be visualized by staining the 
serum prior to ultracentrifugation. These LDL subfractions: 
very light LDL (LDL-1A), light LDL (LDL-IB) and heavy LDL 
(LDL-2) were found to differ in chemical composition and 
molecular size but not in electrophoretic mobility on agarose 
gel or in the presence of apoproteins other than apoprotein 
B-100 (12). 
Because of the differences in physical and chemical 
properties of the LDL subclasses, we considered the 
possibility that LDL subfractions also differ in their 
interaction with cells in culture. It was suggested from in 
vivo experiments in both normal subjects and in patients with 
hyperapobetalipoproteinemia that the LDL receptor hp.d a 
higher affinity for light than for heavy LDL (14). Moreover, 
studies of Teng et al. have shown that antibodies to 
antigenic sites close to the binding region of 
apolipoprotein В react more strongly with light than with 
heavy LDL (15). However, both LDL subfractions showed similar 
binding and degradation by fibroblasts and macrophages in 
vitro (16). These in vitro results were recently confirmed by 
our experiments in which we were unable to detect differences 
between two LDL subfractions, light LDL-1 (consisting of both 
LDL-1A and LDL-lB) and heavy LDL-2, in cell association and 
degradation not only in fibroblasts but also in the cell 
line Hep G2 and in human hepatocytes (17). In the present 
study we extended these experiments on the interaction of the 
LDL subfractions with Hep G2 cells. We determined cell 
association, stimulation of cholesterol esterification and 
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inhibition of sterol synthesis in parallel experiments after 
incubation of Hep G2 cells with increasing amounts of LDL-
protein of three different LDL subfractions (LDL-IA, LDL-IB 
ала LDL-2) isolated form normolipidemic subjects. Differences 
between LDL subfractions in the regulation of cellular 
metabolic events were tested by analysis of covariance. 
MATERIALS AND METHODS 
Experimental protocol 
LDL subfractions isolated from serum pools were 
characterized, and assayed in Hep G2 cells in parallel for 
association, cholesterol esterification and ^C-acetate 
incorporation into sterols. In total four experiments were 
performed with four different LDL subfraction preparations. 
LDL subfractionation 
Blood was sampled from a cohort of 13 (6 women, 7 men) 
healthy laboratory workers, aged 24 to 41 years, after 
overnight fasting. All subjects were normolipidemic and did 
not use medication. Sera of 4-5 individuals were isolated 
within 2 h after sampling and pooled. Levels of total serum 
cholesterol, serum triglycerides and high density 
lipoprotein (HDL)-cholesterol in the four pools studied 
ranged from 4.53-4.95 mmol/l, 0.77-1.25 mmol/1 and 1.19-1.67 
mmol/1, respectively. 
Isolation of LDL subfractions from pooled serum was 
obtained by the density gradient ultracentrifugation in a 
swinging bucket rotor (12) slightly modified to increase the 
distance between the LDL subfractions in order to facilitate 
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the isolation of the various subfractions by aspiration. Of 
the fresh pooled serum 3.0 ml was pipetted into six 
polycarbonate centrifuge tubes. The density of the зегшп was 
raised to 1.10 g/ml by dissolution of 0.42 g of KBr. As 
reference for the position of the LDL subfractions, 18 μΐ of 
a freshly prepared 15 g/1 aqueous solution of Coomassie 
Brilliant Blue R was added to one of the tubes. The serum was 
then overlayered successively with 2.0 ml of d=1.065 g/ml, 
3.0 ml of d=1.035 g/ml, 3.0 ml of d=1.020 g/ml and finally 
with 1.5 ml of ä=1.006 g/ml. For optimal staining, the 
density solutions used in the reference tube were adjusted to 
pH 4.5-5.0 with 1 M HCl. The tubes were then ultracentrifuged 
for 19.5 h at 37,000 rpm (160,000 g«^) in either the IEC SW 
41 rotor (6x14 ml) at 20 "C, in an IEC-B60 ultracentrifuge or 
in a MSE Prespin 75 ultracentrifuge with a MSE Ti 40 rotor. 
With the use of the reference tube, LDL subfractions were 
then accurately isolated by aspiration from tubes to which no 
stain had been added. The non-stained LDL subfractions were 
pooled and concentrated by a second run in a fixed angle 
rotor (IEC no. 468) in an IEC B-60 ultracentrifuge for 10 h 
at 168,000 g«v, dialyzed overnight against 5 1 of saline 
containing 5 mg/1 of gentamycin and 0.1 g/1 of EDTA, pH 7.4. 
The EDTA in the LDL subfractions, used in the in vitro 
experiments, was corrected for by the addition of a 1:1 
(v/v) mixture of CaCl2 (5 mmol/l) and MgClz (5 mmol/1). 
The chemical composition of LDL subfractions derived from 
the four different serum pools (4-5 healthy fasted subjects) 
was determined. From these data the mean ratio of cholesterol 
(free cholesterol + cholesterol moiety of cholesteryl ester 
{»0.59 χ wt CE}) to protein was calculated. 
Cells 
Hepatoma cell line Hep G2 was obtained from Dr. S.H. Yap 
(Division of Gastro Intestinal and Liver diseases. University 
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of Nijmegen, Nijmegen, the Netherlands) and originally 
supplied by Dr. Knowles (18). The Hep G2 cells were grown in 
Eagle's modified basal medium, supplemented with 10% (v/v) 
fetal calf serum, penicillin (100 U/ml), streptomycin (100 
pg/ml), fungizone (2.5 \ig/ml) and L-glutamine (2 mmol/1). On 
day 0 of the experiment Hep G2 cells were seeded at a density 
of 1.4 χ IO* cells per dish (cell culture cluster, 24 χ 16 
mm, Costar, Badhoevedorp, The Netherlands), containing 1 ml 
of culture medium with 10 % (v/v) of fetal calf serum. On day 
3 the medium was renewed. On day 5, after washing the dishes 
with 1 ml of Hanks' balanced salt solution, the cells were 
incubated with 1 ml of fresh medium containing lipoprotein-
deficient serum (LPDS) (isolated from the pooled serum of 
healthy subjects by ultracentrifugation at 160,000 g
e v
 for 46 
h, final concentration 5 mg of protein/ml). All four 
experiments were started on day 7 after the cells had been 
grown for 48 h in the presence of LPDS medium. All cells were 
maintained at 37 eC in a humidified atmosphere of 95 % air/5 
% C02. 
lodination of LDL subfractions 
The LDL subfractions were labeled with "sj ^g^ 20). The 
iodinated LDL was dialyzed overnight against 5 1 of saline 
containing 5 mg/1 gentamycin and 0.1 g of EDTA per liter at 
pH 7.5. Specific activities for the iodinated LDL 
subfractions varied from 75 to 270 cpm/ng of protein and the 
trichloroacetic acid and isopropanol precipitability of LDL 
radioactivity were greater than 99 % and 90 %, respectively. 
Less than 5 % of the radiolabel was found in lipid. 
Assay of cell associated ,25I-LDL siibfraction 
Association studies were performed as described (26). Hep 
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G2 cells were incubated for 5 h with increasing amounts of 
protein (0, 10, 30 and 80 цд/ті) from each of the '^5! 
labeled LDL subfractions in 1 ml LPDS medium. After 
incubation, the media were harvested and the cells were 
cooled to 4 0C and washed five times with 1 ml of buffer 
comprising 50 mM Tris-HCl/150 mM NaCl/2 mg/ml bovine serum 
albumin <pH 7.4), followed by a 1 ml wash with a buffer 
comprising 50 mM Tris-HCl/150 mM NaCl (pH 7.4). 
Subsequently, the cells were solubilized in 0.2 N NaOH at 
room temperature. The cell associated radioactivity (i.e., 
bound and internalized radioactivity) was quantitated and the 
cellular protein was determined by the method of Lowry et al. 
(27). In all four experiments performed, each value 
represents the mean of quadruplicate incubations. 
Aspecif ically associated ^^I-LDL was determined in 
triplicate at LDL-protein concentrations of 10 мд/ті and 30 
цд/ті in the presence of 300 and 500 цд/ті unlabeled LDL, 
respectively. Results were expressed as цд of Hep G2 
associated (i.e., bound and internalized) i;îbl-LDL per mg of 
cell protein. 
Incorporation of "C-oleate into cholesteryl esters. 
The extent of incorporation of ^C-oleate in cholesteryl 
esters was determined as described by others (17, 18). Cells 
were preincubated for 5 h in the presence of increasing 
amounts of protein (0, 3, 18, 70 ug/ml) of each of the LDL 
subfractions in 1 ml LPDS medium. After the preincubation, 
each dish received 10 μΐ of a sodium!1 "-Cjoleate-albumin stock 
solution, comprising ЮтМ [l-^C]oleate (specific activity of 
approximately 10,000 dpm/nmol) and an albumin concentration 
of 120 mg/ml. ([l-v*c] oleic acid in heptane (55-60 mci/mmol) 
was obtained from New England Nuclear, Du Pont de Nemours, 's 
Hertogenbosch, The Netherlands). After a 2 h incubation, 
cells were washed twice with l ml of buffer comprising 50 mM 
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Tris-HCl/150 mM NaCl/2 mg/ml bovine serum albumin (pH 7.4), 
followed by a 1 ml wash with a buffer comprising 50 mM 
Tris-HCl/150 mM NaCl (pH 7.4). One ml of hexane-isopropanol 
(3:2, v/v) was added to each dish. After incubation at room 
temperature, the organic solvent was removed and the cells 
were rinsed briefly with 0.5 ml of solvent of the same 
composition. The two organic solvent extracts were combined 
in a glass tube. An internal standard containing 
3H-cholesteryl oleate (50 цд, approximately 20,000 dpm) , 
unlabeled triolein (50 цд) and unlabeled oleic acic (50 \ig) 
in chloroform-methanol (2:1, v/v) was added as a single 10 μΐ 
addition to each tube. :,H-cholesteryl oleate in toluene 
(60-100 Ci/mmol) was obtained from New England Nuclear. Each 
tube was stirred on a Vortex-mixer. The solvent was 
evaporated under Nz. Lipids in each tube were resuspended in 
60 μΐ of hexane and spotted on a silicagel G thin-layer 
chromatogram (Polygram Sil G, 0.25 mm, art no. 805013, 
Macherey-Nagel, Düren, FRG). The tubes were rewashed with 
another 60 ці of hexane. The chromatogram was developed in 
heptane/ethyl-ether/acetic acid (90:30:1, v/v/v), and the 
cholesteryl ester spot was identified with iodine vapor 
(RB-=0.9), cut from the chromatogram and counted in 10 ml 
Aqualuma (Lumac, Schaesberg, The Netherlands). For the four 
experiments performed the recovery of the internal standard 
averaged 52 + 6 %. After extraction of the lipids from the 
dishes, cell residues were dissolved in 0.2 M NaOH and the 
protein content was determined by the method of Lowry et al. 
(19). In all four experiments performed, each value 
represents the mean of triplicate incubations. The results 
were expressed as runo Is of ^C-oleate incorporated in 
cholesteryl esters per mg of cell protein. 
Incorporation of "C-acetate to sterols 
To determine the ability of LDL subfractions to down-
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regulate sterol synthesis. Hep G2 cells were incubated with 
increasing amounts of protein (0, 3, 18, 70 [ig/ml) of each of 
the LDL subfractions in 1 ml LPDS medium. After 5 h, the 
medium was removed and the cells were washed 3 times with 
Hanks* balanced salt solution; 1 ml of LPDS medium containing 
0.5 мСі of [2-1*C]acetate (sodium salt; 0.89 mM; 124.3 χ IO3 
dpm/pmol) was added and incubated for 2 h. ( [2-ld-C]acetic 
acid (56 mCi/mmol), sodium salt in water (1 mCi/ml) was 
obtained from Amersham, Houten, the Netherlands). At the end 
of the incubation the medium was removed and the cells were 
washed twice with 1 ml of buffer comprising 50 mM 
Tris-HCl/150 mM NaCl/2 mg/ml bovine serum albumin (pH 7.4), 
followed by a 1 ml wash with a buffer comprising 50 mM 
Tris-HCl/150 mM NaCl (pH 7.4). The lipids were extracted by 
the addition of 1 ml hexane/isopropanol (3:2, v/v), for 1 h 
at room temperature, followed by two rapid extractions with 
0.5 ml of solvent of the same composition. The organic 
solvent extracts were combined in a glass tube. 10 μΐ of an 
internal standard comprising 0.028 цСі 3H-cholesterol 
([l«,2œ(n)-3H3-cholesterol in toluene (33 Ci/mmol) was 
obtained from Amersham, Houten, the Netherlands), 50 ug 
unlabeled cholesterol, 50 \ig oleic acic, 50 \ig triolein and 
50 ug cholesteryl ester in chloroform-methanol (2:1, v/v) was 
added as a single 10 μΐ addition to each tube. Each tube was 
stirred on a Vortex-mixer. The solvent was evaporated under 
N2. The cholesteryl ester was hydrolyzed with 1 Ν KOH in 95 % 
ethanol for l h at 85 "C, and the sterols were reextracted 
into 2 ml hexane. The pooled extracts were subsequently 
washed with 2 ml 1 M NaOH and 0.5 ml water. Hexane was 
removed in a stream of N^· Lipids in each tube were 
resuspended in 2 times 60 μΐ of hexane/isopropanol (3:2, v/v) 
and spotted on a silicagel G thin-layer chromatogram 
(Polygram Sil G, 0.25 mm, art no. 805013, Macherey-Nagel, 
Düren, FRG). The chromatogram was developed in diisopropyl-
ether/acetic acid (94:4, v/v), followed by petroleumether 
(60-70 0C)/diethYl-ether/acetic acid (90:10:1, v/v/v), and 
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the cholesterol spot was identified with iodine vapor 
(RF-=0.38), cut from the chromatogram and counted in 10 ml 
Aqualuma (Lumac, Schaesberg, The Netherlands). For the four 
experiments performed the recovery of the internal standard 
averaged 5 3 ± 8 %. After extraction of the lipids from the 
dishes, cell residues were dissolved in 0.2 M NaOH and the 
protein content was determined by the method of Lowry et al. 
(19). In all four experiments performed, each value 
represents the mean of triplicate incubations. The results 
were expressed as pmols of i-1C-acetate in cholesterol per mg 
of cell protein. 
Analytical methods 
Total cholesterol, unesterified cholesterol, phospholipids 
and triglycerides were determined with enzymatic, 
commercially available reagents (Boehringer, Mannheim, FRG, 
cat. no. 237574, 310328, 691844 and Sera Pak, Ames, Italy 
cat. no. 6639, respectively). 
Statistical analysis 
Assuming that the cholesteryl ester formation is out of 
saturation for the LDL-protein range of 0 to 70 \xg/ml, it is 
possible to approximate the curve, depicting the relation 
between cholesteryl ester formation and LDL protein levels by 
a square root function. It is evident that for the 
cholesteryl ester formation the "response curve" to LDL-
protein for the LDL subfractions within one experiment starts 
from the same point at which LDL-protein=0 \ig/ml. Within 
each experiment the cholesteryl ester formation at this point 
was estimated with the mean of triplicate measurements. By 
subtraction of each individual determination of cholesterol 
esterification with this estimation a response curve to the 
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LDL-protein concentration was obtained. It is possible to 
model this response curve as choljj=p1j*vrLDL~protein, in 
which the parameter ß-u depends on experiment (i=l,2,3,4) and 
LDL subfractions (j=lA,lB,2). Differences in response curves 
depending on experiments and LDL subfractions were tested by 
means of covariance analysis in which the cholesteryl 
esteri fication was the dependent variable, the square root 
from LDL-protein the independent regression variable and 
experiment (4 levels) and LDL subfraction (3 levels) the 
independent class variables. In the covariance analysis model 
no intercept was allowed, neither for experiment nor for LDL 
subfraction. The so formed model can be stated as: 
cholij=(ß1.1 + ΣΛ β^
ί
*Ε
ί
 + І
э
 ß ^ F j + 
-i-i 3 — ι 
Σ* Σ' ß4J 1*EFi-í)*VLDL-p; 
Ei's are dummy variables for the experiments, Fj's are dummy 
variables for the LDL subfractions and EF^'s are the dummy 
variables for the combination of experiments and LDL 
subfractions. 
The cholesteryl esterification as function of the LDL-
cholesterol was analyzed with respect to differences in both 
LDL subfractions and experiments with the same two 
assumptions and comparable covariance analysis as described 
above. 
Analogous to the cholesterol v,1C-ester formation, the ХЛС-
acetate incorporation was analyzed as function of the LDL-
cholesterol and as function of the LDL-protein, respectively. 
The aspecific association was measured at the v:?bLDL-
protein concentrations of 10 and 30 \ig/ml. With the least 
square method the best linear regression line through those 
points and the origin was determined. The specific 
association was then calculated from this estimated aspecific 
association and the measured total association. The 
differences between the LDL subfractions and the experiments 
in the response curve of the specific association to the LDL-
protein was analyzed with a covariance analysis comparable to 
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those used for the cholesterol esterification and the ХЛС-
acetate incorporation. 
The statistical analysis was performed with the GLM-
procedure available in the Statistical Analysis System (SAS) 
software package (SAS Institute Incorporated, Cary, NG, USA). 
RESULTS 
Fractionation of LDL from pooled serum 
After density gradient ultracentrifugation, in all four 
pooled sera, three stained LDL subfractions could be seen, 
separated by a clear interface: very light LDL-1A, light 
LDL-IB and heavy LDL-2 (Fig. 1). Subfractions were isolated 
by aspiration and used for the in vitro experiments. 
t 1 
LDL-1A—• 
LDL-1B_^ 
LDL- 2 -• 
Fig. 1. Subdivision of LDL into 
three subfractions after density 
gradient ultracentrifugation of 
prestained human pooled serum. The 
arrows indicate the LDL 
subfractions used in the in vitro 
experiments with Hep G2 cells: very 
light LDL-1A, light LDL-IB and 
heavy LDL-2. VLDL is situated at 
the meniscus and HDL and serum 
proteins at the bottom of the tube. 
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physicochemical characteristics of LDL subfractions 
Chemical composition of the LDL subfractions are shown in 
Table 1. LDL-1A contained relatively more lipid and less 
protein than LDL-IB, which in turn contained more lipid and 
less protein than LDL-2. The mean ratio cholesterol (i.e., 
free cholesterol + cholesteryl moiety of cholesterol ester 
(«0.59 χ wt of cholesterol ester))/protein was 1.51, 1.37 and 
1.04 for LDL-1A, LDL-IB and LDL-2, respectively. This ratio 
was used to convert LDL-protein concentration to LDL-
cholesterol concentration for each LDL subfraction in the 
cholesteryl ester formation and incorporation of ^C-acetate 
to sterol assays, in order to correct for the differences in 
the cholesterol content between the LDL subfractions. By 
gradient gel electrophoresis we have earlier found that LDL-2 
was smaller than LDL-IB and LDL-IB smaller than LDL-1A (7). 
TABLE 1. Density, chemical composition3 and 
cholesterol/protein ratio15 of very light (LDL-1A), light 
(LDL-IB) and heavy (LDL-2) LDL subfractions isolated from 
pooled serum. 
LDL-1A LDL-IB LDL-2 
Density range (g/ml) 1.023-1.029 1.030-1.034 1.036-1.041 
Cholesteryl Ester 41.7 ± 3.0 41.8 + 2.0 39.3 + 2.1 
Free Cholesterol 9.8+1.1 9.2+1.0 7.9+0.9 
Triglycerides 5.0 + 0.4 4.2 + 0.7 4.2 + 0.6 
Phospholipids 20.7±0.5 20.0+0.6 18.8+0.8 
Protein 22.8 + 2.1 24.7 + 1.0 29.8 + 2.0 
Ratio cholesterol/ 1.51 1.37 1.04 
protein 
"Relative chemical composition (percent of dry mass, mean + 
SD, n=4). 
^In this ratio cholesterol= free cholesterol + cholesterol 
moiety of cholesteryl ester («0.59 χ wt of cholesteryl 
ester). 
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Metabolie studies 
Cell specific association, induction of cholesteryl x*c-
ester accumulation and inhibition of "C-acetate 
incorporation to cholesterol were assayed simultaneously 
after incubation of Hep G2 cells with increasing amounts of 
the three LDL subfractions, LDL-lA, LDL-lB and LDL-2, in four 
independent experiments with freshly prepared LDL 
subfractions. The data obtained for these three different 
cellular metabolic events were analyzed using a covariance 
analysis model. From this model the overall curves of 
specific cell association, induction of cholesteryl ester 
accumulation and inhibition of cholesterol synthesis for the 
LDL subfractions as a function of both LDL-protein and LDL-
cholesterol were estimated and compared (Table 2). 
Differences in the relative position of these LDL subfraction 
curves among the individual experiments performed are 
described from Table 3, which shows a representation of the 
estimated parameters in the model used. The variations among 
experiments in the absolute levels of cell association, 
cholesteryl ester formation and sterol synthesis are also 
determined from the covariance analysis model; the results 
are shown in Table 4 and described in comparison with 
reference experiment 1. The estimated curves of the cell 
association, cholesteryl ester formation and sterol 
synthesis for the LDL subfractions are shown for reference 
experiment 1 (Fig. 2). 
Cell specific association 
The overall differences in cell specific association 
between the LDL subfractions could be described as follows: 
the estimated curve for LDL-lA was situated significantly 
above that for LDL-2 (p<0.05). This observation indicates 
that LDL-lA gives a greater association to Hep G2 cells than 
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LDL-2. The e s t i m a t e d c u r v e f o r LDL-IB was i n t e r m e d i a t e 
b e t w e e n t h a t f o r LDL-lA and LDL-2 and d i d n o t d i f f e r 
s i g n i f i c a n t l y from b o t h . The e s t i m a t e d d i f f e r e n c e s be tween 
t h e p a r a m e t e r s of t h e c u r v e s of LDL-lA, LDL-IB and LDL-2 f o r 
t h e c e l l s p e c i f i c a s s o c i a t i o n and t h e l e v e l s of s i g n i f i c a n c e 
a r e i n d i c a t e d i n T a b l e 2. 
TABLE 2. The estimated differences between the parameters of 
the curves of the LDL subfractions for the ce l l specific 
association, cholesteryl ester formation and ^C-acetate 
incorporation to s te ro l s in Hep G2 c e l l s 
Model 
parameters 
Cell specific 
association 
Cholesteryl "Hi-Acetate 
ester incorporation 
formation to s t e r o l s 
(xlO 2 ) 
LDL-protein 
Δ(ΙΑ-ΙΒ) 
Δ(1Α-2) 
Δ(1Β-2) 
7.16 + 5.10 
13.11 + 5,10" 
5.94 + 5.10 
10.82 + 2.31 e 
19.68 + 2.28e 
8.86 + 2.33e 
-2.80 + 8.23 
-19.24 + 7.80" 
-16.44 + 8.24» 
LDL-cho1esterol 
Δ(ΙΆ-ΙΒ) 
Δ(1Α-2) 
Δ(1Β-2) 
7.70 + 1.93e 
12.93 + 2.05e· 
5.23 + 2.13a 
1.40 + 6.89 
-3.24 + 7.03 
-4.65 + 7.53 
The curves are parametrized with the function y=avx, in which 
y=association, cholesteryl ester formation and acetate 
incorporation, respectively and x=LDL-protein and LDL-
cholesterol, respectively. The relations of the association, 
cholesteryl ester formation or sterol synthesis (dependent 
variables) with either LDL-protein or LDL-cholesterol levels 
(independent regression variables) are determined according to 
linear regression models without intercepts. The LDL 
subfraction (3 levels) and the experiment (4 levels) are 
included as class variables in these models. Δ, estimated 
differences between the parameters of the curves of the 
indicated LDL subfractions ; a, 0.01<p<0.05; ь, 0.001<p<0.01; 
c
, p<0.001 
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These overall differences between the estimated curves of 
the specific association for the LDL subfractions were not 
the same for all individual experiments performed; the 
difference between LDL-IA and LDL~2 in experiment 4 was 
significantly greater (p<0.01) than that of in experiment 1. 
A representation of the estimated parameters in the linear 
regression model for the cell specific association is given 
in Table ЗА. In this Table estimated parameters are indicated 
with respect to experiment 1 and LDL~2. The estimated curves 
of the cell specific association for the three LDL 
subfractions within experiment 1 are shown in Fig. 2Ά. 
The estimated curves for the specific association for the 
experiments 2 and 3 were situated significantly below 
(p<0.001), and those for experiment 4 significantly above 
(p<0.001) those of reference experiment 1 (Table 4), 
indicating that the cell specific association varied 
considerably among the four experiments performed. 
Stimulation of cholesteryl ester formation 
When the results of all four experiments were taken into 
account, the estimated curve for the stimulation of the 
cholesteryl ester formation, expressed as a function of the 
LDL-protein, for LDL-IA was situated above that for LDL-1B, 
and the curve for LDL-1B above that for LDL-2. Differences 
between the estimated curves of the subfractions were all 
significant {p<0.001) (Table 2). These results indicate that 
per LDL particle LDL-IA stimulates cholesteryl ester 
accumulation to a greater extent than LDL-1B, and LDL-1B more 
than LDL-2. 
Similar trends of the estimated curves for the cholesteryl 
ester accumulation, expressed as a function of the LDL-
protein level, of the LDL subfractions were found in all four 
experiments. The results obtained in reference experiment 1 
are shown in Fig. 2B. Differences between the estimated 
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curves of t h e c h o i e s t e r y l e s t e r accumulation for t h e LDL 
s u b f r a c t i o n s were s i g n i f i c a n t l y g r e a t e r wi th in t h e 
experiments 2 and 4 in comparison with t h e s e d i f f e r e n c e s 
w i t h i n experiment 1 (Table ЗА). For example, in experiment 2 
t h e es t imated curves of both LDL-1A and LDL-1B were 
s i g n i f i c a n t l y f u r t h e r a p a r t from LDL-2 than in re ference 
experiment 1 (Table ЗА). 
TABLE 3. Representation of the estimated parameters in the linear 
regression model for the cell specific association, choiesteryl ester 
formation and ^C-acetate incorporation to sterols in Hep G2 cells, in 
relation to LDL-protein (A) or LDL-cholesterol (B). 
A 
Effects in 
the linear 
model 
LDL-p 
LDL-p*frac 
LDL-p*exp 
LDL-p*exp*frac 
Model 
exp 
Δ(2-ΐ: 
parameters 
LDL 
sübfraction 
Δ(1Α-2) 
Δ(1Β-2) 
) 
Δ{3-1) 
Δ(4-1 
2 
2 
3 
3 
4 
4 
1 
1 
2 
3 
4 
1 
) 
ΔΜΐΑ-2) 
Δ 418-2) 
Δ41Α-2) 
ΔΜ1Β-2) 
ΔΜ1Α-2) 
ΔΜΐΒ-2) 
Α41Α-2)Λ 
ΔΜΐΒ~2) β 
ΔΙ:,(1Α-1Β) 
Δ11(ΙΑ-IB) 
Δ1i(ΙΑ-IB) 
Δ11{1Α-1Β)Γ 
Cell specific 
association 
73.45+ 8.00e 
13.81+11.31 
2.05+11.31 
49.41+10.58e 
24.98+10.58« 
-39.96+10.58e 
-34.29+14.96 
-14.34+14.96 
-16.25+14.96 
7.04+14.96 
47.71+15.00ö 
22.85+14.96 
-19.95+14.96 
-23.28+14.96 
24.86+15.00 
Choiesteryl 
ester 
formation 
(xio-2) 
9.56+3.210 
6.62+4.53 
1.36+4.53 
-2.14+4.53 
33.16+4.53e-· 
4.81+4.63 
28.98+6.41e 
25.47+6.41e 
2.20+6.41 
-0.73+6.68 
21.10+6.48*» 
5.27+6.48 
3.51+6.41 
2.92+6.68 
15.83+6.41» 
1
*C-Acetate 
incorporation 
to sterols 
-84.16+10.57° 
-25.07+14.94 
-5.43+14.94 
20.47+15.03 
42.24+16.18a 
-23.84+14.94 
12.26+22.08 
-13.70+24.55 
-24.50+22.02 
-38.72+22.02 
35.53+21.13 
8.41+21.13 
25.97+25.27 
14.23+21.13 
27.12+21.13 
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Effects in 
the linear 
model 
LDL-c 
LDL-c*frac 
LDL-c*exp 
LDL-c*exp*frac 
Model 
exp, 
Δ(2-ΐ: 
Δ(3-11 
Δ(4-Ι; 
2 
2 
3 
3 
4 
4 
1 
1 
2 
3 
4 
1 
parameters 
LDL 
subfraction 
Δ(1Α-2) 
Δ{1Β-2) 
I 
I 
I 
Δ41Α-2) 
Δι{1Β-2) 
лміл-г) 
Δ41Β-2) 
ΔΜ1Α-2) 
ΔΜΐΒ-2) 
^{1Ъ-2)а 
лчів-г)0 
ΔΑΜ1Α-1Β) 
Δ^^ΜΙΑ-ΙΒ) 
Δι1(1Α-1Β) 
Δ'i(ΙΑ-IB)' 
Cholesteryl 
ester 
formation 
(xlO-2) 
9.38+3.14° 
3.79+4.08 
-0.05+4.17 
-2.10+4.44 
32.51+4.44e 
4.72+4.54 
23.94+5.78= 
22.03+5.90e 
-3.74+5.78 
-4.81+6.11 
16.37+5.850 
3.89+5.96 
1.91+5.35 
1.06+5.59 
12.48+5.35* 
1
"C-Acetate 
incorporation 
to sterols 
-82.53+10.36ö 
-6.36+13.46 
5.98+13.46 
20.08+14.73 
41.42+15.87a 
-23.38+14.65 
6.56+19.76 
-14.29+22.18 
-26.98+19.99 
-38.42+20.36 
32.89+19.04 
10.19+19.43 
20.86+21.17 
11.43+17.63 
22.70+17.63 
LDL-p, LDL-protein; LDL-c, LDL-cholesterol; LDL-p*frae, the component 
indicating the differences between the estimated parameters of the curves 
for the LDL subfractions ; LDL-p*exp, the component indicating the 
differences between the estimated parameters of the curves for the 
experiments; LDL-p*exp*frac, the component indicating the differences 
between the estimated parameters of the curves for the LDL subfractions 
between the experiments; Δ ( 1 Α - 2 ) , difference between the estimated 
parameters of the curves of LDL-IA and LDL-2 in reference experiment 1; 
Δ(2-1), difference between the estimated parameters of the curves for the 
experiments 1 and 2 for the reference LDL subfraction LDL-2; Δ 1 , 
difference between the estimated parameters of the curves of the 
indicated LDL subfractions within experiments with respect to their 
reference in experiment 1; л і 1(1А-1В), these estimated parameters are 
calculated from the model to complete the interpretation of the LDL 
subfractions. », 0.0l<p<0.05,· ь, 0.00l<p<0.01; c, p<0.00l; a, reference 
for difference between LDL-IA and LDL-2 for the experiments 2 to 4; e, 
reference for difference between LDL-1B and LDL-2 for the experiments 2 
to 4; ', reference for difference between LDL-IA and LDL-IB for the 
experiments 2 to 4 
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The estimated curve for the cholesteryl ester formation for 
experiment l was located significantly below (p<0.001) the 
curves for the other three experiments (Table 4). Thus, 
exposure of the Hep G2 cells of experiment 1 to the LDL 
subfraction preparations used in experiment 1 resulted in a 
significantly lower incorporation of 1*C-oleate to 
cholesteryl esters as compared to the other three 
experiments. 
To exclude that differences between subfractions were 
simply the result of their differences in the 
cholesterol/protein ratio (Table 1), differences in 
cholesteryl ester accumulation were also analyzed as a 
function of LDL-cholesterol concentration. The estimated 
curve for LDL-1A for the cholesteryl ester formation, 
expressed as a function of the LDL-cholesterol 
concentration, was located above that of LDL-IB and LDL-2 and 
in that order. Differences between the subfractions were 
again all significant (p<0.05) (Table 2). 
The differences between the estimated curves for the 
overall cholesteryl ester accumulation of the LDL 
subfractions, expressed as a function of the LDL-cholesterol 
level, were again not as explicite for all four individual 
experiments. The results obtained in reference experiment 1 
are shown in Fig. 2C. As for the results as a function of the 
LDL-protein concentration, the differences between the LDL 
subfractions within the experiments 2 and 4 were 
significantly greater as a function of LDL-cholesterol than 
those within experiment 1 (Table 3B). 
A significantly lower (p<0.001) incorporation of ]L*C-oleate 
to cholesteryl esters is observed for experiment 1 than for 
the other three experiments as a function of LDL-cholesterol 
(Table 4). 
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Fig. 2. The estimated curves for the metabolic variables in the LDL 
receptor pathway measured in Hep G2 cells in experiment 1. Cell specific 
association (A), induction of cholesteryl ester accumulation (page 78: 
B,C) and inhibition of the "C-acetate incorporation to sterol (page 
79: D,E) were assayed in parallel after incubation of Hep G2 cells with 
the three LDL subfractions, LDL-IA, LDL-IB and LDL-2 in four independent 
experiments. To preclude that differences between the estimated curves 
of the LDL subfractions are simply the result of their differences in 
the cholesterol/protein ratio the estimated curves of the cholesteryl 
ester accumulation and sterol synthesis are shown both as a function of 
LDL-protein (B and D, respectively) and as a function of LDL-cholesterol 
(C and E, respectively). Indicated points represent the means of 
triplicate measurements: *, LDL-1A; +, LDL-IB; 0, LDL-2. Solid-, 
interrupted- and dotted lines represent the response curves of LDL-lA, 
LDL-IB and LDL-2 to LDL-protein or LDL-cholesterol concentrations, 
respectively. The models used for estimation of the curves are described 
in Material and Methods and in the legend of Table 2. 
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Inhibition of incorporation of acetate to sterols 
The overall curves of the л "'C-acetate incorporation to 
sterols for the LDL subfractions, expressed as a function of 
LDL-protein, were estimated. It appeared that the estimated 
curve for LDL-2 was situated above that for LDL-lB, and the 
curve for LDL-IB above that for LDL-IA. The position of the 
estimated curve for LDL-2 was significantly higher than the 
position of these curves for LDL-IA and LDL-IB (p<0.05. Table 
2). Thus, per LDL particle, the LDL-2 does not down-regulate 
the cellular sterol synthesis as efficiently as LDL-IA or 
LDL-IB. 
Differences between the estimated curves of the Λ-»C-acetate 
incorporation for the three LDL subfractions within the 
experiments 2, 3 and 4 were comparable to the differences 
within the reference experiment 1 (Table 3Ά, Fig. 2D). 
For the experiments 2 and 3 the inhibition of the хлс-
acetate incorporation to sterols was significantly smaller 
(p<0.05) than for the experiments 1 and 4 (Table 4). 
When differences between estimated curves for the 
inhibition of 1-1C-acetate incorporation of the three LDL 
subfractions were analyzed as a function of the LDL-
cholesterol concentration, it was found that LDL-IB 
suppressed the sterol synthesis of the Hep G2 cells more than 
LDL-IA, and LDL-IA more than LDL-2. However, these 
differences were not significant (Table 2). 
Differences between the estimated curves as a function of 
LDL-cholesterol for the three LDL subfractions within the 
experiments 2, 3 and 4 were also comparable to the 
differences within the reference experiment 1 (Table 3B, Fig. 
2E). 
The inhibition of the '^C-acetate incorporation to sterols 
was significantly smaller for the experiments 2 and 3 
(p<0.05) in comparison to the experiments 1 and 4, expressed 
as function of the LDL-cholesterol concentration (Table 4). 
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TABLE 4. The estimated differences between the parameters of the curves 
of the four experiments for the cell specific association, cholesteryl 
ester formation and 1 "'C-acetate incorporation to sterols in Hep G2 cells 
Model 
parameters 
Cell specific 
association 
Cholesteryl 
ester 
formation 
(xlO г) 
;i
*C Acetate 
incorporation 
to sterols 
LDL-protein 
Δ (expl-exp2) 
Δ (expl-ехрЗ) 
Δ ( e x p l - e x p 4 ) 
-33.21 + 6.11" 
-21.91 + 6 . 1 1 е 
16.44 + 6.12* 
-16.01 + 2 . 6 2 е 
-33.65 + 2 . 6 9 е 
-13.60 + 2 . 6 4 е 
-19.99 + 9.80 г 
-21.17 t 8.87= 
9.19 + 8.63 
Δ (ехр2-ехрЗ) 
Δ(ехр2-ехр4) 
11.29 + 5 . 6 6 a 
49.64 + 5.67^ 
-17.64 + 2.69е 
2.40 + 2.64 
-1.17 +10.02 
29.19 + 9.SO13 
Δ(ехрЗ-ехр4) 38.35 + 5.67е- 20.04 + 2.71е 30.36 + 8.87^ 
LDL-cholesterol 
Δ(expl-exp2) 
Δ(expl-ехрЗ) 
Δ(expl-exp4i 
-13.22 + 2.32е 
-29.66 + 2.38е 
-11.47 + 2.34' 
-17.50 + 8.60a 
-19.62 + 7.91a 
9.02 + 7.64 
Δ(ехр2-ехрЗ) 
Δ(ехр2-ехр4) 
-16.44 + 2.38е 
1.75 + 2.34 
-2.12 + 8.83 
26.52 + в-бО" 
Δ{ехрЗ-ехр4) 18.19 + г^о^ 28.64 + 7.91е 
Information about the statistical analysis performed is included in the 
legend of Table 2. Δ , estimated differences between the parameters of 
the curves of the indicated experiments; a, 0.01<p<0.05; ö, 
0.001<p<0.01; c r p-CO.OOl 
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DISCUSSION 
The aim of our investigation was to determine whether the 
LDL subfractions will differ with regard to their metabolism 
in liver cells. In the present report we determined 
association (i.e., binding and internalization), induction of 
^C-oleate incorporation into cholesteryl ^C-esters and 
inhibition of the 1"1C-acetate incorporation into sterols 
after exposure of Hep G2 cells to very light LDL-1A, light 
LDL-1B and heavy LDL-2. Results obtained for the three LDL 
subfractions were compared by means of covariance analysis. 
Although identical experimental procedures were employed 
for the four experiments performed, the absolute association, 
cholesteryl esterification and inhibition of cholesterol 
synthesis varied considerably between experiments (Table 4). 
To circumvent these difficulties in determining absolute 
parameters when studying lipoprotein metabolism of cells in 
culture (21), the specific association, cholesteryl 
esterification and inhibition of sterol synthesis were tested 
simultaneously for the LDL subfractions obtained from one and 
the same serum pool. This experimental protocol was repeated 
four times with freshly isolated LDL subfractions, each 
consisting of three different LDL subfractions, isolated by 
single spin density gradient ultracentrifugation (12) from 
four different serum pools. 
Since the liver plays a major role in the plasma clearance 
of LDL by the LDL-receptors (25, 26) and probably also in the 
differential catabolism of the LDL subfractions, in vitro 
studies with cultured hepatocytes are indicated. Therefore, 
studies were performed with Hep G2 cells that have been shown 
to provide a reliable model for human hepatocytes with 
respect to the catabolism of LDL through the LDL-receptor 
pathway (27, 28, 29). 
Despite variations between experiments our results 
consistently show for Hep G2 cells that the more dense the 
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LDL subfraction, the less its cell association and 
cholesteryl esterification and the stronger its inhibition of 
the cellular sterol synthesis. When results were expressed 
as a function of LDL-cholesterol concentration similar 
conclusions could be drawn although for the inhibition of the 
^C-acetate incorporation into cholesterol, the differences 
between LDL subfractions appeared not significant. 
The significant decreased cell association for dense LDL-2 
in comparison to buoyant LDL-lA are in line with studies 
performed by Teng et al. on the reactivity of monoclonal 
antibodies against antigenic sites close to the LDL receptor 
binding region of the ligand of the LDL subfractions. They 
found a reduced inununoreactivity of these antigenic 
determinants in dense LDL compared to buoyant LDL (15). 
However, the present findings of the differences in 
association between three LDL subfractions seem to be 
different from previous observations with two LDL 
subfractions in cells in culture (16, 17). In a recent report 
we did not find a difference between LDL-l (consisting of 
both LDL-lA and LDL-1B) and LDL-2 in association and 
degradation by human cultured fibroblasts, human hepatocytes 
and the human hepatoma cell line Hep G2 (17). This apparent 
discrepancy in observations may be explained by the further 
subfractionation of LDL-l to LDL-lA and LDL~1B. Since the 
present study showed that LDL-1B gives a cell association 
that is intermediate between that of LDL-lA and LDL-2, the 
further subfractionation of the LDL-l used in our earlier in 
vitro experiments may enhance the chance of finding 
metabolic differences between LDL subfractions. The same may 
apply to the findings by Knight et al., who also were unable 
to show differences between light and heavy LDL in binding 
and degradation in cells in culture (human fibroblasts and 
macrophages) (16). 
The differences between LDL subfractions in their induction 
of the cholesteryl ^c-ester formation occurred in the same 
order as observed for the cell specific association in that 
83 
LDL-ΙΆ stimulated the cholesterol esterification to a greater 
extent than LDL-1B and LDL-2. These differences in 
cholesteryl esterification were present when the amount of 
LDL added to one ml medium was expressed per both цд LDL-
protein and per цд LDL-cholesterol and could therefore not be 
explained by the increased amounts of cholesterol in the more 
buoyant ала larger LDL subfractions. In addition, LDL 
subfractions seemed to be more distinctive with respect to 
cholesteryl esterification than with respect to cell 
association. This was also found in a study with human 
fibroblasts and five LDL subfractions (30). 
The reason for the reduced cell specific association and 
decreased capacity to induce the cholesteryl esterification 
of the heavy LDL subfraction is not clear. While apo E has 
been reported to increase the affinity of a lipoprotein to 
the apo Β, E receptor (reviewed in ref. 28), we found only 
trace amounts of apo E in the various LDL subfractions, 
hardly detectable by a sensitive rocket immunoelectrophoresis 
method in the concentrated subfractions (LDL-1A, 0.2%; 
LDL-1B, 0.5% and LDL-2, 1.2% Of LDL protein) (12). It is 
also possible that the smaller size of heavy LDL induces 
conformational changes of apo В and decreases its binding, 
degradation and the subsequent cholesteryl ester formation in 
cultured cells. 
Decreased ability of LDL to suppress sterol synthesis in 
upregulated human skin fibroblasts has previously been shown 
for LDL depleted of cholesteryl esters either by 
reconstitution techniques or by the lipid transfer protein 
reaction in vitro (31, 32). Furthermore, the small, 
cholesterol-poor and triglyceride-rich LDL isolated from 
hypertriglyceridemic human subjects has a decreased 1*C-
acetate incorporation to sterols (33). The present study 
demonstrates a similar phenomenon with cholesterol-poor, 
protein-rich LDL subfractions, isolated from a plasma pool of 
normal human subjects. This phenomenon is manifested even 
when LDL-lA and LDL-1B are compared but becomes more 
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pronounced in the comparison of LDL-1B and LDL-2. These 
results are consistent with the decreased cell association 
and cholesteryl ester stimulation of small dense LDL. 
However, when Hep G2 cells are exposed to similar amounts of 
cholesterol of either LDL-1A, LDL-1B or LDL-2, the three LDL 
subfractions exert comparable effects on sterol synthesis. It 
is possible that differences in г*С--acetate incorporation are 
within the experimental error of the method, which is larger 
than that of the cholesteryl esterification assay. If so, any 
difference in '^C-acetate incorporation to sterols, that is 
in agreement with the observed differences in cholesterol 
esterification, are missed. It is also possible that free 
cholesterol that enters the cell by the LDL-receptor pathway 
is more efficient in activation of the enzyme acyl-CoA: 
cholesterol-acyltransferase (ACAT) than in the suppression 
of the rate of synthesis of 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMG-CoA reductase), the rate-controlling enzyme in 
the cholesterol synthesis (34). It is not clear whether 
these differences between LDL subfractions in vitro also 
occur in vivo. Ά less efficient down-regulation of the 
cholesterol synthesis by a dense LDL particle may be 
associated with an ineffective capacity to down-regulate the 
synthesis of the LDL receptor protein. The combination of a 
decreased cell association of a dense LDL-2 particle, 
together with a less efficient down-regulation of the LDL 
receptor activity may theoretically result in either 
relatively high, normal or low rates of LDL-2 metabolism. 
Kleinman et al. performed in vitro studies with the dense, 
cholesterol depleted LDL particles isolated from 
hypertriglyceridemic subjects (33). Analogous to our findings 
with LDL-2, they found a decreased affinity for this 
hypertriglyceridemic LDL for the LDL receptor. Consistently, 
they reported that hypertriglyceridemic LDL did not down-
regulate the LDL receptor as efficiently as normal LDL. These 
in vitro results may be the metabolic basis for the in vivo 
observed accelerated plasma decay for hypertriglyceridemic 
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LDL (35, 36). Thus, despite a lower association, dense LDL 
may disappear faster from the circulation than light LDL; 
this suggestion is supported by our previous results of human 
LDL subfractions in the guinea pig (17). 
Using different approaches several authors found evidence 
for a higher atherogenic potential for dense LDL than for 
light LDL (11, 37-41). The main question, however, remains 
whether this potential is independent from the low HDL-
cholesterol and high serum triglycerides levels, usually 
associated with the presence of dense LDL (11, 37, 40). With 
the current study we addressed this problem in a direct way 
by assessing the in vitro metabolic behavior of LDL 
subfractions in Hep G2 cells. Our conclusions for the in vivo 
behavior of the LDL subfractions and their differences in 
atherogenic potential remain speculative. Different in vitro 
experimental systems (42), or the use of other cells as for 
example macrophages or endothelial and smooth muscle cells 
may provide additional tools for the evaluation of the 
atherogenic potential. 
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ABSTRACT 
1. By means of a single spin density gradient 
ultracentrifugation method, sera of six human volunteers and 
six pigs were studied; three or four distinct low density 
lipoprotein (LDL) subfractions could be seen in the pig serum 
{LDL-1A, LDL-1, LDL-2 and LDL-3) and three in the human 
serum (LDL-1A, LDL-1B and LDL-2). The subdivision of LDL 
into subfractions was less clear for the human subjects than 
for the pigs. 
2. Physicochemical characteristics (chemical compo-
sition, apoprotein content, size and density) of the LDL 
subfractions were determined and showed many similarities. 
3. In both species, in order of increasing density, 
relative protein content of the LDL subfractions increased, 
accompanied with a decrease in size. However, total pig LDL 
was of higher density, smaller and contained more protein. 
4. In conclusion, the pig appears a suitable animal model 
for the study of LDL heterogeneity. For these studies the 
density gradient ultracentrifugation method with 
visualization of the lipoprotein bands is the method of 
choice. 
INTRODUCTION 
Low density lipoprotein (LDL) is the major cholesterol 
carrying lipoprotein in both pig and man (1). Heterogeneity 
for pig LDL was described as early as 1966 by Janado et al. 
(2). By differential ultracentrifugation followed by 
analytical ultracentrifugation in the density range up to 
1.090 g/ml two LDL subfractions were found; light LDL-1 and 
heavy LDL-2. This subdivision of pig LDL into two subclasses 
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was confirmed in the later years (3, 4). The existence of LDL 
subfractions in man was suggested in the early seventies (5, 
6, 7) and has recently been confirmed by various authors (8, 
9, 10). 
The origin of LDL heterogeneity and the possible 
differences of the various LDL subfractions to induce 
atherosclerosis remains to be established. A greater 
understanding can be obtained by means of a suitable animal 
model. 
Here we describe LDL heterogeneity in the pig. LDL 
subfractions were visualized and isolated by means of a 
recently developed single spin density gradient 
ultracentrifugation method (11). Physicochemical 
characteristics of the LDL subfractions were determined and 
compared with those obtained for man. 
MATERIALS AND METHODS 
Fresh fasted pig (Sus domesticus) blood of three males and 
three females was obtained from the slaughter house. Human 
blood was sampled from healthy subjects, aged 25-54 years, 
three women and three men after overnight fasting. Serum was 
isolated within 2 h immediately followed by density gradient 
ultracentrifugation essentially as described previously (11). 
Serum was stained with Coomassie Brilliant Blue R and 
overlayered by solutions of decreasing density. After 
ultracentrifugation in a swinging bucket rotor for 19.5 h LDL 
subfractions were visible as distinct bands in the middle of 
the tube. The LDL subfraction patterns were registrated by 
photography; subsequently the LDL subfractions were isolated 
by aspiration with a rubber bulb Pasteur pipette. The density 
boundaries of the LDL fractions were determined as described 
(11). 
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Total cholesterol, unesterified cholesterol, phospholipids 
and triglycerides were determined by enzymatic, commercially 
available reagents (Boehringer, Mannheim, FRG, cat. no. 
237574, 310328, 691844 and Sera Pak, Ames, Italy cat. no. 
6639, respectively). Protein was determined by the method of 
Lowry et al. (12). LDL-cholesterol was calculated by 
subtraction of VLDL+lDL-cholesterol and HDL-cholesterol from 
serum cholesterol. 
Gradient gel electrophoresis was performed using 2-16% 
Polyacrylamide gels (8), commercially available (Pharmacia, 
Uppsala, Sweden cat. no 19-1264-01). 
The apoprotein composition of the LDL subfractions 
including apo B-100 and other high molecular weight proteins 
was studied with SDS gel electrophoresis using 3%/4% 
discontinuous Polyacrylamide disc gels (13). 
RESULTS 
Compared to human volunteers, serum cholesterol in pigs was 
considerably lower due to a twice lower LDL-cholesterol 
concentration. Serum triglycerides and HDL-cholesterol in 
pigs were slighly lower (Table 1). Inter-individual 
variation in the concentration of serum lipids and 
lipoproteins was less for pigs compared to man. For both 
species differences in concentration of serum lipids and 
lipoproteins between the sexes were small (Table 1). 
In pigs, the LDL subfraction pattern was relatively 
constant except in one (Fig. 1Ά). Three distinct well 
separated LDL bands could be seen. In the other pig one 
additional fraction of a relatively low density was present. 
The presence of this band was accompanied with an increase in 
the density of the subsequent LDL band. In this animal serum 
lipids were not deviating from the others. No sex differences 
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Fig. 1. Banding pattern of LDL subfractions after density gradient 
ultracentrifugation of the serum from six pigs (ΙΑ) and six human 
volunteers (page 97, IB). The numbers on the tubes A indicate the 
fractionation marks used to determine the density of the LDL 
subfractions. Arrows indicate the detected LDL subfractions. VLDL is 
situated at the meniscus and HDL and the serum proteins are found from 
fractionation mark 16 downwards. The tubes on the left (А, в and C) 
contain serum of the males and the tubes on the right (D, E and F) 
contain the serum of the females. The photographic procedure causes a 
loss of sensivity. 1A: Pig A shows four LDL subfractions in the order of 
increasing density: LDL-1A (hardly visible on the photograph but clearly 
visible by visual inspection of the tube), LDL-1, LDL-2 and LDL-3. Pigs В 
to F all show only three subfractions as indicated for pig D in the order 
of increasing density: LDL-l, LDL-2 and LDL-3. IB: all human volunteers 
show three LDL subfractions as indicated for man D in the order of 
increasing density LDL-1A, LDL-1B and LDL-2. The human volunteer D has 
the highest HDL concentration as can be seen in the bottom of the tube. 
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TABLE 1. Lipids and lipoprotein concentrations of pig and 
man* 
Total cholesterol 
Total triglycerides 
HDL-cholesterol 
LDL-cholesterol 
2 
0 
1 
1 
M 
6+0 
8 + 0 
2 + 0 
4 + 0 
PIG 
mmc 
3 
1 
1 
2 
F 
1/1) 
2.5 + 0 
0.6 + 0 
1.1 + 0 
1.2+0 
3 
1 
2 
2 
5 
1 
1 
3 
MAN 
M F 
(mmol/1) 
1+0.6 
0+0.3 
4+0.5 
3+0.4 
4.8+0 
1.0 + 0 
1.2 + 0 
3.2 + 0 
5 
4 
2 
5 
=Mean + SD of three male (M) and three female (F) pigs and 
three human subjects of both gender 
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Fig. 2. Polyacrylamide gradient gel electrophoresis of the LDL 
subfractions of pig and human volunteers. The molecular weight of the 
pig subfraction LDL-3 is comparable with œ2-macroglobulin (828.000). 
between the pig LDL subf rac t ion p a t t e r n s could be observed 
(Fig. 1A). With inc reas ing dens i t y the LDL bandswere 
a r b i t r a r i l y defined as LDL-1A, LDL-l, LDL-2, and LDL-3 (Fig. 
1A). The d i s t a n c e in the u l t r a c e n t r i f u g a t i o n tube between 
LDL-l and LDL-2 i s smal ler than the d i s t ance between LDL-2 
and LDL-3. 
LDL subf rac t ion p a t t e r n s in man showed a much l a rge r i n t e r -
i nd iv idua l v a r i a t i o n (Fig. IB) . Differences in LDL 
subf rac t ion p a t t e r n between the sexes were not obvious (Fig. 
IB) . Three LDL subf rac t ions could be observed, in the order 
of inc reas ing d e n s i t y : LDL-1A, LDL-1B and LDL-2. This 
subd iv i s ion of LDL in to t h r e e subf rac t ions was not as c l e a r 
as for p i g s . For some se ra any sub f r ac t i ona t ion was hard ly 
v i s i b l e (Fig. IB) , which i s p a r t l y caused by the l o s s of 
s e n s i v i t y by the photographic procedure . However, by 
dens i tomet r i c a n a l y s i s of the s l i d e s made from the 
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ultracentrifugation tubes evidence was obtained for the 
existence of three distinct LDL subfractions for all six 
studied human volunteers (data not shown). 
In both species, the relative content of free cholesterol, 
cholesteryl esters and phospholipids decreased and that of 
protein increased with increasing density (Table 2). 
On exclusion gradient gel electrophoresis clear differences 
were present in the relative migration of the various LDL 
subfractions from both species: those fractions with the 
highest densities migrated further into the gel and thus had 
the smallest diameter (Fig. 2). 
TABLE 2. Relative composition of LDL subfractions from pig and man3 
Component 
Free Cholesterol 
Cholesteryl Ester 
Triglycerides 
Phospholipids 
Protein 
Density (g/ml) 
Component 
Free Cholesterol 
Cholesteryl Ester 
Triglycerides 
Phospholipids 
Protein 
Density (g/ml) 
LDL-lA 
9.1 
45.7 
3.3 
17.3 
24.7 
1.027-1.030 
LDL-lA 
9.6+0.6 
44.9+1.2 
4.4+0.9 
20.2+0.8 
20.9+0.8 
1.023-1.029 
LDL-1 
PIG 
LDL-2 
7.5+0.5 7.3+0.6 
43.7+0.6 46.9+2.0 
4.0+1.4 2.2+0.5 
19.5+1.1 11.7+3.4 
25.2+1.0 31.9+2.5 
1.030-1.035 1.035-1.039 
HAN 
LDL-IB 
8.8+0.7 
43.1+2.4 
5.2+1.7 
20.5+0.7 
22.5+1.1 
1.030-1.034 
LDL-2 
7.9+0.7 
41.0+2.1 
5.5+1.5 
16.0+4.4 
29.6+2.8 
1.035-1.039 
LDL-3 
5.8+0. 
36.3+2. 
5.3+1. 
13.2+2, 
39.3+2. 
1.047-1. 
,9 
.3 
.5 
.0 
.1 
.052 
'Percent of dry mass, mean + SD of six studied pigs and man. 
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The LDL subfractions of pig and man can be arranged in 
order of increasing density, increasing relative protein 
content and decreasing size. This order is: man LDL-1A, pig 
LDL-1A, man LDL-1B and pig LDL-1, man LDL-2 and pig LDL-2, 
pig LDL-3. 
With SDS Polyacrylamide gel electrophoresis no differences 
were found in the apoprotein composition of the various LDL 
subfractions of either pigs and of man and also not between 
those of both species. By densitometric scanning less than 5% 
of the absorbance was due to staining outside the apo B-100 
band (data not shown). 
DISCUSSION 
Long before human LDL was considered to be heterogeneous 
two LDL subfractions were described for pigs (2, 10). These 
two LDL subfractions were found by differential ultra-
centrifugation followed by analytical ultracentrifugation (2, 
3). In later years the two LDL subfractions could be 
effectively isolated by means of zonal ultracentrifugation 
(4). 
In contrast to these results, using an improved density 
gradient ultracentrifugation method (11), we found three or 
four sharp LDL bands. The not very sharp peak of light LDL-l 
previously found by analytical ultracentrifugation (2) 
probably consists of more than one LDL subfraction. 
The more marked subdivision of pig LDL compared to human 
LDL after density gradient ultracentrifugation may be the 
reason why pig LDL was considered to be heterogeneous long 
before human LDL. 
How can these differences in LDL subfractionation between 
the two species be explained? A low pig plasma cholesteryl 
ester transfer activity, which is only 19 % of that of man 
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(14), may prevent diffusion of the distinct LDL bands. 
Whether the independent LDL production, as described for pigs 
(15), is responsible for a specific pig LDL subfraction 
remains to be elucidated. 
Austin et al. showed evidence that LDL heterogeneity in man 
is genetically determined (16). The low inter-individual 
variation for the LDL subfraction patterns of the six pigs 
studied may be of genetic origin or may be caused by 
similarities in external conditions. The six studied pigs 
were obtained on the same day from the slaughter house. So 
the chance that the pigs are genetically related may not be 
neglected. Moreover, those domestic pigs are raised under 
similar conditions. To exclude the possibility of having 
studied six pigs with the same rare genetic trait of three or 
four LDL subfractions, LDL heterogeneity was studied on 
another occasion. Identical results were then obtained. 
The systematical higher density of pig LDL compared to 
human LDL we found in the density gradient is confirmed by 
Janado et al. (2) and Mahley et al. (17). This higher density 
and the subsequently lower position of pig LDL in the density 
gradient is in agreement with the increased relative protein 
content of pig LDL in comparison to human LDL. 
The tendencies in chemical composition going from the light 
to the heavy LDL subfractions for pig and man correspond with 
those described previously (11). 
More than 95 % of the protein component of pig and human 
LDL subfractions consists of apo B-100. These findings agree 
with those of Jackson et al. (3), who showed that the 
apoproteins of pig LDL-1 (1.020 to 1.060 g/ml) and pig LDL-2 
(1.060 to 1.090 g/ml) were essentially identical, and with 
those of Knipping et al, (18), who isolated a lipoprotein 
from pigs that contains only apo В from the density range 
1.015-1.080 g/ml by gel filtration chromatography. 
In conclusion, the pig is a suitable animal model for more 
insight in the cause and consequences of LDL heterogeneity. 
Density gradient ultracentrifugation can than be used to 
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detect and isolate LDL subfractions to study genetic and 
environmental influences and to perform turnover studies. 
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ABSTRACT 
Low density lipoprotein (LDL) subfractions in sera of 
normolipidemic controls and patients with the various forms 
of primary hyperlipoproteinemia (HLP) phenotypes I to V (two 
of each) were isolated by density gradient ultra-
centri f ugat ion and their physicochemical characteristics 
were compared. In each subject, depending on the type of HLP, 
two to four LDL subfractions, divided among six density 
ranges, were detected: LDL-l (1.022-1.025 g/ml), LDL-2 
(1.026-1.032 g/ml), LDL-3 (1.033-1.038 g/ml), LDL-4 (1.036-
1.041 g/ml), LDL-5 (1.041-1.049 g/ml) and LDL-6 (1.049-1.054 
g/ml). LDL-1, LDL-2 and LDL-3 were present both in normal 
controls and in the patients with hypercholesterolemia 
(phenotype IIA). LDL of patients with familial dysbeta-
lipoproteinemia (Type III) was visible as a diffuse smear in 
the density range 1.023-1.038 g/ml without a clear boundary 
between intermediate density lipoprotein (IDL) and LDL. The 
predominant LDL subfraction in hypertriglyceridemia 
(phenotypes I, IV and V) is more dense and smaller compared 
to the main LDL subfraction in normolipidemia. Thus, in 
hyperchylomicronemia (phenotype I), LDL-5 was predominant 
next to a LDL-1 band of low intensity. In patients with 
familial hypertriglyceridemia (phenotype IV) LDL-4 was the 
main LDL subfraction but small amounts of LDL-1, LDL-2 and 
LDL-6 were also present. With increasing serum triglycerides 
this polydispersity of LDL is replaced by monodispersity in 
phenotype V HLP, where LDL is concentrated in a narrow 
density range 1.046-1.049 g/ml (LDL-5). In HLP the 
composition of total LDL was related to the levels of serum 
triglycerides and reflected the chemical composition data of 
the composing distinct LDL subfractions. The compositional 
ratio lipid/protein, as well as the particle size and the 
partial specific volume of the LDL subfractions decreased 
with increasing density. These results strongly suggest that 
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the physicochemical characteristics of LDL subfractions in 
the various forms of HLP are regulated by lipid transfer 
reactions. 
INTRODUCTION 
Epidemiological studies have shown a positive relationship 
of low density lipoprotein (LDL) cholesterol levels with 
atherosclerosis (1, 2). Besides cholesterol LDL contains 
triglycerides, phospholipids and protein (3). The relative 
contribution of these components determines the size and 
density of LDL which differs between subjects and may vary 
with the serum cholesterol and triglycerides levels of the 
various forms of hyperlipoproteinemia (4-22). 
LDL consist of discrete subspecies with different 
physico-chemical characteristics and, probably, different 
metabolic properties (22-32). 
With analytical and density gradient equilibrium ultra-
centri f ugat ion Fisher et al. distinguished poly- and 
monodisperse LDL (27, 32). Polydispersity, defined as the 
distribution of the majority of the LDL mass over a wide 
range of density, was frequently observed in hyper-
triglyceridemia. On the other hand, monodisperse LDL, 
consisting of a single class of macromolecules within a 
narrow density range, was found in normolipidemia and 
hypercholesterolemia (27, 32). 
Recently, we developed a density gradient ultra-
centri f ugat i on method for identification and isolation of LDL 
subfractions suitable for analysis in normo- and 
hyperlipidemic sera (28). We applied this method to study the 
LDL subfraction patterns in normolipidemics and in subjects 
with the various forms of primary hyperlipoproteinemia 
phenotypes I to V. The physicochemical characteristics of 
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these subfractions were determined and compared in order to 
gain more insight in the metabolic origin of LDL 
heterogeneity. 
For comparison with previous reports the structural 
characteristics of total LDL of the various forms of 
hyperlipoproteinemia were also determined. 
MATERIALS AND METHODS 
Sera 
Overnight fasted blood of two apparently healthy laboratory 
workers and of two subjects with each of the primary hyper­
lipoproteinemia phenotypes I to V was sampled on one and the 
same day. Some characteristics of the subjects studied are 
shown in Table l. Both subjects with hyperchylomicronemia 
(type I) differed in their pathogenesis i.e. one subject (A) 
was deficient for apoprotein c-ll (33), the activator of 
lipoprotein lipase; the other subject (B) had normal levels 
of apoprotein C-II but was lipoprotein lipase deficient (34). 
Both subjects A and В had relatively low hepatic lipase 
activities of 12.5 and 6.6 μιηοΐ FFA/ml/h, respectively 
(normal males, n=14, 25.9+9.1 pmol FFA/ml/h; normal females, 
n=15, 16.2+6.4 цтоі FFA/ml/h). All patients were on a 
appropriate lipid lowering diet, but nobody was using any 
medication at the time of this study, except for insulin in 
the apo C-II deficient patient. 
LDL subfractions 
Serum was isolated within two hours immediately followed by 
density gradient ultracentrifugation essentially as described 
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previously (28). 3.4 ml of serum was stained with coomassie 
Brilliant Blue R and overlayered by three solutions of 
decreasing density. After ultracentrifugation in swinging 
bucket rotors for 19.5 h LDL subfractions were visible as 
distinct bands in the middle of the tube. However, the 
separation between subfractions for some of the sera was 
incomplete, especially for the sera of patients with hyper­
cholesterolemia (phenotype IIA); this is caused by an excess 
of LDL in a relatively narrow density range (1.022-1.038 
g/ml). For more precise analysis of the physicochemical 
characteristics of the LDL subfractions of these hyper-
cholesterolemic subjects the density gradient ultra­
centrifugation procedure was repeated with 1 ml instead of 
3.4 ml serum. 
After ultracentrifugation the tubes were placed in a 
specially designed rack (35) and photographed using the 
following conditions: lens, 135 mm (Olympus, OM-1N); 
aperture, f/11; shutter speed, 1/30 s,- filter Kodak wratten 
no. 81 and 30 m; illumination 15 cm behind the tubes from a 
diffuse light source (illumination for X-rays); distance 45 
cm; film, Kodak Ektochrome 200, EPD 135-36, process E 6. The 
subdivision into the various subfractions has faded'slightly 
in this photographic procedure (Fig. 1). More accurate 
documentation of the different subfraction patterns was 
obtained by scanning the slides on a LKB 2202 ultrascan laser 
densitometer (Fig. 2). 
Subsequently, the LDL subfractions were isolated by 
aspiration with a rubber bulb Pasteur pipette. The density of 
the LDL subfractions were determined as described (28). 
Analytical methods 
The apoprotein composition of the LDL subfractions 
including apo B-100 and other high molecular weight proteins 
(apoproteins B-48, А, С and E and albumin) was studied with 
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SDS gel electrophoresis using 3%/4% discontinuous 
Polyacrylamide disc gels (36). Lipoproteins mixed with 
SDS-phosphate buffer and dithiothreitol as a reducing reagent 
were boiled and immediately loaded onto the gels. This 
resulted in complete delipidation of the apoproteins. 
Albumin, apo A-I, and apo E were determined in duplicate by 
rocket Immunoelectrophoresis (37). Monospecific antisera 
against apo A-I, apo E and albumin were raised in rabbits. 
Apo A-I and apo E were purified by Sephacryl S~200 column 
chromatography (Pharmacia, Uppsala, Sweden). Apo E was 
further purified by preparative flat-bed isoelectric focusing 
(37). LDL subfractions were analyzed without further dilution 
(protein range 70-1100 mg/1) against a serum pool of known 
albumin and apoprotein concentrations in suitable dilutions. 
The presence of Lp(a) in LDL subfractions with a mean 
density above 1.036 g/ml (LDL-4, LDL-5 and LDL-6) was checked 
by immunodiffusion on 0.8 % agarose using monospecific 
antiserum against Lp(a) raised in rabbits (38) (kindly 
provided by Dr. V. Armstrong, Department of Clinical 
Chemistry, University of Göttingen, FRG). 
For comparison of the relative size of the various LDL 
subfractions gradient gel electrophoresis was performed as 
described using 2-16% Polyacrylamide gels (Pharmacia, 
Uppsala, Sweden cat. no 19-1264-01) (4). 
Lipoproteins and lipids were analyzed as follows. The 
density of 5 ml of serum was raised to d=1.019 g/ml by the 
addition of D20 (d=1.10 g/ml). VLDL+IDL were isolated as 
described (39) by ultracentrifugation for 16 h at 40,000 rpm 
(168,000 g^) in an IEC B-60 fixed angle rotor no 468 (DAMON 
IEC, Needham Heights, MA, USA). HDL-cholesterol was 
determined in whole serum by the polyethylene glycol 6000 
method (40). LDL-cholesterol was calculated by subtraction 
of VLDL+lDL-cholesterol and HDL-cholesterol from total serum 
cholesterol. 
Total cholesterol, unesterified cholesterol, phospholipids 
and triglycerides were determined by enzymatic, commercially 
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available reagents (Boehringer, Mannheim, FRG, cat. no. 
237574, 310328, 691844 and Sera Pak, Ames, Italy cat. no. 
6639, respectively) and protein by the method of Lowry et al. 
(41). 
Partial specific volumes were taken to be: triglycerides, 
1.093; cholesteryl ester, 1.044; free cholesterol, 0.968; 
phospholipids, 0.970; and protein, 0.705 ml/g (42). 
To correct the marked skew in the VIDL-triglyceride levels 
(d<1.019 g/ml) at higher concentrations, VIDL-triglycerides 
levels were transformed to logarithmic scales (log 10). 
Linear regression analysis was used to determine 
coefficients of correlation. 
RESULTS 
LDL subfraction patterns 
Clear differences in number and intensity of the diverse 
subfractions, visible as colored bands along the density 
gradient, could be observed between the various types of HLP 
(Fig. 1). The LDL subfraction distribution appeared 
reproducible upon repeated examination of freshly isolated 
sera at different time points during the year, indicating the 
specificity of the LDL subfraction patterns for the subjects 
studied. Analysis of the densitometric scans showed that for 
the various hyperlipoproteinemia phenotypes the number of LDL 
subclasses varied from one (patients with phenotype V) to 
four (patients with phenotype IV), divided among six 
different density ranges (Figs. 1 and 2, Table 2). 
In the sera of both normolipidemic controls three LDL 
subfractions were present: LDL-1, LDL-2 and LDL-3 with their 
mean densities shown in Table 3. 
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TABLE 1. Characteristics of the subjects studied. 
Phenotype 
-
I 
II 
III 
IV 
V 
A 
В 
A a 
Bto 
A 
В 
A 
В 
A 
В 
A 
В 
Sex 
M 
F 
M 
F 
F 
M 
M 
F 
M 
M 
M 
F 
Age 
years 
28 
27 
40 
28 
39 
59 
58 
60 
47 
32 
38 
48 
Quetelet 
index 
19.7 
21.9 
21.4 
21.9 
26.2 
21.8 
26.9 
22.5 
23.0 
27.9 
26.4 
29.4 
Serum 
Chol 
mmol/l 
3.4 
4.1 
18.6 
3.4 
9.1 
11.7 
6.4 
8.8 
5.6 
5.3 
9.5 
15.1 
Trig 
mmol/l 
1.1 
0.7 
64.0 
7.9 
1.9 
1.7 
3.7 
4.3 
5.9 
3.1 
16.9 
28.1 
VI DL 
Chol 
mmol/l 
0.4 
0.4 
17.7 
2.5 
1.4 
1.0 
3.1 
6.4 
2.3 
2.0 
7.7 
12.7 
Trig 
mmol/l 
0.8 
0.6 
54.3 
6.7 
1.0 
0.9 
2.4 
3.1 
5.0 
2.4 
15.5 
11.6 
LDL 
Chol 
mmol/l 
1.8 
1.7 
0.7 
0.6 
7.0 
9.9 
2.4 
1.3 
2.5 
2.7 
1.2 
1.5 
HDL 
Choi 
mmol/l 
1.2 
2.0 
0.2 
0.3 
0.7 
0.8 
0.9 
1.1 
0.8 
0.6 
0.6 
1.0 
A and В refer to the two normolipidemic subjects and to the two subjects of each 
of the hyperlipoproteinemia phenotypes I to V studied. a, subject with apo C-II 
deficiency; to, subject with lipoprotein lipase deficiency; chol, cholesterol; 
trig, triglycerides 
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Fig. 1. Banding pattern of LDL subfractions after density gradient 
ultracentrifugation of two normolipidemic subjects (A and B) and two 
subjects (A and B) of each of various forms of primary 
hyperlipoproteinemia. The numbers on the tubes of the controls indicate 
the fractionation marks used to determine the density of the LDL 
subfractions. Arrows indicate the detected LDL subfractions. 
Chylomicrons and VLDL are situated at the meniscus and HDL and the serum 
proteins from fractionation mark 15 downwards. Characteristics of the 
studied subjects are shown in Table 1. 
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Fig. 2. Densitometrie scanning patterns of LDL subfractions of normo-
and hyperlipidemic subjects. LDL subfraction patterns correspond with 
those in Fig. IB. The phenotypes of the various forms of 
hyperlipoproteinemia are indicated. Fractionation marks on the X-axis 
correspond with those on the tube in Fig. IB. Because of the large 
inter-individual variation in LDL-cholesterol the absolute absorbance of 
the curves is standardized. Arrows indicate peaks of the observed LDL 
subfractions. Peak numbers correspond with those used in Fig. 1 and 
Tables 2 and 3. The dotted lines indicate the position of the LDL 
subfractions of the normolipidemic subject(s). 
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Although the pathogenesis differed between the two patients 
with hyperchylomicronemia (Table 1), they both had a similar 
LDL subfraction pattern: a faint LDL-1 and a more intense 
LDL-5 band. There was a clear difference in HDL distribution 
among the HDL subfractions between both these patients with 
phenotype I. In contrast to the subject with a deficiency of 
apo C-II, the subject with the lipoprotein lipase deficiency 
showed a clear HDL-2 band (Fig. 1). 
The patients with hypercholesterolemia (phenotype IIA) 
showed the same subdivision into three bands as 
normolipidemic subjects. For both hypercholesterolemic 
patients an additional lipoprotein was visible in the density 
range 1.008-1.022 g/ml (Fig. l), with apo E contributing 
19.9 % (patient A) and 25.8 % (patient B) to its total 
protein mass and a particle size slightly smaller than LDL-1A 
(Fig. 3), apparently IDL. 
LDL of patients with familial dysbetalipoproteinemia (Type 
III) was diffuse in the density range 1.023-1.038 g/ml 
without a clear boundary between IDL and LDL (Figs. 1 and 2). 
TABLE 2. Subclasses of serum LDL for normo- and 
hyperlipidemic subjects 
LDL subfraction Hyperlipo- Density range 
proteinemiaa g/ml 
1 C, I, IIA, IV 1.022-1.025 
2 С, IIA, IV 1.026-1.032 
3 С, IIA 1.033-1.038 
4 IV 1.036-1.041 
5 I, V 1.041-1.049 
6 IV 1.049-1.054 
Ä
 С, control; I to V, hyperlipoproteinemia pheno-
types I to V 
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Serum of patients with hypertriglyceridemia (phenotype IV) 
showed one predominant LDL subfraction (LDL-4). This band was 
accompanied with two other bands in the density range of 
normolipidemic sera, LDL-1 and LDL-2, and one with a very 
high density (LDL-6). In the sera of patients with phenotype 
V only one LDL band was visible of low intensity and high 
density (LDL-5) (Figs. 1 and 2). 
Relative size of LDL subfractions 
On exclusion gradient gel electrophoresis clear differences 
were present in the relative migration of the various LDL 
subfractions: those with the highest density migrated further 
into the gel and thus had the smallest size (Figs. 3 and 4Ά). 
LDL of patients with phenotype IV patients showed the 
greatest difference in size between the LDL subfractions 
compared to LDL of controls, subjects with phenotype IIA and 
phenotype V. 
Chemical composition of the LDL subfractions 
The LDL subfractions were isolated as discrete bands and 
their physicochemical characteristics were analyzed. 
In general, going from the light to the heavy LDL 
subfractions, the relative content of cholesteryl esters, 
free cholesterol and phospholipids decreased and that of 
proteins increased; consequently, the ratio lipid/protein 
decreased (Tables 3 and 4, Fig. 4). The partial specific 
volumes of the LDL subfractions, calculated from their 
chemical composition, were inversely correlated with their 
densities (Tables 3 and 4, Fig. 4C). 
In hypertriglyceridemia, especially in patients with 
phenotype I and phenotype V, the LDL subfractions have a 
relatively high triglyceride content and a compensatory low 
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content of free and esteri fied cholesterol and phospholipids 
(Table 3). The partial specific volumes are relatively lower 
for these subfractions (Table 3). Note that for patients with 
phenotype IV there was a relatively increase of the 
triglyceride content from LDL-S to LDL-6 (Table 3). 
Although patient В with phenotype I has lower total serum 
triglycerides (7.9 mmol/l) compared to both phenotype V 
patients (16.9 and 12.9 mmol/l, respectively) the relative 
triglyceride content of her LDL subfractions is higher (Table 
3), indicating that the triglyceride content of the LDL 
subfractions in hypertriglyceridemia is not a simple function 
of the serum triglycerides level. 
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Fig. 3. Polyacrylamide gel electrophoresis of the LDL subfractions of 
normolipidemic and hyperlipidemic subjects. From left to right (A and В 
refer to the series mentioned in Fig. 1): LDL subfractions of control 
(B), LDL subfractions of phenotype I (A), IDL of phenotype II (A), LDL 
subfractions of phenotype II (A), total LDL of Type III (A), VIDL from 
phenotype IV (B), LDL subfractions of phenotype IV (A), LDL subfraction 
of phenotype V (B), LDL subfractions of phenotype Ι (Β), VIDL of 
phenotype IV (B). The figure is a combination of three different 
gradient gels. The migration distances of standard proteins, 
3-lipoproteins (a), «z-macroglobuline (b), thyroglobuline (c), 
apoferritin (d) and catalase (e) are indicated on the left. Molecular 
weights of these marker proteins are 2 χ IO6 (a), 828.000 (b), 669.000 
(c), 443.000 (d) and 240.000 (e). 
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Chemical composition of LDL-I, LDL-2 and LDL-3 of the 
patients with hypercholesterolemia (phenotype IIA) was 
similar to that of normolipidemics. Only in the LDL 
subfractions of patient В the contribution of triglycerides 
and protein to total LDL mass was somewhat lower while that 
of free and esterified cholesterol appeared somewhat higher 
(Table 3). 
Apoprotein composition of LDL subfractions 
After densitometri с scanning of SDS Polyacrylamide gels, 
less than 5 % of the absorbance appeared to be due to 
staining outside the apo B-100 band. The only exception was 
the LDL-5 fraction of patient В with hyperchylomicronemia; in 
this case the staining outside the apo B-100 band accounted 
for approximately 25 % of the densitometric absorbance (data 
not shown). 
Rocket immunoelectrophoresis of the LDL subfractions showed 
that the residual albumin, apo E, and apo A-I contributed 
generally less than 5 % to the protein mass of the respective 
LDL subfractions (Table 3). LDL-5 protein of patient В with 
phenotype I consisted for 29.2 % of apo A-I. Because of the 
apparent absence of HDL contamination in the LDL-5 
subfraction on exclusion gradient gel electrophoresis (Fig. 
3), apo A-I must be an integral part of LDL-5. LDL of the 
patients with Type III HLP had a relatively high content of 
apoprotein E. For patients with phenotype IV LDL-6 contained 
a relatively increased amount of albumin and apoproteins A-I 
and E. For both total LDL of Type III and LDL-6 of phenotype 
IV patients there was no contamination with other 
lipoproteins as appeared from exclusion gradient gel 
electrophoresis (Fig. 3). 
Immunochemical analysis of LDL-5 from patients with pheno­
type I and phenotype V and LDL-4 and LDL-6 from patients with 
phenotype IV appeared negative with specific antiserum 
against lipoprotein(a). 
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Table 3. Physicochemical characteristics of the LDL subfractions from two nonnolipidemic and from two patients with phen-
-otypes I to V hyperlipoproteinemia (HLP) 
HLP 
Pheno-
T.yjje 
С 
0 
N 
τ 
Η 
О 
L 
I 
II 
A 
В 
A 
В 
A 
В 
LDL·5 
1 
2 
3 
1 
2 
3 
1 
S 
1 
5 
1 
2 
3 
1 
2 
3 
mean 
density 
g/ml 
1.024 
1.029 
1.036 
1.024 
1.029 
1.036 
1.023 
1,042 
1.023 
1.046 
1.023 
1.029 
1.036 
1.023 
1.028 
1.035 
Free 
Cholesterol 
% 
9.5 
9 3 
7.9 
9.9 
9.2 
8.1 
8.5 
5.8 
6.4 
3.5 
9.8 
9.1 
8.2 
10.4 
10.3 
9.4 
Chemical composition» 
Cholesterol 
Ester 
% 
42.8 
41.9 
40.6 
42.0 
41.6 
38.5 
5.1 
14.0 
20.8 
21.8 
42.6 
42.5 
40.6 
46.1 
45.2 
44.2 
Tri­
glyceride 
% 
5.0 
5.1 
3.6 
4.9 
4.8 
5.8 
36.0 
26.5 
26.3 
25.1 
6.0 
5.5 
4.4 
3.8 
3.7 
2.9 
Phospho­
lipid 
% 
19.7 
20.0 
17.4 
20.0 
20.1 
17.0 
19.7 
16.4 
14.4 
12.8 
20.8 
20.0 
18.0 
20.1 
19.1 
18.6 
Protein 
% 
22.9 
23.8 
30.5 
23.2 
24.2 
30.7 
30.7 
37.3 
32.0 
36.9 
20.8 
22.9 
28.8 
19.6 
21.7 
24.8 
lipid/ 
protein 
mg/mg 
3.36 
3.21 
2.28 
3.31 
3.13 
2.26 
2.26 
1.68 
2.12 
1.71 
3.81 
3.37 
2.47 
4.10 
3.61 
3.02 
partial0 
specific 
volume 
ral/g 
0.946 
0.945 
0.923 
0.945 
0.941 
0.925 
0.936 
0.914 
0.932 
0.920 
0.954 
0.947 
0.929 
0.957 
0.950 
0.939 
- Low molecular 
weight 
Albu­
min 
% 
1.1 
0.6 
0.4 
0.9 
0.8 
0.3 
_ 
4.7 
1.8 
2.6 
0.2 
0.4 
0.2 
2.4 
1.1 
-
apoproteins0 
Apo E 
% 
0.4 
0.3 
0.7 
1.0 
0.5 
1.3 
1.0 
1.6 
_ 
0.7 
0.7 
0.1 
0.4 
0.2 
0.7 
0.6 
Apo A 
% 
0.2 
0.3 
_ 
0.3 
0.7 
_ 
0.2 
_ 
29.2 
-
-
-
0.1 
0.1 
HLP 
Pheno-
\.y¡JC 
III 
IV 
ν 
Ά 
Β 
Α 
Β 
LDI 
Α 
Β 
1 
2 
4 
6 
1 
2 
4 
6 
5 
5 
β 
tot 
tot 
mean 
density 
g/ml 
1.028 
1.028 
1.023 
1.031 
1.037 
1.053 
1.023 
1.030 
1.039 
1.050 
1.047 
1.047 
Free 
Cholesterol 
% 
8.9 
7.9 
8.8 
8.5 
6.2 
4.5 
8.5 
7.8 
6.6 
6.1 
4.7 
4.0 
Chemical composition" 
Cholesterol 
Ester 
% 
34.6 
34.1 
40.8 
42.1 
44.8 
33.7 
39.1 
39.6 
41.1 
30.1 
33.2 
28.6 
Tri­
glyceride 
% 
11.0 
12.5 
5.6 
4.4 
3.4 
8.5 
10.3 
7.7 
5.9 
8.9 
11,2 
16.6 
Phospho­
lipid 
% 
20.6 
16.5 
18.4 
18.2 
17.6 
12.4 
17.5 
17.5 
16.3 
10.2 
14.9 
15.2 
Protein 
% 
24.8 
28.8 
26.3 
26.7 
28.0 
40.8 
24.6 
27.4 
30.1 
44.6 
35.9 
35.7 
lipid/ 
protein 
mg/mg 
3.02 
2.46 
2.79 
2.74 
2.57 
1.45 
3.10 
2.65 
2.32 
1.24 
1.78 
1.80 
partial0 
specific 
volume 
ml/g 
0.942 
0.932 
0.936 
0.935 
0.933 
0.896 
0.946 
0.936 
0.928 
0.884 
0.912 
0.917 
- Low 
weight 
Albu­
min 
% 
0.2 
-
1.9 
0.4 
0.6 
3.5 
-
-
1.4 
5.0 
0.3 
1.6 
molecular 
apopro 
Ape E 
% 
1.6 
2.3 
2.3 
0.6 
0.5 
3.5 
0.7 
0.2 
0.3 
3.4 
0.6 
0.8 
teins0 
Ape A 
% 
0.1 
-
-
-
2.9 
-
-
-
2.0 
0.6 
0.7 
", percent of dry mass; b, calculated by summing the partial specific volume contribution of the individual LDL 
subfraction constituents where the partial specific volumes were as follows: protein, 0.705 ml/g; phospholipid, 0.970 
ml/g; free cholesterol, 0.968 ml/g; cholesterol ester, 1.044 ml/g; triglycerides, 1.093 ml/g; e, determined in duplicate 
by rocket immunoelectrophoresis and expressed as percent of LDL protein; e, the LDL subfractiens mentioned are indicated 
with arrows in Fig, l. A and В refer to the series A and В in Fig. 1. 
Interrelations of physicodiemical characteristics of LDL 
subfractions 
The lipid/protein ratio, the density, mobility and the 
partial specific volumes of the various LDL subfractions from 
the normo- and hyperlipidemic subjects correlated 
significantly with each other: a low LDL particle size is 
associated with an enhanced relative protein content, 
elevated density and decreased relative lipid content and 
partial specific volume (Table 4 and Fig. 4). All 
subfractions fall on the same (regression) line which could 
suggest that all subfractions are controlled by a common 
process which removes lipids, enhances density and decreases 
size (24, 43). The position of the LDL subfractions of the 
patients with phenotype I in Figure 4B can be explained by 
the relatively high amount of triglycerides and compensating 
low content of cholesterol esters in these subfractions, for 
triglycerides are less dense and occupy approximately 1.5 
times more volume per molecule than cholesterol esters. 
TABLE 4. Interrelations of the physicochemical 
characteristics of LDL subfractions 
lipid/protein partial 
mobility ratio specific 
volume 
(mm) (mg/mg) (ml/g) 
density (ml/g) 0.57 (14)* 0,62 (28)c 0.76 (28)c 
partial specific 0.60 (14)* 0.87 (28)c 
volume (ml/g) 
lipid/protein 0.69 (14)to 
ratio (mg/mg) 
Correlations are indicated. Enclosed between brackets: 
number of subfractions studied. ", p<0.05; * · , p<0.01; c , 
p<0.001 
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Fig. 4. Plots of the 
density versus the 
mobility (A), the 
lipid/protein mass 
ratio (B) and the 
partial specific volume 
(C) of the LDL 
subfractions from 
normolipidemic and 
hyperlipidemiс subjects 
(data Table 3 and Fig. 
3). Coefficients of 
correlation are shown 
in Table 4. C, normo-
lipidemic controls ; 
numbers 1-5 refer to 
the hyperlipoprotei­
nemia phenotypes I to V 
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Relationship between the cholesterol/apo В ratio and the 
partial specific volume of total LDL and the triglycerides 
in the d<1.019 g/ml fraction 
VIDL-triglycerides (d<1.019 g/ml) (log transformed) 
correlated significantly with the LDL-chol/LDL apo В (p=0.78, 
p<0.005) and with the partial specific volume of LDL (p=Q.66, 
p<0.025) (Figs. 5Ά and 5B). Therefore, it can be concluded 
that in hypertriglyceridemia total LDL has a lower partial 
specific volume (increased density) and has a decreased ratio 
LDL-chol/LDL apo B. 
LDL Chol ' LDL apo В í mmoí/g t · 
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Fig. 5. Relationship of 
the composition, 
expressed as the LDL-
cholesterol/LDL "apo В 
ratio (A), and the 
partial specific 
volume (B) of total LDL 
with the (log 10) VIDL-
triglycerides in the 
d<1.019 g'/ml fraction. 
Values are obtained for 
the same subjects 
mentioned in Fig. 1. 
C, normolipidemic 
controls; numbers 1 to 
5 refer to the 
hyperlipoproteinemia 
phenotypes I to V 
16 32 64 
VIDL triglycerides I mmol /I ] 
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DISCUSSION 
Human LDL of normo- and hyperlipidemic subjects has been 
shown to be heterogeneous, with varying buoyant density, Sf 
rates, size and composition (22-28). By analytical and 
density gradient ultracentrifugation, LDL in hyper-
triglyceridemia was found to be polydisperse, a term 
originally introduced by Hammond and Fisher et al. (27, 32) 
to describe LDL mass distribution over the entire LDL density 
range. On the other hand, monodisperse LDL consisting of a 
single class of macromolecules, was reported in normo-
lipidemia and hypercholesterolemia (27, 32). Indeed, the 
density distribution of LDL of our patients with phenotypes I 
and IV covered a wide density range from 1.022 to 1.048 g/ml 
in phenotype I and from 1.022 to 1.054 g/ml in phenotype IV, 
concentrated in two and four discrete LDL subfractions, 
respectively. For the normolipidemic and hypercholesterolemic 
subjects three distinct LDL subfractions in the relative 
narrow density range (1.022-1.038 g/ml) could be detected. 
However, in contrast with the above mentioned report, we 
observed that polydispersity is not a simple function of 
serum triglycerides because in the subjects with phenotype V 
polydispersity was absent and only one LDL subfraction in the 
narrow density 1.046 to 1.049 g/ml was seen. 
A mechanism that may explain some of the differences in LDL 
subfraction distribution among the various forms of 
hyperlipoproteinemia is the activity of plasma core lipid 
transfer proteins (44). These proteins are known to initiate 
a transfer of cholesteryl ester from LDL to VLDL and of 
triglycerides in the opposite direction (6, 7, 45). The 
presence of triglycerides in LDL, then allows continued 
particle size reduction through the action of lipase, 
yielding LDL populations that gradually become smaller and 
denser (46, 47). Such exchange reactions are related to the 
mass ratio between VLDL and LDL. This mechanism is 
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consistent with the inverse relation between triglyceride-
rich lipoprotein levels and the size and density (partial 
specific volume) of total LDL or its predominant subfraction 
(5-9, Fig. 5B). Furthermore, the previously described 
relative increase in triglyceride and protein content at the 
expense of free and esterified cholesterol and phospolipids 
in hypertriglyceridemia in total LDL is also related to the 
activity of the VLDL-triglycerides/LDL-cholesteryl ester 
exchange reaction (8, 11, 21). In the present study this 
deviation in LDL composition from normal is shown to be a 
reflection of the contributing LDL subfractions in the 
various forms of hyperlipoproteinemia. 
The presence of a larger and more slowly metabolized VLDL 
mass together with a decreased LDL mass in the phenotypes I 
and V, in comparison to phenotype IV, accelerates the lipid 
transfer/triglyceride hydrolysis cycles more into the 
direction of the smaller, heavier LDL particles. This may 
result in the presence of all intermediate products (LDL-l, 
LDL-2, LDL-4 and LDL-6) in phenotype IV and only the 
'end-product' (LDL-5) in phenotype V. In this respect, 
however, the presence of LDL-1A in familial 
hyperchylomicronemia remains unexplained. 
Next to the concentration of the serum triglycerides and 
the activity of the exchange reaction, other factors i.e. the 
production and the clearance rate of LDL may also be relevant 
in the formation of LDL subfraction patterns (36, 48-52). In 
the phenotypes I and V the intensity of the main LDL 
subfraction (LDL-5) was rather low, probably a reflection of 
a low synthesis of LDL combined with an enhanced fractional 
catabolic rate (FCR). In both subjects with phenotypes IV a 
predominant LDL svibfraction (LDL-4) was observed with a high 
intensity compared to the LDL-5 fraction of phenotype I and 
V. This may be the result of a normal or overproduction of 
LDL with an enhanced clearance of LDL. 
By definition, the circulation time of LDL determines the 
extent to which LDL is modified by lipid transfer reactions. 
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In vitro studies with human cultured fibroblasts showed that 
LDL in hypertriglyceridemia exhibited lower affinity toward 
the LDL receptor and was a less efficient regulator of 
cellular sterol synthesis and cellular receptor activity (53, 
54). These abnormalities appeared to correlate with the 
cholesterol content of LDL and reverted toward normal upon 
treatment with bezafibrate (53). Indeed, LDL apo В turnover 
studies in hypertriglyceridemic subjects reported accelerated 
removal of the apo В part of the lipoprotein from the plasma 
(51, 52). In one study, the mean half life of LDL apo В in 
normals, phenotypes IV and V were 4.3, 3.4 and 2.5 days, 
respectively (51). Thus, in vitro and in vivo metabolic 
studies suggest that for phenotype IV the circulation time of 
LDL is prolonged in comparison to the phenotypes I and V 
which are characterized by more elevated serum triglycerides. 
Therefore, it can be reasoned that in phenotype IV, despite a 
lower VLDL/LDL mass ratio in comparison with the phenotypes I 
and V, the very small and dense LDL-6 subfraction is 
generated. 
The increased relative triglycerides of LDL-6 compared to 
LDL-4 for both type IV patients may indicate that further 
hydrolization of triglycerides does not occur. This may be 
caused by a less access of lipase to triglycerides in LDL of 
decreased size or to other structural limitations imposed 
upon the LDL macromolecule. 
In contrast to the LDL in subjects with the phenotypes I, 
IV and V the elevated serum triglycerides in familial 
dysbetalipoproteinemia (Type III) are not associated with 
small and heavy LDL, possibly as a result of the decreased 
circulation time of LDL (55) and the presence of an excess of 
VLDL remnants (56). Compared to VLDL of normal subjects these 
remnant particles are cholesterol enriched and may therefore 
be considered as an inferior substrate for the exchange 
reaction. Indeed, Type III LDL, if present, was light with 
density characteristics between those of LDL-1 and LDL-2. 
Compared to normal LDL this LDL was enriched in 
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triglycerides, as reported previously (19), and apo E. 
The presence of an altered LDL in familial hyper­
cholesterolemia in terms of an enhanced size and molecular 
weight, cholesterol enrichment and triglyceride and protein 
depletion, has been reported (12-17). Indeed, the data in the 
present study suggest that the chemical composition of LDL 
subfractions might differ from normal. However, in agreement 
with Fisher et al. these differences are not impressive (14). 
The processing of LDL along a continuous cascade from large 
to small LDL species as suggested by the concept of 
Deckelbaum et al. (б, 7) does not explain the occurrence of 
discrete LDL subfractions. It has been postulated by Krauss 
and Musliner et al. that VLDL and IDL subpopulations may 
function as precursors of these distinct LDL subfractions 
(57, 58). They Constructed a hypothetical metabolic model, 
consisting of dual pathways, incorporating these precursor-
product relationships (58). In one pathway the processing of 
LDL in hypertriglyceridemia gives rise to the subsequent LDL 
subfractions II, HIB and IVB. Another pathway appeared to be 
involved in the apo В overproduction in familial combined 
hyperlipidemia. However, our data of the diverse distinct LDL 
subfractions for the various forms of hyperlipoproteinemia 
make a different explanation necessary (see above). 
In conclusion, the present study indicates that the LDL 
subfraction patterns and the physicochemical characteristics 
of the LDL subfractions were pathognomonical for the various 
forms of primary hyperlipoproteinemia. However the small 
sample size prevents definite conclusions to be drawn. It 
may be possible that both serum lipid and lipoprotein levels 
and the lipid binding capacity of the LDL apo В molecule are 
determined by a common genetic trait (59-61), Use of 
molecular biological probes to detect restriction fragment 
length polymorphisms within the apo в gene may prove useful 
in delineating the responsible genetic marker. 
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Summary 
The significance of a decreased low density lipoprotein cholesterol/apolipoprotein В ratio (LDL-
chol/LDL apo B), or protein-enriched LDL, to predict atherosclerosis was studied in 121 males with 
angiographically defined coronary artery disease (CAD) and compared to 98 male controls, without 
history or complaints of vascular disease. Controls were selected for similar age, smoking habits and 
relative body weight characteristics compared to the CAD group. Covariance analysis with adjustment for 
hyperlipoproteinemia, apoprotein E phenotype, smoking, age and relative body weight revealed that high 
density lipoprotein (HDL)-cholesterol was the only parameter that differed significantly between both 
groups. By logistic regression analysis HDL-cholesterol had the highest predictive power for the develop­
ment of CAD. The LDL-choI/LDL apo В ratio appeared significantly different between controls and 
CAD patients (3.1 ± 0.7 vs. 2.9 ± 0.6 nunol/g, Ρ < 0.05), indicating a predominance of subjects with 
protein-enriched LDL in the CAD group. However, within the group of CAD patients with normal 
LDL-cholesterol levels no clear distinction could be found between patients with normal and increased 
LDL apo В levels. Furthermore, it appeared that the LDL-chol/LDL apo В ratio correlated significantly 
with age (p = -0.24), serum triglycerides ( p = -0.24), and HDL-cholesterol (ρ-0 .24) . Thus, the LDL-
chol/LDL apo В ratio cannot be considered an independent risk factor for CAD. When adjusted for age, 
smoking habits and relative body weight the significance of protein-enriched LDL as a risk factor for 
coronary heart disease diminishes, and HDL-cholesterol appears to be the best indicator for CAD. 
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Introduction 
The presence of high levels of low density lipo­
protein (LDL)-cholesterol is associated with 
coronary artery disease (C\D) [1] The apoprotein 
E (apo E) phenotvpe, because of its influence on 
serum lipids and lipoproteins, may also be consid­
ered to be a nsk factor for CAD [2.3] 
Several reports have shown that besides the 
cholesterol content apoprotein В (apo B) in the 
LDL fraction is also a sensitive marker for CAD 
[4-8] Among patients with CAD Smderman et al 
[8] could delineate a subgroup with normal LDL-
cholesterol but enhanced LDL protein concentra­
tion (hyperapobetahpoprotememia) suggesting 
that CAD is associated with an abnormal 
protem-ennched LDL However, HDL-choIesterol, 
apo E phenotype, smoking habits and relative 
bodv weight were not determined Moreover, in 
the visual presentation of the relation between 
LDL-cholesterol and LDL apo В levels group 
differences in age and sex were not taken into 
account Vega and Grundv [9] also studied LDL 
apo B/LDL-cholesterol ratios of normolipidemic 
(NLP) and hypertnglycendermc (HTG) CAD pa­
tients and normo- and hypertensive normolipi­
demic controls (NTN-NLP and HTN-NLP, re­
spectively) They detected no significant difference 
in this parameter between NLP CAD patients and 
NTN- and HTN-NLP controls On the other hand, 
the HTG group with CAD had a significantly 
higher ratio of LDL apo B/LDL-chol than all the 
other groups In the same study, increasing age 
and hypertnglycendemia appeared to contribute 
to higher LDL apo B/LDL-chol ratios in some 
CAD patients Moreover, obesity in hypertn-
glycendenuc CAD patients and in hypertensive 
controls was associated with a higher LDL apo 
B/LDL-chol ratio These results emphasize the 
importance of adjusting for various parameters 
such as age, body weight and hypertnglycendemia 
in these studies 
Therefore, we have attempted m the present 
study to determine whether the composition of 
LDL, expressed as the ratio of LDL-cholesterol to 
LDL protein, is an mdependent nsk factor for 
CAD and whether it has any predictive power to 
detect subjects with CAD in companson with 
other known Upid and lipoprotein nsk factors For 
this purpose serum lipids lipoproteins, apo E phe­
notype and apo В in LDL were determined in 121 
male subjects with CAD and 98 male controls 
with similar nsk profiles for age, smoking habits 
and relative body weight and weighted statistical 
analysis was performed 
Materials and methods 
Stud} design 
Male cases were selected dunng a 2-year penod 
at the Department of Cardiology pnor to ex­
amination by coronary artenography usmg the 
Judkms technique [10] On the base of their his­
tory and laboratory parameters these cases were 
screened for secondary factors related to coronary 
heart disease or to lipid metabolism The screen­
ing procedure resulted m the exclusion of all sub­
jects with hypertension, diabetes mellitus and en­
docrine or metabolic disorders, also all patients 
older than 65 years were excluded The angio­
grams were judged by cardiologists who had no 
pnor knowledge of the lipoprotein profiles Only 
pauenu with at least one stenosis > 50% were 
included in the study (n = 121) 
As male controls a group was sought with 
similar relative body weight, age and smoking 
habits The same exclusion entena as formulated 
for the cases were used The control selection was 
performed parallel in tune with the case selection 
and consisted of a systematic search of mainly 
older men (40-65 years) among the subjects visit­
ing the out-patient clinic of the Department of 
General Internal Medicine All selected controls 
(n = 98) were onginally referred to the clinic be­
cause of unexplained complaints of weakness, ab­
dominal discomfort or arthralgia, in none of the 
cases related to a metabolic or endocrine disorder 
All controls were free from complaints or a his­
tory related to the cardiovascular system On 
physical examination and on electrocardiogram 
none of them showed signs of atherosclerotic dis­
ease 
Relative body weight was calculated according 
to the Metropohtan Life Insurance Company Ta­
bles 1983, and the smoking habits were scored as 
follows 1 = non-smoking, 2 = less than 10 
cigarettes/day, 3 » 10-20 cigarettes/day, and 4 = 
20 or more cigarettes/day The normolipidemics 
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(NLP) were divided into subclasses on the basis of 
their apo E phenotypes (1) subjects with the most 
frequently occurring apo E phenotype E 3/3 (NLP 
E 3/3) (2) subjects heterozygote for the E 4 allele 
(NLP E 4/3), (3) subjects heterozygote for the E 2 
allele (NLP E 3/2). and (4) subjects with the less 
frequently occurring apo E phenotypes E 2/4 
(η - 1), E 2/2 (η - 1) and E 4/4 (η = 4) (NLP-
rest) The HLP subjects were classified according 
to their Frednckson type The cut-off limits and 
the entena for this classification have been re­
ported elsewhere [11] For the separation between 
normo- and hypercholesterolemia age-adjusted 
LDL-cholesterol levels between 4 9 and 5 2 
mmol/1 were used [12] This resulted in 3 sub­
classes (1) those having type IIA or type IIB 
(HLP II), (2) those with type IV (HLP IV), and 
(3) those with type III (n = 3) and V (n = 2) 
(HLP-rest) To allow companson of our results 
with the previous report of Smderman et al [8], 
we also studied a subtotal class, not including the 
subjects with elevated LDL-cholesterol levels 
Analysis of lipoproteins and apoproteins 
Serum was separated within 3 h after collecting 
blood from the subjects fasted overnight Very low 
density and intermediate density lipoproteins 
(VLDL + IDL) (d < 1 019 g/ml) were isolated by 
ultracentnfugation at 168000 Xg [13] and HDL-
cholesterol was determined in whole serum by the 
polyethylene glycol 6000 method [14] LDL-
cholesterol was calculated by subtraction of 
VLDL + IDL-cholesterol and HDL-cholesterol 
from total serum cholesterol LDL apo В was 
determined in quadruplicate by radial immunodif­
fusion ш the d > 1 019 g/ml fraction Determina­
tion of apo В ш this fraction circumvents the 
possible interference of large tnglycende-nch hpo­
proteins in the immunoassay [15] The 0 8% (w/v) 
agarose contained 0 3% (v/v) anti-apo В anti­
serum, which was raised m rabbits against LDL 
(1 030 - 1 050 g/ml) Precipitation rmgs were read 
after incubation at room temperature for 48 h 
The coefficient of variation between assays was 
6% The apoprotein E phenotype was determined 
by isoelectnc focusing of the urea-soluble 
apoproteins m the d < 1 019 g/ml fraction [16] 
Statistical analysis 
Differences for lipids, lipoproteins, LDL apo В 
and the LDL-chol/LDL apo В ratio between the 
CAD group and the control (C) group were 
analysed by covanance analysis with age, smoking 
habits, and relative body weight as the covana-
bles Class vanables were the CAD and С groups 
and the subclasses NLP E 3/3, NLP E 4/3, NLP 
3/2, HLP II and HLP IV Subjects with HLP-rest 
and NLP-rest were not included In the covanance 
analysis model the interaction term between groups 
(CAD/C) and subclasses was mcluded The esti­
mated least square means of the serum lipids, 
hpoproteins, apo В and LDL-chol/LDL apo В 
ratio are determined for the subclasses NLP E 
3/3, NLP E 4/3, NLP E 3/2, HLP II and HLP 
IV as well as for the CAD and control group [17] 
The Bonferrom method was used to control the 
error rate of the tests for differences between 
subclasses In this method the desired significance 
level for the expenment as a whole is divided b\ 
the number of compansons made Stepwise lo­
gistic regression was performed to estimate 
whether lipids, hpoproteins, LDL apo В and the 
LDL-chol/LDL apo В ratio are significant nsk 
factors for CAD Both backward elimination and 
forward selection were performed to achieve uni­
formity Age, smoking habits and relative body 
weight were included m each model and the selec­
tion techniques were performed on the other van­
ables {lipids, hpoproteins, LDL apo В and LDL 
chol/LDL apo В ratio) Correlations were tested 
with the Pearson correlation test Differences m 
the mean values of the vanous nsk fac'ors (serum 
lipids, lipoproteins, LDL apo B, LDL chol/LDL 
apo В rano, age, smoking habits and relative body 
weight) between the CAD and the control group 
were tested for significance by Student's /-test to 
allow companson with previous reports 
The statistical analyses were performed with 
procedure available m the Statistical Analysis Sys­
tem (SAS) software package (SAS Institute Incor­
porated, Сагу, NC) In particular, covanance 
analysis was performed by the GLM procedure 
and for stepwise logistic regression the LOGIST 
procedure was used 
Results 
Table 1 shows that the studied total CAD and 
control group did not differ significantly with 
regard to age, smoking habits and relative body 
weight The same was true for the respective CAD 
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and control group in the subtotal (HLP II ex­
cluded), except for a difference in the mean age of 
2.9 years. 
In the total group of patients with CAD all 
measured bpid and lipoprotein concentrations as 
well as LDL apo В and the LDL chol/LDL apo В 
ratio differed significantly from the total group of 
controls (Table 1). When the subjects with HLP 
type II were excluded from the total, the CAD 
patients still had significantly ( P < 0.001) lower 
HDL-cholesterol and a lower (P < 0.05) ratio of 
LDL-choi/LDL apo B; the levels of serum 
cholesterol, serum triglycerides, LDL-cholesterol 
and LDL apo В did not differ significantly (Table 
1). 
Apo E phenotypes and the various types of 
hyperlipoproteinemia are not equally distributed 
over the control and CAD groups (Table 2). 
Therefore, the differences m lipids, lipoproteins, 
LDL apo В and LDL-chol/LDL apo В ratio, as 
dependent variables, between CAD patients and 
controls were tested for significance by со алапсе 
analysis using as class variables the CAD and 
control groups and the subclasses NLP E 3/3, 
NLP E 4/3, NLP E 3/2, HLP II and HLP IV 
(Table 2). The results are shown m Table 3. Only 
HDL-cholesterol differed significantly between 
control and CAD groups (P < 0.001). The interac­
tion found for serum triglycerides is caused by the 
lower triglycerides m the CAD group compared to 
the controls for the subclasses NLP 3/3 and HLP 
IV and the reverse for the subclasses NLP E 4/3, 
NLP E 3/2, and HLP II (Tables 2 and 3). 
The estimated least square means of the serum 
lipids, lipoproteins, LDL apo В and LDL-
chol/LDL apo В ratio for the subclasses NLP E 
3/3, NLP E 4/3, NLP E 3/2, HLP II and HLP 
IV as well as for the CAD and control groups are 
shown m Table 4 The significant differences be­
tween these subclasses observed for the estimated 
least square means of serum lipids, lipoproteins, 
LDL apo В and the ratio of LDL-chol/LDL apo 
В (Tables 3 and 4) are at least partly inherent in 
the entena used for classification. The estimated 
least square mean for the ratio of LDL-chol/LDL 
apo В was significantly higher for subclass HLP II 
representing the subjects with type II (3.3 ± 0.1 
mmol/g). than for each of the other subclasses 
(range 2.8-3.1 mmol/g). Subjects of the HLP type 
TABLE 2 
SERUM LIPIDS LIPOPROTEINS LDL APO В AND LDL-CHOL/LDL APO В RATIO (MEAN±SD) IN THE SUBJECTS 
WITH CAD AND CONTROLS (С) OF THE SUBCLASSES STUDIED 
Subclass Group о 
Л ormoliptdemic 
N L P E 3 / 3 С 
CAD 
N L P E 4 / 3 С 
CAD 
N L P E 3 / 2 С 
CAD 
Myperliptdemtc 
HLPII С 
CAD 
HLP IV 
Total 
С 
CAD 
С 
CAD 
Age Smoking Relative Serum Serum HDL LDL LDL LDL-chol/ 
(years) body chol tng. chol chol apo В LDL apo В 
weight (mmol/l) (mmol/l) (mmol/1) (mmol/l) (g/1) (nunol/g) 
(*) 
32 497±85 24±13 П9±П 58±07 16±04 П±03 38+06 133±036 31±07 
28 521±77 22±1J П3±14 58±11 14±04 10±03 40±09 П2±028 30±05 
21 532±78 28±11 112±16 60±09 13±04 11±02 42±07 135-040 33±08 
18 560±36 2.7±11 115±10 62±09 18t04 09±03 42±07 158±036 27±05 
11 489±63 22±13 111±I3 56±12 15±04 12±03 34±П П8±029 29±07 
5 543±48 2.;±13 119±13 S5±ll 18±04 10±01 34±09 102±033 32±02 
9 507±7.2 20±10 П8±10 79±07 18±05 1 2±0J 57±05 161±020 36±04 
27 471±89 30±10 117±11 85±14 2.6±10 09±02 58±08 198±059 31±07 
18 514±63 22±12 Π4±13 67±10 38±15 12±03 3é±09 133±033 28±05 
39 530±56 25±12 120±10 67±09 33±1Q 09±02 38±07 149±036 27i06 
91 509±75 24±12 Π5±13 62±11 20±12 11±03 40±10 135±035 31±07 
117-519±73 26±11 117±12 68 + 15 24±11 09±02 44±11 156±048 29±06 
IV subclass showed the lowest value (18 ± 0 1 
mmol/g) for the estimated least square mean of 
the LDL-chol/LDL apo В ratio (Table 4) 
By stepwise logistic regression analysts of the 
total population of controls and CAD patients 
(Table 1) both forward selection and backward 
elimination revealed that HDL-cholesterol was 
significantly predictive for CAD ( P < 0 001) 
Serum cholesterol, serum triglycerides, LDL-
cholesterol, LDL apo В and the ratio of LDL-
chol/LDL apo В provided no significant ad­
ditional contribution to the model HDL-
TABLE 3 
Ρ VALUES OF THE COVARIANCE ANALYSIS ON SERUM LIPIDS AND LIPOPROTEINS 
Covanables 
Age 
Relative weight 
Smolung 
Class vanables 
Subclasses 
C/CAD 
Interaction 
Groups/subclasses 
Serum 
chol 
- (1 41) 
•••(2 20) 
- (7 59) 
» · * 
-
-
Scrum 
tng 
- (0 27) 
· · (136) 
- ( - 3 55) 
* # * 
-
»· 
HDL-
chol 
- ( - 0 02) 
- ( - 0 1 9 ) 
• ( - 3 29) 
Φ * * 
. . . 
-
LDL-
chol 
- (1 45) 
(108) 
· · (1214) 
. . . 
-
-
LDL 
apo В 
* · · (130) 
• (0 47) 
• (5 01) 
. . . 
-
-
LDL-chol/ 
LDL apo В 
· · ( - 1 8 9 ) 
- ( - 0 1 7 ) 
- ( - 0 7 5 ) 
m 
-
-
Covanance analysis was performed with the nsk factors age relative body weight and smolung habits as covanables (upper pan of 
the table) Cocffiaents (XWO) of the covanables are indicated in brackeu Class vanables (lower part) were C/CAD and the 
subclasses NLP E 3/3 NLP E 4/3. NLP 3/2 HLP II and HLP IV -, />>005, · 0 0 K Ρ < 005 • • 0 0 0 К Ж 0 0 0 1 
· " / > < 0 001 
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TABLE 4 
ESTIMATED LEAST SQUARE MEANS-SD' OF THE SERUM LIPIDS AND LIPOPROTEINS FOR THE VARIOUS 
SUBCLASSES AS WELL AS FOR THE CONTROL AND CAD GROUPS 
Subclass 
NLP E 4/3 
NLP E 3/3 
NLP E 3/2 
HLPIV 
HLPII 
Group 
Control 
CAD 
Serum 
Chol 
• * l ± 0 2 i 
•58±01 
Ι ·56±03 
6 7 ± 0 1 -
8 2 ± 0 2 
6 5 ± 0 1 
6 5 * 0 1 
Serum 
tng 
- 1 6 ± 0 1 
- 1 4 ± 0 1 
¡-16*0 2-, 
3 5 * 0 1 
2 2 ± 0 1 J 
2 0 * 0 1 
2 1 * 0 1 
HDL-
chol 
r l 0 ± 0 0 
- 1 0 * 0 0 
1-1 1*01 
0 8 * 0 0 
4 1*0 0 
1 1 * 0 0 
0 9 * 0 0 
LDL-
chol 
41 ±01-1 
r39±01-l 
-3 4*0 2, 
L3 7 ± 0 1-¡ 
5 8 * 0 1 
4 2 * 0 1 
4 2 * 0 1 
LDL 
apoB 
1 4 2 * 0 06-1 
1 3 5 * 0 0 5 -
1 1 1 * 0 1 1 -
140*005-1 
1 8 2 * 0 0 7 
1 3 8 * 0 0 5 
1 4 6 * 0 05 
LDL-chol/ 
LDL apo В 
3 1 ± 0 1 - | 
3 0 * 0 1 -
з о і о г -
2 8*01-1 
3 3 - 0 1 
3 1 * 0 1 
3 0 * 0 1 
Brackets link two subclasses that do not differ significanti;, 
* According to the со апалсе analvsis 
cholesterol appeared to correlate significantly with 
smoking habits (p= - 0 1 7 , Ρ < 0 05), serum tn-
glycendes ( p = - 0 40, Ρ < 0 001), LDL apo В 
(Ρ = - 0 1 9 , Ρ < 0 01) and LDL chol/LDL apo В 
ratio ( ρ = 0 24, Ρ < 0 001 ) (Table 5) 
The relationship between LDL-cholesterol and 
LDL apo В values for both controls and patients 
with CAD is shown in Fig 1 The mean ratio of 
LDL-chol/LDL apo В is significantly higher for 
the CAD than for the control group (3 1 ± 0.7 vs 
2.9 ±0.6 mmol/g, P < 0 0 5 , Table 1) Neverthe­
less, for both the class with or without the subjects 
with type II hyperhpoproteinemm (Table 1) there 
is a considerable overlap between controls and 
LDLapoB(g/l) 
i On 
30 
20· 
10-
ь°
0 
Λ 9 
Д о 
*
4 U 
Λ 
LDL-cholesterol (mmol/I ) 
Fig. 1 Relaüonsbp between LDL-cholesterol and LDL apo В of CAD paaents and controls For the separation of normo- and 
hypercholesterolemia age adjusted LDL-cholesterol levels between 4 9 and 5 2 mmol/l were used [12). л, conuol, o, CAD 
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TABLE S 
PEARSON CORRELATIONS OF THE DIFFERENT \ ARI 
ABLES WITH THE LDL-CHOL/LDL APO В RATIO A N D 
HDL-CHOLESTEROL 
Variable 
Age 
Smoking 
Relative weight 
Serum chol 
Serum mg 
HDL-chol 
LDL-chol 
LDL apo В 
LDL-chol/LDL apo В 
HDL-chol/ 
LDL apo В 
- 0 24 ( · · * ) 
- O O l ( - ) 
- 0 05<-) 
- 0 1 0 ( - ) 
- 0 2 4 ( · * · ) 
0 24 ( · * · ) 
0 2 5 ( · · · ) 
- 0 S 0 ( * · · ) 
-
HDL-chol 
- 0 05 (-) 
- 0 1 7 ( · ) 
- 0 1 3 ( - ) 
- 0 0 4 ( - ) 
- 0 4 0 ( * · * ) 
-
0 03(-) 
- 0 1 9 ( · · ) 
0 2 4 ( · * * ) 
Levels of sigmficaoce are given in parentheses - Ρ > 0 05 
* 0 0 1 < / > < 0 0 5 * * 0 0 0 1 < Я < 0 0 1 * · * Ρ < 0 0 0 1 
CAD patients and no special cluster of CAD 
patients with normal LDL-cholesterol and in­
creased LDL apo В could be identified (Fig 11 
The ratio of LDL-chol/LDL apo В appeared 
to correlate significantly with age ( ρ = - 0 24, Ρ 
< 0 001), serum triglycerides ( p ^ - 0 24 Ρ < 
0 001) and HDL-cholesterol (p = 0 24, Ρ < 0 001) 
(Table 5) 
Discussion 
Serum cholesterol and especially LDL-choles­
terol are important nsk factors for coronary artery 
disease [1] Other reports have shown that the 
discnminatmg power for coronary heart disease of 
LDL apo В appeared to be supenor to that of 
LDL-cholesterol [4-8] Thus, among the patients 
with CAD some have an increased LDL protein 
concentration despite normal LDL-cholesterol 
levels These patients with hyperapobetahpopro-
teineima [SJ have by definition an abnormal com­
position of LDL with a decreased ratio for LDL-
chol/LDL apo В [18] 
The composition of LDL is reportedly related 
to a number of factors such as the concentration 
of LDL- and HDL-cholesterol, serum tri­
glycerides, age, physical activity, and is also de­
termined by genetic factors [19-26] The composi­
tion of LDL is at least partly determined by 
exchange of triglycerides for cholesteryl esters [24] 
Through this mechanism LDL becomes ennched 
in triglycerides at the expense of cholesteryl esters 
The presence of an abundant amount of tri­
glycerides m the LDL particle allows continued 
particle size reduction through lipase action which 
finally may result m small protem-ennched LDL 
particles This concept is supported by the rela­
tively low ratio of LDL-chol/LDL apo В for 
subjects with increased serum triglycérides com-
pared to that of noiraohpidemic subjects and of 
subjects with elevated LDL-cholesterol concentra-
tion (Tables 2 and 4) Comparable results are 
reported by others Smderman et al [8,27,28] found 
that a significant proportion of patients with hy-
perapobetahpoprotememia have elevated plasma 
triglycerides Vega and Grundy [9] described an 
enhanced LDL apo B/LDL-chol ratio for hyper-
tnglycendemic CAD patients compared to 
normolipidemic CAD patients and controls Also 
HDL-cholesterol participates in the exchange re-
action and its concentration is inverselv related to 
that of serum triglycerides [24,26,29.30] There-
fore, it can be reasoned that when subjects with 
different values for the compositional ratio of 
LDL-chol/LDL apo В are compared the levels of 
HDL-cholesterol and serum triglycerides will dif­
fer too This is especially the case when subjects of 
different age, smoking habits and relative body 
weight, which each are associated with HDL-
cholesterol [31], are compared 
In agreement with the literature [4-8] our CAD 
patients had an increased LDL apo В concentra­
tion Furthermore, the LDL-chol/LDL apo В ratio 
was decreased, whether or not the subjects with 
elevated LDL-cholesterol were included However, 
adjusted for hyperhpoprotememia, apo E pheno-
type, age, smoking and relative body weight, the 
concentration of LDL apo В and the cholesterol-
to-apo В ratio ш LDL did not differ significantly 
and HDL-cholesterol appeared to be the only 
parameter of the measured lipids and lipoprotems 
that differed significantly between CAD patients 
and controls This independent predictive power 
of HDL-cholesterol supports earlier findings 
[29,31] Moreover, m contrast to Smderman et al 
[8] but in agreement with Vega and Grundy [9], we 
were unable to identify a subgroup of patients 
with CAD with an abnormal low LDL-chol/LDL 
apo В ratio Thus, although some CAD patients 
may fit the criteria of h y p e r a p o b e t a -
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hpoproteinemia. LDL apo В m our subjects is not 
a clear indicator of coronary risk. 
These differences m outcome may be explained 
by the selection critena for the CAD and control 
group and the adjustment for confounders in the 
statistical analyses performed and in the results 
presented. In the study of Sniderman et al. [8] 
cases and controls were documented by coronary 
arteriography. In our study we used a symptom-
free control group and all possible precautions 
were taken that the control group was free of 
CAD and had no secondary factors which could 
interfere with their lipid and lipoprotein pattern. 
Because Vega and Grundy [9] showed that the 
ratio of LDL-chol/LDL apo В is associated with 
age and obesity (in hypertensive controls and hy­
pertriglyceridemia) these parameters were taken 
into account in our study both by the selection of 
the groups and in the different statistical analyses 
performed. Thus. CAD and controls m Fig. 1 were 
of similar age and sex, whereas this was nol the 
case in a similar figure presented bv Sniderman et 
al. [8]. 
In addition to differences in the design of the 
studies methodological aspects may also explain 
the differences reported concerning the signifi­
cance of LDL apo В and protein-ennched LDL as 
(independent) nsk factors for CAD. In most re­
ports the concentration of LDL apo В was esti­
mated by immunological techniques, using whole 
un fractionated serum [4-8,32,33]. These methods 
may be less accurate compared to measurement of 
apo В in the LDL fraction as apo В containing 
small VLDL and IDL may interfere [34,35]. Vega 
and Grundy [9] and we circumvented this possible 
source of error by measurement of apo В in the 
d = 1.019-1.067 g/ml fraction Ъу a modification 
of the method of Lowry et al. and by radial 
immunodiffusion in the d> 1.019 g/ml fraction, 
respectively. 
Although in the present study LDL of CAD 
patients appeared more protein-enriched com­
pared to LDL of controls, the ratio of 
LDL-chol/LDL apo В cannot be considered an 
independent risk factor for CAD. Due to the 
correlation of this compositional ratio with age, 
serum triglycerides and HDL-cholesterol, changes 
in these parameters can at least be expected to 
affect the LDL-chol/LDL apo В rauo. When 
CAD patients and controls of similar age, smek­
ing habits and relative body weight are compared 
the significance of altered LDL as a risk factor for 
coronary disease m the present study diminishes 
and HDL appears to be the best indicator. 
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ABSTRACT 
By a recently developed sensitive density gradient 
ultracentrifugation method, the distribution of low density 
lipoprotein (LDL) subfractions was studied in serum of 
healthy blood donors (20-62 years). For each subject a 
specific LDL subfraction distribution was observed 
characterized by the relative contribution of the three major 
LDL subfractions, LDL-I (1.020-1.028 g/ml), LDL-2 (1.027-
1.034 g/ml) and LDL-3 (1.033-1.039 g/ml) to total LDL. 
Statistical analysis was performed using the LDL density 
variable defined as: (% of LDL-1) χ 1.024 + (% of LDL-2) χ 
1.0305 + (% of LDL-3) x 1.036 as a continuous variable. 
Controlling for age, smoking habits, relative body weight 
and, when appropriate, for sex, it appeared that i) dense LDL 
subfraction patterns, characterized by a predominant LDL-3 
subfraction and a decreased LDL particle size were more 
likely to be found among men than among women, ii) with 
increasing density of LDL the levels of serum triglycerides 
increased, whereas the concentration of HDL-cholesterol and 
the ratio LDL-cholestero1/LDL apo В decreased and iii) the 
best model with significant contribution in the prediction 
of the LDL subfraction distribution was the three-variable 
model total cholesterol, serum triglycerides and LDL apo в 
(Rs=0.40), whereas the best two-variable model consisted of 
serum triglycerides and HDL-cholesterol (Rz=0.37). These data 
are consistent with results described previously, using a 
different approach based on LDL subfraction quantification by 
gradient gel electrophoresis of whole plasma. 
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INTRODUCTION 
Plasma levels of low density lipoproteins (LDL) are 
positively correlated with the prevalence of coronary artery 
disease (CAD) (1). By various methods LDL was found to be 
heterogeneous, consisting of subfractions which differ in 
physicochemical characteristics (2-7). This raises the 
question whether the various LDL subfractions differ in their 
ability to induce atherosclerosis, 
Evidence has been obtained that the distribution of LDL 
subfractions has a genetic base (8, 9) and two phenotypes 
could be distinguished, characterized by either a major peak 
of LDL subclasses with large (A) or smaller (B) diameters 
after gradient gel electrophoresis (9). The subjects with 
either phenotype, however, also showed significant 
differences in serum lipids and lipoprotein concentrations, 
leaving the question whether the LDL subclass pattern is 
primary or secondary to these differences in serum lipids and 
lipoproteins. It has been suggested, that one of the 
phenotypes may represent familial combined 
hyperlipoproteinemia or hyperapobetalipoproteinemia, both 
characterized by an increased risk for CAD (10, 11). 
To study the relationship of LDL subfraction distribution 
with serum lipids and (apo)lipoproteins, LDL subfractions 
were analyzed and quantitated in serum of 62 male and 69 
female blood donors by a recently developed sensitive density 
gradient ultracentrifugation method (7). Different LDL 
subfraction patterns emerged and serum lipids and 
lipoproteins were determined and compared in order to gain 
insight into the possible metabolic factors that underly the 
heterogeneity of LDL. In the discussion results were compared 
with those obtained recently by McNamara et al., who 
separated the LDL subfractions by gradient gel 
electrophoresis of whole plasma (12). 
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MATERIALS AND METHODS 
Study protocol 
Blood was sampled from apparently healthy blood donors 
(n=146), aged 20-62 years, non-fasted but within 2 h after a 
light continental breakfast. Under these conditions 
chylomicrons may be expected to be absent in normolipidemics 
and the variation in serum triglycerides due to the non-
fasting condition does not exceed the rather large biological 
variation of 25 % in sera after 10 h of fasting (13). Sera 
were isolated within 2 h. The subjects had filled out 
questionnaires designed to identify the most important risk 
factors for coronary heart disease and other factors known to 
influence serum lipids and lipoproteins as the use of drugs, 
smoking habits, height and weight, age and physical activity. 
Relative body weight was calculated according to the 
Metropolitan Life Insurance Company tables 1983. Physical 
activity of the studied subjects was low or moderate. 
Subjects using ß-blockers and/or diuretics (n-2) as well as 
women taking oral contraceptives (n=5) and subjects with 
total serum cholesterol or triglycerides, exceeding 7.75 and 
3.50 mmol/l (n=7) respectively, were excluded from the study. 
In addition, one excessively obese woman with a relative 
body weight of 194%, was also excluded. The resulting study 
population consisted of 62 males and 69 females. 
Detection of LDL subfractions 
LDL banding pattern was analyzed as described (7): 3.4 ml 
of serum was prestained with Coomassie Brilliant Blue R 
(CBBR) and ultracentrifuged in a density gradient at 160,000 
g™v and 20 0C for 19.5 h in the IEC SW 41 rotor (no. 488, 
6x14 ml) in an IEC-B60 ultracentifuge (Damon/IEC, Needham 
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Heights, MA, USA) or an MSE Prespin 75 ultracentrifuge with 
a MSE Ti 40 rotor (cat. no 43127-111). After 
ultracentrifugation an almost linear density gradient was 
obtained (7) with up to three major LDL subfractions in the 
density range 1.020 to 1.039 g/ml (between fractionation 
marks 8.5 and 12), very light LDL-1 (1.020-1.028 g/ml), light 
LDL-2 (1.027-1.034 g/ml) and heavy LDL-3 (1.033-1.039 g/ml). 
Prolonging the ultracentrifugation time from 19.5 to 39 h 
resulted in LDL bands that i ) were located somewhat further 
apart: LDL-1 moved slightly towards the top of the tube, 
whereas LDL-2 and LDL-3 moved slightly towards the bottom, 
ii) were less sharp; the LDL peaks became broader and the 
peak heights decreased. 
The effect of the prestaining procedure was evaluated 
previously by means of density gradient ultracentrifugation 
of pooled serum (7). The profile of the cholesterol content 
along the gradient was determined in the tube after 
tiltracentrifugation of both serum non-stained and serim 
prestained with CBBR. It appeared that the staining procedure 
did not result in a change of density of the LDL (7). In 
addition, density gradient ultracentrifugation was performed 
in one and the same run with 2 non-stained (a), and 2 
stained tubes (b). When three subfractions were observed they 
were all yellow for method "a", whereas for method "b" all 
subfractions colored blue. It appeared that for samples that 
were run without stain, the LDL bands were in fact visible 
and the number of bands, their position and their chemical 
composition were similar for both methods. However, because 
of the yellow color of the non-stained subfractions some 
experience is needed for visual differentiation of these 
subfractions. Furthermore, the staining procedure allows 
better the recording of the LDL banding pattern by 
photography and densitometry. 
In 50 out of the 131 studied sera one (n=42), two (n=7) or 
three (n=l) additional minor bands (less than 5 % of the 
densitometric absorbance of the total LDL band) in the 
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density range 1.039-1.061 g/ml (between the fractionation 
marks 12 and 15.5) (7) could be detected. The sera of six of 
the 50 individuals with polydisperse sera were 
ultracentrifuged in the density gradient on a second occasion 
and a total of twelve minor bands emerged (one serum showed 
one minor LDL subfraction, four sera showed two minor LDL 
bands and one serum showed three minor bands). These minor 
bands were then isolated and characterized by Polyacrylamide 
gradient gel electrophoresis (5) and by immunodiffusion on 
0.8 % agarose using specific antisera against the Lp(a) 
protein raised in a sheep. 
After ultracentrifugation the tubes were placed in a 
special designed rack and photographed (14). The following 
conditions were used to obtain optimal photographs: lens, 135 
mm (Olympus, OM-1N); aperture, f/11; shutter speed, 1/30 s ; 
filter, Kodak wratten no. 81 and 30 m; illumination 15 cm 
behind the tubes from a diffuse light source (illumination 
for X-rays); distance 45 cm; film, Kodak Ektochrome 200, EPD 
135-36, process-E6. 
LDL subfractions were quantitated by densitometric scanning 
of the slides on a LKB 2202 ultrascan laser densitometer, 
beamsize 0.8x0.05 mm with a Gaussian distribution. The scan 
was started at fractionation mark 12.5 and was ended at 
fractionation mark 6. Peak identification, integration of 
peak areas and calculation of the relative contribution of 
each peak area to the total LDL band was performed by the 
LKB 2190 GelScan program on an Apple lie computer. For peak 
identification the peak width was set in such a way that the 
(number of) peaks found by an automatic search of the 
GelScan program were in agreement with those seen in the 
tube. The program then started to fit each peak using a 
Gaussian curve (inaccuracy at most 5 % ) . The area under each 
Gaussian was calculated and expressed as a percentage of the 
total LDL band. Repeating this computerized modelling 
procedure for the same densitometric scan results in an 
identical solution. 
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Analysis of lipoproteins and apoprotein В 
The density of 5 ml of serum was raised to d=1.019 g/ml by 
the addition of D^O (â=1.10 g/ml). Very low density 
lipoprotein and intermediate density lipoprotein (VLDL+IDL) 
were isolated by ultracentrifugation for 16 h at 40,000 rpm 
(168,000 g^^) in an TEC B-60 fixed angle rotor no. 468 (Damon 
IEC, Needham Heights, ΜΆ, USA) (15). High density lipoprotein 
(HDL)-cholesterol was determined in whole serum by the 
polyethylene glycol 6000 method (16). LDL-cholesterol was 
calculated by subtraction of VLDL+IDL-cholesterol and HDL-
cholesterol from total serum cholesterol. Apoprotein В (apo 
B) in the d>1.019 g/ml fraction was determined in duplicate 
on two different plates by radial immunodiffusion in 0.8% 
(w/v) agarose in barbital buffer, pH=8.6 (17). The 0.8 % 
(w/v) agarose contained 0.3 % (v/v) anti-apo В antiserum, 
which was raised in rabbits against LDL (1.030-1.050 g/ml). 
When duplicates differed more than 10 % radial 
immunodiffusion was repeated. 
Statistical analysis 
Statistical analysis used the LDL density defined as: (% of 
LDL-1) X 1.024 + (% Of LDL-2) X 1.0305 + (% Of LDL-3) X 1.036 
as a continuous variable. In this equation the weighted 
factors, 1.024, 1.0305 and 1.036 represent the midpoints of 
the density intervals of the LDL subfractions, LDL-I, LDL-2 
and LDL-3, respectively. 
Multiple linear regression was performed to determine the 
influence of gender, age, relative body weight and smoking 
habits (independent variables) on the LDL density variable 
(dependent variable). 
A different multiple linear regression was performed to 
examine the influence of the LDL density variable, gender, 
age, relative body weight and smoking habits (independent 
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variables) on the serum cholesterol, serum triglycerides, 
HDL-cholesterol, LDL apo B, LDL-cholesterol and the ratio 
LDL-cholesterol/LDL apo В (dependent variables). 
Pearson correlation coefficients were computed to i) 
determine correlations between the variables: serum 
cholesterol, serum triglycerides, HDL-cholesterol, LDL-
cholesterol, LDL apo В and LDL-cholesterol/LDL apo B, ii) 
identify among these same variables those having a 
significant correlation with the LDL density variable. 
Differences of the correlations obtained in the present 
study and in a previous report by McNamara et al. (12) were 
tested for significance using Fisher's Ζ transformation. 
Multiple linear regression model selection techniques 
including forward selection, backward elimination and a 
stepwise procedure, was used to examine significant 
contribution of the independent variables (total cholesterol, 
total triglycerides, HDL-cholesterol, LDL apo B, LDL-
cholesterol and the ratio LDL-cholesterol/LDL apo B) to the 
prediction of the LDL density variable. Any influence of sex, 
age, smoking habits and relative body weight was taken into 
account by including them in each model. 
Statistical analysis involved procedures from the 
Statistical Analysis System (SAS) computer programs (SAS 
Institute Incorporated, Cary, NC, USA). 
Reproducibility of the quantification of the LDL density 
variable 
The sera of ten blood donors were ultracentri fuged in 
duplicate at the same time in two different tubes placed in 
two different swinging bucket rotors. Both tubes were then 
photographed separately and the LDL subfractions were 
quantitated by densitometric scanning as described above. The 
mean value for the LDL density variable (+ SD) for the 
duplicates was 103.08 (+ 0.16) and 103.12 (+ 0.15), 
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respectively. The mean difference (+ SD) in the value of the 
LDL density variable between the duplicates was 0.04 (+ 
0.09). There was no systematic error in the calculated LDL 
density variable between the two rotors. An one-way analysis 
of variance was performed with the LDL density variable as 
dependent- and "subject" as independent variable to estimate 
the between- and within subject variation (18). The SD 
between subjects (within population) and within subjects 
(measurement error) were estimated as 0.141 and 0.067, 
respectively. This between subjects/within subjects SD ratio 
of approximately 2, reflecting a correlation coefficient of 
0.83 between the duplicates of the LDL density variables, is 
acceptable to detect differences within the studied 
population. 
RESULTS 
The number of major LDL subfractions found for the 131 
studied individuals was two (n=16) or three (n=115) in the 
density range 1.020-3.039 g/ml: LDL-1 (1.020-1.028 g/ml), 
LDL-2 (1.027-1.034 g/ml) and LDL-3 (1.033-1.039 g/ml) (Fig. 
1). As described in the method section, in 50 sera one 
(n=42), two (n=7) or three (n=l) additional minor bands in 
the density range 1.039-1.061 g/ml could be detected. For six 
sera in total twelve minor bands could be isolated, which 
could be characterized as LDL-4 (n=2), LDL-5 and Lp(a) (n=4) 
or LDL-4 and LDL-5 "contaminated" with Lp(a) (n=l, 5, 
respectively). The minor LDL bands LDL-4 and LDL-5 are 
arbitrarily defined on the basis of increasing density 
(1.039-1.049 g/ml versus 1.049-1.061 g/ml) and decreasing 
size. The presence of minor subfractions in the density 
gradient and the gradient gel electrophoresis is shown for 
one donor in Figure 2: Lp(a) is present in two of the three 
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minor subfractions and at increasing density the minor LDL 
bands are of decreasing size. 
For each individual the LDL subfraction distribution was 
determined by the relative contribution of the major 
subfractions, LDL-1, LDL-2 and LDL-3 to total LDL (Fig. 3). 
This LDL subfraction distribution was approached by the LDL 
density variable, constructed from the weighted average of 
the relative percentages of the three observed major LDL 
bands: (% of LDL-1) χ 1.024 + (% of LDL-2) χ 1.0305 + (% Of 
LDL-3) x 1.036. In Figure 3 each individual is represented by 
a square, which size, indicated by the length of the side, is 
directly proportional to the calculated value for the LDL 
density variable. A low value for the LDL density variable 
(small squares) was obtained for subjects with a predominant 
LDL-1 fraction, whereas a high value (large squares) was 
obtained for individuals with a predominant LDL-3 fraction 
(Fig. 3). Furthermore, an enhanced LDL density variable 
indicated a preponderance of LDL particles of relatively 
small size (Fig. 2). The frequency distribution of the LDL 
density variable among the 131 subjects studied showed a 
normal distribution (Fig. 4). 
Characteristics, as well as lipids and (apo)lipoprotein 
levels for the studied subjects are shown separately for men 
and women in Table 1. Minor LDL bands were more frequently 
seen in men than in women (Table 1). Variables that correla­
ted significantly (p<0.05) with the LDL density variable were 
serum triglycerides and HDL-cholesterol for both men and 
women. Moreover, increased LDL apo В levels correlated 
significantly with denser LDL for men (Table 1). Note the 
tendency (p<0.10) of a correlation of a more dense LDL 
subfraction pattern with increased smoking hcibits for women 
and a decreased ratio LDL-cholesterol/ LDL apo В for men. 
Multiple linear regression revealed that sex had a 
significant (p<0.05) influence on the LDL density variable 
(Table 2A). This indicates that men are more likely to have 
heavy LDL than women. 
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Fig. 1. LDL subfraction distribution in healthy subjects. 
A) LDL banding patterns after density gradient ultracentrifugation for six different 
individuals. Marks were drawn on the tube to facilitate the layering. 1, 2, and 3 
represent LDL-1, LDL-2 and LDL-3, respectively. Fractionation marks (tube A) are used for 
determination of the density of the LDL subfractions (7). Note that the photographic 
procedure causes a loss of sensitivity. 
B) LDL subfraction distribution determined by densitometric scanning of the tubes shown 
above, followed by computerized mathematical modelling. 
Solid line=curve obtained by densitometric scanning of the bands visible on the 
photographic slides taken from the tubes; Interrupted line=Gaussian curve determined by 
deconvolution analysis of the measured curve; Dotted line=curve representing the sum of the 
composing Gaussian curves. Peak densities of the Gaussian curves are indicated. Going from 
subject A to F the contribution to total LDL of LDL-1 is 8.2%, 7.8%, 20.3%, 18.3%, 42.6% 
and 64.0%, Of LDL-2 is 13.0%, 62.0%, 34.8%, 63.2%, 27.6% and 15.0% and Of LDL-3 is 78.8 %, 
30.3%, 44.9%, 18.4%, 29.9% and 21.0%, respectively. For subject A to F the value of the LDL 
density variable, defined as (% of LDL-1) χ 1.024 + (% of LDL-2) χ 1.0305 + (% of LDL-3) χ 
1.036, is 103.430, 103.269, 103.165, 102.929, 103.041 and 102.749, respectively. 
To examine the influence of the LDL density variable on 
lipids and (apo)lipoproteins at first a multiple linear 
regression model was applied including the interaction terms 
between the LDL density variable and age, smoking habits, 
relative body weight and sex. Since no significant inter­
action terms were found, indicating that the influence of the 
LDL density variable on lipids and (apo)lipoproteins did not 
depend on the age, number of cigarettes smoked, relative body 
weight or gender, only the model with main effects is 
presented. This model delineated a significant influence of 
the LDL density variable on the concentrations of serum 
triglycerides {p<0.00l) and HDL-cholesterol (p<O.0Ql) and on 
the ratio LDL-cholesterol/ LDL apo В (p<0.05), independent of 
influences of other "risk factors" as age, smoking habits, 
relative body weight and sex (Table 2B). Hence, dense LDL was 
accompanied by enhanced triglyceride- and HDL-cholesterol 
levels and a decreased ratio LDL~cholesterol/LDL apo B. 
In the stepwise multiple regression analysis the three-
variable model total cholesterol, serum triglycerides and LDL 
apo В appeared the best model with significant contribution 
in the prediction of the LDL density variable (R:?=0.40). No 
other parameter met the p=0.05 level for entering the model. 
The best two-variable model (R:'=0.37) in the prediction of 
the LDL density variable consisted of serum triglycerides and 
HDL-cholesterol. In Table 3 the regression coefficients and 
their level of significance are given for the variables 
selected. Apparently, the combination of the variables LDL 
apo В and total cholesterol in the three-variable model was a 
slightly better predictor for the variation in the LDL 
density variable than the HDL-cholesterol in the two-variable 
model.To be able to understand the relevance of the above 
mentioned two- and three-variable models in the prediction of 
the LDL density variable, we determined the correlations 
between variables (Table 4). The higher the correlation 
between two variables, the better the comparability between 
models in the prediction of the LDL density variable in case 
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TABLE 1. Characteristics for the studied subjects and their correlations with the LDL density variable. 
number of subjects} 
Age (years) 
Body weight (%) 
Smoking (cig. per day) 
LDL density var. 
Total cholesterol 
Total triglycerides 
HDL-cholesterol 
LDL-cholesterol 
LDL apo В (g/1) 
103 
LDLC/LDL apo В (mmcl/g) 
mean + SD 
69 (19) 
32.7 + 9.6 
115 + 14 
5 + 8 
.016 + 0.140 
5.1 + 0.9 
1.2 + 0.5 
1.4 + 0.3 
3.2 + 0.7 
0.97 + 0.28 
3.5 + 0.7 
WOMEN 
correlation* 
present study 
study 
-0.09 
-0.15 
0.20" 
-0.19 
0.39! 
-0.38 fi 
-0.16 
-0.02 
-0.07 
ref.12 
0.22« 
0.23ІІ 
0.66K 
-0.5811 
0.27« 
p-valueT 
0.04 
0.00 
0.01 
0.08 
0.00 
mean + SD 
62 (31) 
39.0 + 11.3 
111 + 12 
6 + 10 
103.102 + 0.183 
5.4 + 1.0 
1.6 + 0.7 
1.2 + 0.3 
3.4 + 0.8 
1.00 + 0.37 
3.7 + 1.0 
MEN 
correlation* 
present study 
study ref. 12 
0.11 0.17S 
0.03 
0.13 
0.08 0.28|| 
0.4711 0.7911 
-0.5011 -0.581 
0.09 0.15 
0.25S 
- 0 . 2 4 " 
p-value 
0.69 
BOTH 
coi 
mean + SD 
131 (50) 
35.7 + 10.9 
113 + 14 
5 + 9 
103.057 + 0.167 
0.18 
0.00 
0.47 
0.70 
5.2 + 0.9 
1.4 + 0.6 
1.3 + 0.3 
3.3 + 0.8 
0.98 + 0.32 
3.6 + 0.8 
SEXES 
rrelaticn' 
present 
study 
0.10 
-0.09 
0.17S 
0.01 
0.49fl 
-0.49fl 
0.02 
0.16" 
-0.13 
Values are indicated in mmol/l unless otherwise stated. 
*, Pearson correlations and their level of significance of the indicated variables with the LDL density variable for the 
presented study (present study) and a previous report12; t, the p-value of the differences in correlation between both 
studies, t, between brackets the number of subjects with at least 1 minor band in the density range 1.039-1.061 g/ml; §, 
0.01<p<0.05; II, 0.001<p<0.01; 1, p<0.001; **, 0.05<p<0.10; LDLC/LDL apo B, LDL-cholestercl/LDL ape B; LDL density var., 
LDL density variable 
в 
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Density (g/ml ) 
1 2 3 4 5 6 
Flg. 2. A) LDL subfraction distribution of a subject showing a total of 
six LDL bands : 3 major bands in the density range 1.020-1.039 g/ml (1, 
2 and 3) and 3 minor bands in the density range 1.039-1.061 g/ml (4, 5 
and 6). B). LDL subfraction distribution determined by densitometric 
scanning of the tube shown in A, followed by computerized mathematical 
modelling. Explanation for the solid, interrupted and dotted lines is 
given in the legend of Fig. IB. C) Gradient gel electrophoresis of the 
fractions l t o 6 . 1, 2, 3, 4, 5 and 6 are characterized as LDL-1, LDL-2, 
LDL-3, LDL·^, LDL-5 and Lp(a), Lp(a), respectively. 
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TABLE 2. Estimates of coefficients of variables in multiple linear regression 
A. LDL density variable 
Intercept 
Gender (xlO"1)! 
Age (xlO-3) 
Rel. body weight (xlO-
Smoking (xlO-2) 
103.197+0.128 
-0.727+0.307Ï 
0.937+1.465 
-0.690+1.143 
0.289+0.162* 
Total HDL LDL 
cholesterol triglycerides cholesterol cholesterol ape В 
(mmol/l) <mnral/l) (mmol/l) (rnnol/l) (g/1) 
cholesterol/ 
apo В (лшюі/g) 
Intercept 32.3+ 47.0 
LDL density var. (xlO-2) -28.8+ 45.6 
Gender (X10-3]|| -209.9+159.9 
Age (xlO-4) 306.0+ 74.7S 
Rel. body weight (xlO"*) 148.8+ 58.3t 
Smoking (xlO-") 114.5+ 83.4 
-168.8+28.2§ 76.3+13.8S 15.6+ 39.7 
164.1+27.3S -72.6+13.4§ -14.1+ 38.5 
-314.6+95.8ί 
90.4+44.8T 
103.0+34.9Í 
37.2+49.9 
124.0+46.9І 
-2.8+21.9 
-25.8+17.1 
-34.8+24.4 
-75.7+135.2 
264.5+ 63.2S 
119.8+ 49.3t 
78.3+ 70.5 
-32.6+16.6* 121.2+ 44.7Î 
31.6+16.1* -112.3+ 43.3t 
20.9+56.6 -217.2+152.2 
83.3+26.5Í 8.1+ 71.1 
63.4+20.6t -144.7+ 55.5Г 
-4.5+29.5 194.8+ 79.3t 
A) Dependent variable is the LDL density variable; independent variables are gender, age, relative body weight 
and smoking habits. 
B) Dependent variables are lipids and (apo)lipoproteins. Independent variables are the LDL density variable, 
gender, sex, rel. (relative) body weight and smoking habits. 
Significance of influence of independent variables on the dependent variables are indicated: *, 0.05<p<0.10; 
f, 0.01<p<0.05; X, 0.001<p<0.01; S, p<0.001; ||, men are given number 1 and women number 2 
LDL-I (%) 
Fig. 3. Triangular presentation of the contribution of the three major 
LDL subfractions, LDL-1, LDL-2 and LDL-3, t o t o t a l LDL for the 131 
studied healthy subjects. Each square represents the LDL subfraction 
d i s t r i b u t i o n of one individual. The length of the sides of the squares 
i s d i r e c t l y proportional to the value of the LDL density variable that 
i s defined as : (% of LDL-1) χ 1.024 + (% of LDL-2) Χ 1.0305 + (% of 
LDL-3} χ 1.036. 
t h e s e v a r i a b l e s r e p l a c e e a c h o t h e r . T h u s , when t o t a l 
c h o l e s t e r o l and LDL apo В were i n d e p e n d e n t l y r e p l a c e d by LDL-
c h o l e s t e r o l t h i s r e s u l t e d i n a c o m p a r a b l e b u t somewhat l e s s 
p r e d i c t i v e t h r e e - v a r i a b l e m o d e l . 
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Table 3. Regression coefficients and the level of significance for the variables of the 
models with significant contribution in the prediction of the LDL density variable. 
Three-variable model Two-variable model 
Regression coefficient 
103.35 
-0.226 + 0.273 
0.623 + 1.292 
-1.760 + 0.985 
0.247 + 0.136 
-0.091 + 0.021 
.) 0.154 ± 0.023 
p-value 
0.41 
0.63 
0.08 
0.07 
0.00 
0.00 
Regi cession coefficient 
103.37 
0.045 + 0.279 
-0.339 * 1.256 
-2.021 + 0.983 
0.099 + 0.139 
0.104 + 0.024 
-0.182 + 0.049 
p-value 
0.87 
0.79 
0.04 
0.47 
0.00 
0.00 
Intercept 
) Gender (xlO" 
Age (xlO-3) 
Rei. body weight (xlO"3) 
Smoking (xlO-2) 
Total cholesterol (mmol/l) 
Total triglycerides (mmol/l
HDL-cholesterol (mmol/l) 
LDL apo В (mg/1 xlO"3) 0.168 + 0.057 0.00 
R2 for the three-variable and two-variable model are 0.40 and 0.37, respectively 
Number of subjects 
30 
20-
10 
ι г & & д> 
* <? «? 
u 
Τ г 
Λ« 'Ъ \» 
LDL density variable 
Fig. 4. Frequency distribution of the LDL density variable among 131 
studied healthy subjects. The values of the midpoints of the intervals 
of the LDL density variable are indicated. The median is located between 
102.938 and 103.081. 
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Table 4. Pearson correlations of the lipids and (apo)lipoproteins, predictive for the LDL 
density variable, with relevant other variables. 
Total HDL LDL 
cholesterol triglycerides cholesterol cholesterol apo В 
Total Triglycerides 0.47 
HDL-cholesterol 0.08 
LDL-cholesterol 0.92 
LDL apo В 0.75 
LDL-chol/LDL apo В -0.15 
-0.48 t 
0.36 t 
0.41 Г 
-0.20 * 
-0.09 
-0.16 
0.15 
0.81 t 
-0.17 -0.67 Г 
Significance levels of the Pearson correlations are indicated: *, 0.01<p<0.05; Î, p<0.00l 
DISCUSSION 
By means of single spin density gradient 
ultracentrifugation with prestaining of the serum, LDL 
appears heterogeneous and consists of various subfractions. 
Each subject has his own LDL subfraction pattern that is 
characterized by the distribution of LDL among three major 
LDL subfractions in the density range 1.020-1.039 g/ml. 
Similar results were obtained in our laboratory by means of 
gradient gel electrophoresis of total serum using 2-16% 
Polyacrylamide gels (D.W. Swinkels and P.N.M. Demacker, 
unpublished data) (5). 
The major LDL subfractions LDL-I (1.020-1.028 g/ml), LDL-2 
(1.027-1.034 g/ml) and LDL-3 (1.033-1.039 g/ml) detected in 
the present study are actually more buoyant and appear to be 
concentrated in a more narrow density range than the LDL 
subfraction groups I (1.025-1.035 g/ml), II (1.035-1.040 
g/ml). III (1.040-1.050 g/ml) and IV (1.050-1.060 g/ml), 
found by Krauss and Burke after equilibrium density gradient 
ultracentrifugation of LDL from normolipidemic subjects (5). 
However, the density boundaries of the most frequently 
occurring LDL subfraction reported here (LDL-2, d=l.027-1.034 
g/ml) and recently by Chapman et al. in a similar gradient at 
15 0C (LDL-7, d=l.0297-1.0327) appear comparable (19). 
In our study the bands with a density higher than 1.039 
g/ml (1.039-1.061 g/ml) contributed less than 5 % to the 
total LDL band and were therefore depicted as minor fractions 
and excluded from the analyses. These observations correspond 
with those of Krauss and Burke obtained by gradient gel 
electrophoresis of the d<1.063 g/ml lipoprotein fraction. 
These authors noted, that the small LDL particles (size 
region F, 23.2-24.3 run) are observed frequently but always as 
minor species in normal subjects (5). In a recent report by 
McNamara et al., however, 29 % of the studied normal subjects 
appeared to have LDL subfractions (LDL-4 to LDL·-?) with a 
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d>1.038 g/ml as their most intense LDL subfraction band 
after gradient gel electrophoresis of total plasma (12). 
These apparent discrepancies can only be elucidated by 
comparing the quantitative LDL subfraction distribution, 
measured by both density gradient ultracentrifugation and 
gradient gel electrophoresis for a great number of normal 
subjects in one and the same study. 
The fractions isolated from the density 1.039 g/ml on 
downwards usually reacted positively with antiserum against 
Lp(a). similar results were obtained for the fractions 5 and 
6 (d>1.050 g/ml) in a report by Krauss et al. (5), for LDL 
layer 4 (d 1.046-1.054 g/ml) in the study of Lee and Downs 
(20) and for the LDL fractions 11 to 15 (d>1.045 g/ml) in a 
recent work by Chapman et al. (19). 
The LDL subfractions were objectified by densitometric 
scanning of the prestained LDL bands. The curves, thus 
obtained, appeared similar to the densitometric gradient gel 
electrophoresis curves reported previously by Austin and 
Krauss (9) and could also be deconvoluted into three 
components. This conformity in the detection of LDL 
subfractions by size (by gradient gel electrophoresis) and 
density (by density gradient ultracentrifugation) supports 
the existence of LDL heterogeneity as a physiological 
phenomenon. 
The peak areas were integrated and expressed as the 
percentage of the total LDL band. The LDL subfraction data, 
thus obtained for the 131 subjects, were shown to be of 
great inter-individual variety with 3 peaks in the majority 
of subjects. Austin and Krauss, however, distinguished no 
more than two different LDL subfraction patterns A and B, in 
which the LDL peak represents the smaller (<25.5 nm) and the 
larger (>25.5 nm) LDL particles, respectively (9). Although 
this subdivision in two LDL subclass patterns may be 
appropriate for the study of the genetic control of LDL 
subfractions, it does not fully reflect the great inter-
individual variety in LDL subfraction distribution. 
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Although there is loss of information in the calculation of 
the LDL density variable, using this variable as a continuous 
scaling allows the contribution of all three major 
subfractions to total LDL to be taken into account. In 
contrast, the classification of LDL subfractions in seven LDL 
types, recently described by McNamara et al., was based on 
the subfraction with the greatest scan area after 
polyacrylamide-agarose gradient gel electrophoresis of whole 
plasma (12). In spite of this difference in classification of 
LDL subfraction types, both the present study and that of 
McNamara et al. found serum triglycerides and HDL-cholesterol 
as the best two-variable model in the prediction of the LDL 
subfraction type. However, the value of the R-square for this 
two-variable model in the prediction of LDL subfraction type 
was higher in their study than in the present study ^=0.69 
versus R2=0.36). Correlations between LDL subfraction type 
and lipid and (apo)lipoprotein concentrations found by 
McNamara et al. are shown in Table 1. Differences in 
correlations found in their study and that obtained in the 
present study are tested for significance and are most 
clearly observed for the women studied. In addition, 
McNamara et al. detected stronger correlations between LDL 
subfraction types and serum triglycerides and HDL-cholesterol 
(Table 1). These differences between both studies may be 
explained by differences in i) the method used for 
subfractionation of LDL (gradient gel electrophoresis versus 
density gradient ultracentrifugation), ii) the definition of 
LDL subfraction distribution (predominant LDL band versus LDL 
density variable) and iii) the population studied (i.e., mean 
age of the studied individuals of approximately 50 years 
versus approximately 35 years). 
In agreement with published data (21-24) we found a shift 
from small heavy LDL-3 to large light LDL-1, with decreasing 
serum triglycerides and increasing HDL-cholesterol levels 
(Tables 1, 2). This relationship of the LDL subfraction 
distribution with serum triglycerides and HDL-cholesterol may 
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be explained by the hypothesis of Deckelbaum et al. (23), 
that size and density of LDL are at least partly determined 
by exchange of triglycerides from VLDL for cholesteryl esters 
from LDL. Through this mechanism LDL becomes enriched in 
triglycerides at the expense of cholesteryl esters. The 
presence of an excess amount of triglycerides in the LDL 
particle then allows continued particle size reduction 
through lipase action, which may finally result in lipid poor 
and thus protein enriched LDL particles of relatively high 
density. The best model: total cholesterol, serum 
triglycerides and LDL apo B, however, predicts only 40 % of 
the variability in the LDL subfraction patterns. The 
remainder may be due to factors not measured i.e. the 
activity of lipoprotein lipase, hepatic lipase, exchange 
proteins, lecithin-cholesterol-acyltransferase (LCAT) 
activity and genetic variation in apoprotein В (25-30). 
Men are more likely to have a dense LDL subfraction 
pattern than women (Table 2A). In view of the enhanced serum 
triglycerides concentration and decreased HDL levels for men 
and the interrelations in the metabolism of the different 
lipoproteins, as described above, this is not surprising. 
We found an association of an enhanced LDL density 
variable with a decreased ratio LDL-cholesterol/LDL apo B, 
indicating that as the contribution of dense LDL (LDL-3) to 
total LDL increases, LDL becomes relatively more protein 
enriched. Also for the disorder hyperapobetalipoproteinemia, 
which is strongly associated with atherosclerosis such a 
protein enriched LDL particle has been described (11). This 
suggests that patients with hyperapobetalipoproteinemia may 
have an increased LDL density. 
Thus, variations in the LDL subfraction distribution are 
not independent of differences in other variables which are 
related to coronary artery disease such as total cholesterol, 
total triglycerides, HDL-cholesterol, LDL apo B, LDL-
cholesterol/LDL apo B, smoking habits and sex. 
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S А М Е Л М Л / А Т Т I ISf G 
In de bloedbaan wordt cholesterol voornamelijk vervoerd in 
zogenaamde lage dichtheidslipoproteïnen (LDL), die behalve 
ongeveer 50 % cholesterol, ook fosfolipiden, triglyceriden en 
eiwit (apoproteïne-B) bevatten. De concentratie van LDL-
cholesterol is positief gecorreleerd met het risico voor 
hart- en vaatziekten. Toch zijn er patiënten met vaatlijden 
met een normale LDL-cholesterolconcentratie in hun bloed. Nu 
blijkt uit de literatuur dat LDL niet homogeen zijn, maar 
bestaan uit subfracties die verschillen in samenstelling, 
dichtheid en deeltjesgrootte. Over de fysiologische betekenis 
van de LDL-subfracties is nog veel onbekend, hoewel er 
aanwijzingen zijn dat sommige vormen van LDL meer atherogeen 
zijn dan andere. De studies beschreven in dit proefschrift 
hadden als doel een beter inzicht te verkrijgen in het 
atherogene gedrag van LDL en tevens de mogelijkheden te 
verbeteren tot het onderkennen van een verhoogd individueel 
risico voor athérosclérose. 
In Hoofdstuk 1 wordt een overzicht gegeven van de 
structuur, de funktie en het metabolisme van lipoproteïnen in 
het algemeen en van LDL in het bijzonder. De in de literatuur 
beschreven detectie- en isolatiemethoden voor LDL-subfracties 
worden besproken. Ook de fysisch-chemische eigenschappen van 
de LDL-subfracties en hun onderlinge relatie worden 
toegelicht. Tevens worden de huidige inzichten in het 
erfelijkheidspatroon, de metabole oorsprong, de modulatie 
tijdens circulatie, het katabolisme en het atherogene gedrag 
van de LDL-subfracties besproken. LDL zijn het eindprodukt 
van een metabole cascade die loopt van de door de lever 
gevormde zeer lage dichtheidslipoproteïnen (VLDL), via 
intermediaire dichtheidslipoproteïnen (IDL) naar LDL. De 
belangrijkste functie van LDL is de voorziening aan de lever 
en de perifere cellen van cholesterol. Over de oorsprong van 
de LDL-subfracties is nog veel onduidelijk. Familiestudies 
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suggereren een erfelijke component in het bestaan van een 
voor een bepaald individu specifiek LDL-subfractie-patroon. 
De nieuwe recombinant DNA technieken maken het mogelijk deze 
erfelijkheid ook op DNA nivo te onderzoeken. Er is 
gesuggereerd dat LDL heterogeniteit het resultaat is van het 
katabolisme van eveneens heterogene VLDL en IDL populaties. 
Veranderingen in de samenstelling van de verschillende typen 
lipoproteïnen blijken afhankelijk van elkaar te verlopen. Zo 
worden de LDL door middel van overdracht van cholesterol naar 
de VLDL zwaarder, kleiner en relatief cholesterol-arm en 
eiwit-rijk. Er zijn aanwijzingen dat de kleine LDL-deeltjes 
met een hoge dichtheid het meest atherogeen zijn. 
In Hoofdstuk 2 wordt een methode beschreven voor de 
detectie en isolatie van de LDL-subfracties door middel van 
dichtheidsgradiënt-ultracentrifugatie. De LDL-subfracties 
werden duidelijk zichtbaar gemaakt door voorafgaand aan de 
ultracentrifugatie van 19,5 uur aan het serum de kleurstof 
Coomassie Brilliant Blue R toe te voegen. In 13 onderzochte 
serumpools konden 2 of 3 LDL-subfracties worden 
onderscheiden: zeer licht LDL-1A, licht LDL-1B (samen licht 
LDL-1) en zwaar LDL-2. De relatieve concentraties van vrij 
cholesterol, veresterd cholesterol en fosfolipiden namen af 
en die van eiwit nam toe van LDL-1A, via LDL-1B naar LDL-2. 
LDL-2 bleek het kleinste deeltje, gevolgd in afmeting door 
LDL-1B en LDL-1A. 
Het metabole gedrag van de LDL-subfracties wordt beschreven 
in de Hoofdstukken 3 en 4. Voor twéé LDL-subfracties, LDL-l 
(een mengsel van LDL-1A en LDL-1B) en LDL~2, werden in vitro 
in humane hepatoma cellen (Hep G2), in humane hepatocyten en 
in fibroblasten de associatie (waarmee binding plus opname 
gemeten wordt) en de degradatie (afbraak) van de 
eiwitcomponenten vergeleken (Hoofdstuk 3). Er werden geen 
verschillen waargenomen. Het is echter mogelijk dat de 
heterogene samenstelling van LDL-l in deze experimenten 
eventuele bestaande metabole verschillen van LDL-lA en LDL-lB 
met LDL-2 maskeert. In een later stadium van het onderzoek 
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zijn daarom in plaats van LDL-I, LDL-IA en LDL-1B samen met 
LDL-2 vergeleken voor wat betreft hun metabole gedrag in Hep 
G2 cellen, als model voor humane hepatocyten (Hoofdstuk 4). 
Nu bleek dat de associatie van LDL-1A significant groter was 
dan die van LDL-2. De associatie van LDL-1B lag tussen die 
van LDL-1A en LDL-2 in. Ook de stimulatie van de 
cholesterolestervorming was significant groter voor LDL-1A 
dan voor LDL-1B, en voor LDL-lB significant groter dan voor 
LDL-2, onafhankelijk van het cholesterolgehalte van de 
subfracties. In overeenstemming met deze resultaten gaven 
LDL-lA en LDL-1B een significant sterkere remming van de 
eigen cholesterolsynthese in de Hep G2 cellen dan LDL-2. 
Wanneer echter gecorrigeerd werd voor de verschillen in 
cholesterolgehalte van de LDL-subfracties bleek dit 
onderscheid niet meer significant. Ook in vivo werden 
metabole verschillen tussen de LDL-subfracties gevonden; in 
de cavia bleek na injectie van humane LDL-subfracties de 
eiwitcomponent van LDL-2 sneller uit de bloedbaan te 
verdwijnen dan die van LDL-1 (Hoofdstuk; 3), hetgeen in 
tegenspraak lijkt met de in vitro studies. Deze paradox is 
mogelijk te herleiden tot: 1) species verschillen, 2) 
omzetting van LDL-1 in LDL-2 in vivo en 3) verschillen tussen 
LDL-1 en LDL-2 in de "down-régulâtie" van de LDL-receptor in 
vivo. Gezien deze metabole verschillen lijkt het 
waarschijnlijk dat de LDL-subfracties ook verschillen in hun 
atherogeen gedrag. Aanvullende in vitro en in vivo 
experimenten zijn nodig om hierover definitieve uitspraken te 
doen. 
Voor het onderzoek naar het metabool gedrag van LDL-
subfracties in het bijzonder en naar LDL heterogeniteit in 
het algemeen, zijn we op zoek gegaan naar een geschikt 
diermodel. Zo werd de verdeling van LDL-subfracties 
onderzocht in het serum van 6 varkens en 6 gezonde mensen 
(Hoofdstuk 5). Bij het varken werden drie tot vier LDL-
subfracties gevonden en bij de mens drie. De verschillende 
LDL-subfracties in de dichtheids-gradiënt waren in het serum 
177 
van het varken beter te onderscheiden dan in dat van de mens. 
De geïsoleerde subfracties van beide species toonden een 
grote overeenkomst in fysisch-chemische eigenschappen. Een 
toename in de dichtheid van de LDL-subfracties ging gepaard 
met een toename in de relatieve eiwit-concentratie en een 
afname in de deeltjesgrootte. Wel bleek dat de LDL van het 
varken gemiddeld een hogere dichtheid hadden, kleiner waren 
en meer eiwit bevatten dan de LDL van de mens. De conclusie 
lijkt gerechtvaardigd dat het varken een geschikt model is 
voor verder onderzoek naar LDL heterogeniteit. 
In Hoofdstuk 6 wordt een onderzoek beschreven naar de LDL-
subfracties bij patiënten met hyperlipoproteïnemie. De LDL-
subfracties werden geïsoleerd uit de sera van 
normolipidemische individuen en van patiënten met primaire 
hyperlipoproteinemieen typen I tot V (twee van elk type) en 
hun fysisch-chemische eigenschappen werden vergeleken. Het 
bleek dat zowel de verdeling van de LDL-subfracties als hun 
fysisch-chemische eigenschappen vrijwel pathognomonisch waren 
voor de diverse vormen van hyperlipoproteïnemie. Bij 
hypercholesterolemie (type IIA) waren de 3 LDL-subfracties 
van gelijke dichtheid en grootte als de subfracties bij de 
normolipidemische individuen. Bij hypertriglyceridemie (typen 
I, IV en V) daarentegen waren de predominante LDL-subfracties 
kleiner en van een hogere dichtheid. Bij hyperlipidemie was 
de samenstelling van LDL, en ook die van LDL-subfracties, 
gerelateerd aan de concentratie van triglyceriden in het 
serum. De ratio lipide/eiwit, de deeltjesgrootte en het 
partiële specifieke volume van de LDL-subfracties namen af 
bij een toenemende dichtheid. De resultaten doen vermoeden 
dat de fysisch-chemische eigenschappen van de LDL-subfracties 
bij de diverse vormen van hyperlipoproteïnemie beïnvloed 
worden door de uitwisseling van lipiden tussen de 
lipoproteinen onderling. 
Uit de literatuur blijkt dat een normaal LDL-cholesterol-
gehalte in combinatie met een verhoogd LDL-eiwit (LDL-
apoproteine-B = LDL-apoB) een risicofactor is voor coronair 
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vaatlijden. We hebben daarom onderzocht in hoeverre 
eiwitrijk LDL (dus met een hoge dichtheid) als een 
onafhankelijke risicofactor kan worden beschouwd (Hoofdstuk 
7). In een studie onder 121 mannelijke patiënten met coronair 
vaatlijden, bewezen met angiografie, en 98 gezonde mannelijke 
controlepersonen werd gevonden dat deze patiënten gemiddeld 
inderdaad een verhoogd LDL-apoB hadden en dat bovendien de 
LDL-cholesterol/LDL-apoB ratio verlaagd was. Wanneer echter 
rekening wordt gehouden met de aanwezigheid van 
hyperlipoproteïnemie, apoproteïne-E fenotype, roken, relatief 
lichaamsgewicht en leeftijd vermindert het belang van een 
eiwitrijk LDL als risicofactor voor coronair vaatlijden en 
komt het hoge dichtheidslipoprotem (HDL)-cholesterol naar 
voren als de beste indicator voor coronair vaatlijden. 
In Hoofdstuk 8 wordt een onderzoek beschreven naar het 
voorkomen van LDL-subfracties bij 131 gezonde individuen in 
de leeftijd van 20 tot 62 jaar. Hierbij werd tevens de 
relatie met andere risicofactoren voor hart- en vaatziekten 
onderzocht. Elk bloedmonster bleek in het bezit van een 
specifiek LDL-subfractie-patroon. Dit patroon werd gekenmerkt 
door het in wisselende mate voorkomen van drie subfracties, 
LDL-1 met een dichtheid van 1.020-1.028 g/ml, LDL-2 met een 
dichtheid van 1.027-1.034 g/ml en LDL-3 met een dichtheid van 
1.033-1.039 g/ml (tevoren respectievelijk LDL-lA, LDL-1B en 
LDL-2 genoemd). De LDL-subfracties werden gekwantificeerd 
door densitometrisehe scanning van dia's van de LDL-banden, 
gevolgd door deconvolutie-analyse. Door berekening van de 
oppervlakten onder de densitogrammen werd de relatieve 
bijdrage van de subfracties aan totaal LDL bepaald. 
Gecorrigeerd voor leeftijd, roken, relatief lichaamsgewicht 
en geslacht word gevonden dat: 
i) LDL-subfractie-patronen die gekenmerkt worden door de 
aanwezigheid van een dominante LDL-3 band meer voorkomen bij 
mannen dan bij vrouwen; 
ii) de dichtheid van het LDL toeneemt met de concentratie 
van de serumtriglyceriden; 
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iii) het beste model met een significante bijdrage in de 
voorspelling van het LDL-subfractie-patroon het drie-
var i abelen-model totaal cholesterol, serumtriglyceriden en 
LDL-apoB is (voorspellende waarde op groepsnivo 40 % ) , 
terwijl het beste twee-variabelen-model bestaat uit 
serumtriglyceriden en HDL-cholesterol (voorspellende waarde 
op groepsnivo 37 % ) . De LDL-subfractie-patronen blijken dus 
niet onafhankelijk te zijn van het geslacht en de 
concentratie van de lipoproteïnen. De vraag rijst welke 
andere factoren betrokken zijn bij het ontstaan van LDL-
subfractie-patronen, Verder onderzoek naar met name het 
aandeel van de erfelijkheid hierin lijkt aangewezen. 
Uit het onderzoek beschreven in dit proefschrift kan worden 
geconcludeerd dat de intraindividuele verdeling van de LDL-
subfracties en andere risicofactoren elkaar wederzijds 
beïnvloeden (Hoofdstukken 6-8) en dat gezien de gevonden 
metabole verschillen tussen de samenstellende LDL-
subfracties, het LDL-subfractie-patroon een mogelijke 
onafhankelijke risicofactor is voor hart- en vaatziekten 
(Hoofdstukken 3 en 4). 
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STELLINGEN 
behorend bij Vincent Piket, 
Louis AUchinrloss: The Growth oí л Woveli-st, 
te verdedigen op 5 april, 19S9, om 13.30 unr 
1. Louis Auchincloss' voortdurende nadruk op het individu en 
individualiteit als de primaire bron van inspiratie voor 
zijn schrijverschap staat op een gespannen voet met het in 
zijn werk wederkerende thema van het illusoire karakter van 
mepselijke individualiteit. 
2. Louis Auchincloss' klacht dat sommige literaire critici 
een doctrinaire visie hebben op de noodzaak van literaire 
innovatie is terecht. 
Vgl. Louis Auchincloss, "Doctrinaire," New York Times, 
October 12, 1968, Sect. II, p. 8. 
3. Het gebruik, waarbij citaten uit romans worden gemarkeerd 
door middel van aanhalingstekens, terwijl deze onder­
scheidingsmethode achterwege wordt gelaten Ьіз het citeren 
van namen van karakters uit romans, is inconsequent en duidt 
op een hoge mate van personificatie van romankarakters door 
lezers. 
4. Gezien de geringe eensges-indheid oyer de definitie van 
"postmoderne literatuur," moet de wisselende kwaliteit van 
de werken van John Barth niet worden topgesehreven aan 
mankementen die inherent zijn aan het "postmodernisme," maar 
adm het tekortschieten van Barth's schrijversschap. 
5. Terwijl het literaire Modernisme sinds de Tweede 
Wereldoorlog tot de universitaire curricula is gaan behoren, 
is het de vraag of het ooit zal doordringen tot de 
leeslijsten van het voortgezet onderwijs, hoezeer dit ook 
gewenst is. 
6. De platvloerse vermelding van de hoorn en de truwpet in 
In het veertiende eeuwse dichtwerk Fiers Plowman (W.w, 
Skeat, ed.. Versie A, Passus V, r. 193-94) is opmerkelijk 
gezien de nobele status die deze instrumenten tijdens dp 
Middeleeuwen bezaten, en moet worden geïnterpreteerd ais een 
poging van de auteur om de verdorvenheid van zijn personage 
Glutton aan te duiden. 
Vgl. Curt Sacho, The History of Musical Instruments (New 
York, 1940), pp. 280-81, 328. 
7. De in de Wet Wetenschappelijk Onderwijs gekozen benaming 
"vakgroep" voor de universitaire organisatorische eenheid op 
subfacultair niveau benadrukt de interne bestuursstructuur 
van de universiteiten, en draagt niet bij tot de gewenste 
profilering van de universiteiten in de richting van de 
Nederlandse en internationale samenleving. 
8. Vanuit onderwiJspsychologisch perspectief, alsmede vanuit 
een respect voor de individuele integriteit van de 
betrokkenen, zou niet meer moeten worden gesproken van 
"omscholing," maar van "bijscholing." 
9. De woorden "grootschalig," "kleinschalig," "schaal-
vergroting," en "schaalverkleining" worden door het 
overgrote deel van de Nederlandse taalgemeenschap consistent 
op een oneigenlijke manier gebruikt, en vormen een positief 
bewijs voor de stelling dat een taal een verzameling van op 
zich willekeurige afspraken is. 
10. Het is te verwachten dat de Nederlandse universiteiten 
en hogescholen de via of door hen geboden mogelijkheden van 
studieverblijven in het buitenland zullen opnemen in hun 
wervingscampagnes voor aanstaande studenten. 
11. De naam van de slagerijketen "Je eigen slager" kan 
onbedoeld associaties oproepen van auto-kannibalisme. 
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STELLINGEN 
I 
Het verschi l in metabole verwerking tussen LDL-subfracties 
suggereert een v e r s c h i l in atherogeen e f fec t . 
Dit Proefschrift, Hoofdstukken 3 en 4. 
I I 
Hyperapobetalipoproteinemia i s geen onafhankelijke r i s i c o ­
factor voor h a r t - en vaatz iekten. 
Dit Proefschrift, Hoofdstuk 7. 
I I I 
Het card iovascu la i re r i s i c o toegeschreven aan een verhoogd 
serumtr ig lycer idengehal te kan veroorzaakt worden door een 
zwaar LDL-subfractie-patroon. 
Dit Proefschrift, Hoofdstukken 6-8. 
IV 
Hoewel de indel ing van de LDL-subfract ie-dis t r ibut ie in de 
patronen A en В geschikt l i j k t voor h e t onderzoek naar de 
genet ische component in het onstaan van LDL h e t e r o g e n i t e i t , 
doet z i j geen recht aan de grote verscheidenheid in LDL-
subf r a c t i e - p a t r o n e n . 
Austin MA, Krauss RM. Lancet 1986; i: 592. 
Dit Proefschrift, Hoofdstuk 8. 
V 
De in de l i t e r a t u u r beschreven " in vivo" s tudies met LDL-
s u b f r a c t i e s z i jn methodologisch dermate v e r s c h i l l e n d dat de 
r e s u l t a t e n n i e t met elkaar vergeleken kunnen worden. 
Teng В et al. J Clin Invest 1986; 77: 663. 
Vega GL, Grundy SM. Arteriosclerosis 1986; 6: 395. 
Dit Proefschrift, Hoofdstuk 3. 
VI 
De overeenkomst in LDL-subfractie patronen gevonden met 
gradiënt-ge1-elect rophorese en met d ich the idsgrad iën t -
u l t r a c e n t r i f u g a t i e i s een i nd i ca t i e voor liet bestaan van LDL 
he t e rogen i t e i t a l s fysiologisch fenomeen. 
Dormans TPJ, Swinkels DW. Niet gepubliceerde waarnemingen. 
VII 
Activering van het (proto onco)gen dat codeert voor p l a t e l e t -
derived growth factor i s mogelijk een oorzaak van de vorming 
van a the rosc le ro t i sche plaques. 
Sejersen Τ et al. Proc Natl Acad Sci USA 1986; 83: 6844. 
Penn A et al. Proc Natl Acad Sci USA 1986; 83: 7951. 
V i l i 
Gezien de gevonden inbouw van retrovirus in het DMA van 
patiënten met multipele sclerose kan men in de toekomst voor 
de therapie van deze ziekte wellicht gebruik maken van de 
ervaringen opgedaan met AIDS. 
Reddy EP et al. Science 1989; 243; 529. 
Waksman BH. Nature 1989; 337: 599. 
IX 
Serumspiegels van ß-endorphine lijken niet informatief voor 
het optreden van zogenaamde "highs" in de sport; 
eiwitmoleculen van dit type kunnen de bloed hersenbarrière 
niet passeren. 
Guillemin R. Nature 1989; 337: 26. 
X 
In een goede research setting zijn de ideeën van de 
promovendus niet minder belangrijk dan die van de promotor. 
XI 
Angst voor statistiek belemmert wetenschappelijke 
vooruitgang. 
XII 
De toegenomen mondigheid van de patiënt ontslaat de dokter 
niet van zijn verantwoordelijkheid tot het nemen van 
beslissingen voor de patiënt. 
Marzuk PM. The right kind of paternalism. 
N Eng J Med 1985; 313: 1474. 
XIII 
Als een jeugdteam slechts een uur in de week hockeytraining 
krijgt is elke minuut die er gewerkt wordt zonder stick en 
bal verloren tijd. 
XIV 
Positieve discriminatie maakt vrouwen juist afhankelijker. 
XV 
Wie veel vet eet, zal er wel van lusten. 
Nijmegen, 7 april 1989 Dorine Swinkels 
